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ABSTRACT 
 
 
The oleaginous yeast, Yarrowia lipolytica, is becoming a popular host for 
industrial biotechnology because of its ability to grow on non-conventional feedstocks 
and naturally accumulate significant amounts of lipids. With new genome editing 
technologies, engineering novel pathways to produce lipid-derived oleochemicals has 
become easier. The goal, however, is to expand the genetic toolbox to improve the 
efficiency of metabolic engineering such that production capacities could expand from 
proof-of-concept shake flasks to an industrial scale.  
Building efficient metabolic circuits require controlling strength and timing of 
several enzymes in a metabolic pathway. One method to do this is through transcription – 
using suitable promoters to control the expression of genes that code for enzymes. Native 
promoters have limited application because of complex regulation and non-tunable 
expression. Engineering hybrid promoters alleviate these issues to obtain predictable and 
tunable gene expression. In Y. lipolytica, how to design these promoters is not fully 
understood, resulting in only a handful of engineered promoters to date.  
In this work, we aim to develop tools for gene expression by investigating 
promoter architecture and designing tunable systems. In addition to Upstream Activating 
Sequences (UAS), tuning promoter strength can be achieved by varying sequence in the 
core promoter, TATA motif, and adjacent proximal sequences.  
UASs can modulate transcription strength and inducibility, enabling controlled 
timing of expression. A promoter of the acyl-CoA oxidase 2 (POX2) from the β-
oxidation pathway was truncated heuristically to identify oleic acid (OA) UAS 
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sequences. By fusing tandem repeats of the OA UAS elements, tunable yet inducible 
fatty acid hybrid promoters were engineered.  
The current approaches to identify novel UAS elements in Y. lipolytica are 
laborious. Therefore, we investigated DNA accessibility through nucleosome positioning 
to determine if a relationship between POX2 UASs and DNA accessibility can be 
inferred. The goal is to eventually apply this approach develop newer hybrid promoters 
efficiently. 
Finally, the hybrid fatty acid inducible promoter we developed was used to 
rationally engineering a Y. lipolytica strain capable of producing high amounts of free 
fatty acids. By localizing the fatty acyl / fatty aldehyde reductase in the peroxisome, we 
compartmentalized fatty alcohol production.  This strategy led to upwards of 500 mg/L of 
fatty alcohols produced. It is a promising route to eventually make short to medium chain 
fatty alcohols in Y. lipolytica by utilizing the native β-oxidation machinery. 
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CHAPTER ONE 
INTRODUCTION 
Today, most industrial chemicals used to produce materials, plastics, surfactants, 
and solvents are derived from the non-renewable petroleum feedstock which leaves 
environmental problems and threats for human beings. As a result, the paradigm of 
research has shifted towards exploiting methods for production of sustainable and green 
products. Bio-based technology can be a good alternative to address this problem. While 
petrochemical based chemical production dominates much of the commodity chemical 
market, biochemical production has already shown promise for chemical production at 
commercial scale [1-3] requiring lower capital investments, therefore, providing a 
competitive edge. Furthermore, several commodity-scale chemicals have also been 
produced using biomass at costs lower than petrochemical processes [4, 5]. 
Industrial biotechnology is a rapidly expanding industry built upon a biological 
foundry to solve global challenges, offering new potential to meet demands for 
chemicals, fuel, and food with significantly reduced impact on the environment. The 
problems to be tackled can be broadly categorized in two sets, not mutually exclusive of 
one another. To minimize fossil-fuel based dependence for chemical production, a core 
challenge is to be able to tap into a biological, yet efficient means to utilize naturally 
abundant feedstocks such as plant biomass and sunlight as a fuel to drive the biochemical 
process. The second challenge is optimizing biological platforms for the production of 
selective chemicals in a cost-effective, economically feasible manner. To date, both 
concepts have been explored using plants, algae, and microbes. 
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1.1. Plants for Sustainable Chemical Production 
Plants and algae are unique biological platforms because of their ability to harness 
energy from sunlight to drive photosynthesis making food in the form of carbohydrates to 
sustain physiological processes. Phototrophic systems, in theory, are a robust 
economically feasible process, however, there are limitations to harnessing solar energy. 
The theoretical efficiency is limited to the range of wavelengths applicable to 
photosynthesis and the quantum requirements of the photosynthetic process. The 
photosynthetically active radiation from solar energy is in the range of 400 and 700 nm, 
accounting for about 45% of the suns light energy. In combination with the quantum 
requirements for CO2 fixation in photosynthesis, the theoretical maximum efficiency is 
around 11% of solar energy [6]. Practically, the magnitude of photosynthetic efficiency is 
further decreased due to reflection of the sun’s wavelengths, respiration requirements for 
photosynthesis and the lack of optimal solar radiation. This drops efficiency to between 
3% and 6% of the total solar energy that is harnessed. For crops, it should be noted that if 
only agriculturally relevant products such as seeds, fruits, and tubulars are considered 
rather than total biomass, this amounts to lower photosynthetic efficiencies.  
 In addition to growing crops for primary metabolites such as carbohydrates, fats, 
oils, and proteins, plants also naturally produce a variety of secondary metabolites which 
are industrially relevant and important for human health. Flavonoids, terpenoids, 
carotenoids, and phenolics are some of the compounds that encompass the broad range of 
chemicals that are produced in plants [7]. In recent decades, advances in genetic tools 
have improved the ability to engineer transgenic crops for not only maximizing yields of 
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primary metabolites but increasing the landscape for production of valuable 
pharmaceuticals [8-10].  
While promising, metabolic engineering of plants has its drawbacks. If 
sustainable chemical production to replace current methods is the goal, then exploiting 
plants as a production platform requires consideration of the long growth times and small 
production capacity of secondary metabolites. Chemical production can be maximized by 
growing more genetically engineered crops but the limitation is arable landmass creating 
competition with crops grown for food. From the approximately 2.3 billion acres of land 
in the United States, around 349 million acres are utilized for growing crops [11]. 
Increasing growth capacity of select crops for biochemical production would only 
increase competition for arable land against crops grown for food or be in direct 
competition with land mass used for urbanization.  
Although plants may not be the best solution for biochemical production, there is 
a lot that can be learned about the biosynthetic pathways to produce a diversity of 
chemicals. These pathways can be applied to more feasible biological platforms such as 
microbes via heterologous expression of enzymes to engineer novel production pathways. 
Table 1.1 summarizes some of the more successful application of plant biosynthetic 
pathways in microbial systems for sustainable chemical production. Escherichia coli and 
Saccharomyces cerevisiae are the predominant conventional microbes for heterologous 
expression of plant pathways because of the wide array of genetic tools that facilitate 
engineering efforts. If transgenic crops were to become feasible for biochemical 
production in the future, there is still the backlash from the public perception about using 
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genetically modified organisms (GMOs), particularly applying to transgenic crops that 
need to be addressed and resolved [12, 13].  
 
1.2. Algae for Sustainable Chemical Production 
Algae are phototrophic organisms requiring solar energy and CO2, to grow and 
thrive in nutrient-depleted conditions. Unlike common crops such as wheat and barley, 
algae grow faster and occupy less space making it a better system for the development of 
sustainable, biorenewable production practices. The fact that some algae can gown in salt 
water conditions and tolerate wide pH conditions makes it more advantageous than 
agriculture practices that require large quantities of fresh water. Furthermore, algae can 
be grown more densely than plants reducing arable land use. 
One of the major applications of algae in industrial biotechnology is biofuel 
production [14]. However, algae have also been explored extensively to produce high 
value-added chemicals. The world market of products from macroalgae has been 
estimated to be close to USD 6 billion per year while the retail price of products from 
microalgae was estimated at USD 5 to 6.5 billion [15, 16]. Hydrocolloids such as agar, 
alginate, and carrageenans are produced at industrial scale using algae. These chemicals 
are used as gelation and thickening agents in different food, pharmaceutical and 
biotechnological applications with a current estimated global value of over USD 1.1 
billion [17]. Hydrocolloids are extracted from the cell wall of red seaweed algae at 
industrial scale since algae grow robustly and accumulate significant biomass.  
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Other valuable products that have been produced from algae at commercial scale 
include proteins, polyunsaturated fatty acids, the keto-carotenoid astaxanthin, and food 
dyes such as phycoerythrin and phycocyanin [18-21]. The ability to produce these 
chemicals economically is a result of their natural production capabilities and to a lesser 
effect, metabolic engineering efforts. The development of better genetic tools to facilitate 
efficient metabolic engineering could make algae a more promising host for sustainable 
chemical production. Currently, some of the tools available are transformation protocols, 
stable expression of transgenes [22],  targeted microRNA mediated gene knockdown and 
silencing [23] and more recently, efficient CRISPR-Cas9 mediated genome engineering 
[24]. A majority of these genetic tools have been developed in the green algae, 
Chlamydomonas reinhardtii; however, they are being rapidly translated and developed 
for diatoms and other algal species that are of industrial importance.  
One of the criticisms of engineering metabolic pathways in algae is the difficulty 
in scale-up that causes a loss in productivity. Although technically and economically 
more viable than crops, there is still a lot of work that needs to be done to make chemical 
production feasible and reduce the cost of downstream processes such as chemical 
extraction and separation. The future of microalgae scale-up requires optimization and 
design of advanced bioreactors and developing low-cost technologies for biomass 
harvesting, drying, and oil extraction. Furthermore, since algae show a strong dependence 
on a variety of environmental stress conditions, advancing the genetic toolbox to elicit 
more controlled expression under different stress signals is required to enhance metabolic 
engineering capabilities and make it a sustainable platform for chemical production. In 
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the meantime, like plants, there are important biosynthetic pathways from algae that can 
be translated into microbes to produce a plethora of industrially relevant chemicals. Table 
1.1 highlights some of these biosynthetic pathways engineered into microbes. 
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Table 1.1. Engineering biosynthetic pathways in conventional microbes for intricate 
biochemical synthesis using plant and algal enzymes. 
Host Enzymes for pathway biosynthesis Product 
E. coli 4-coumarate: CoA ligase: 
Lithospermum erythrorhizon (gromwell) 
stilbene synthase: 
Arachis hypogaea (peanut) 
Stilbene synthesis 
[25] 
E. coli 4-coumarate: CoA ligase: 
chalcone synthase: 
Glycyrrhiza echinata (licorice) 
chalcone isomerase: 
Pueraria lobata (kudzu) 
flavone synthase: 
Petroselinum crispum (parsley) 
Flavone synthesis 
[25] 
E.coli Geranylgeranyl pyrophosphate synthase: 
Taxadiene synthase: 
taxadiene 5a-hydroxylase: 
Taxus brevifolia (Pacific yew tree) 
Advancements in 
taxol synthesis  
[26] 
E. coli phytoene desaturase: 
ζ-carotene desaturase: 
Arabidopsis thaliana (Thale cress) 
Pro-lycopene 
production 
[27] 
S. cerevisiae Δ4-desaturase: 
Euglena gracilis (micro algae) 
Δ5-desaturase: 
Phaeodactylum tricornutum (diatom) 
Δ5-elongase: 
Thalassiosira pseudonana (marine diatom) 
Δ6-elongase: 
Ostreococcus tauri (marine algae) 
Docosahexaenoic acid 
(22:ω3) production 
from C18:3 
[28] 
E. coli 
 
 
 
 
 
S. cerevisiae 
norcoclaurine synthase: 
norcoclaurine 6-O-methyltransferase: 
coclaurine-N-methyltransferase: 
3-hydroxy-Nmethylcoclaurine-4-O-
methyltransferase: 
Coptis japonica (Japanese Goldthread) 
Cytochrome P450 (CYP80G2): 
Corytuberine N-methyltransferase: 
Coptis japonica (Japanese Goldthread) 
 
Reticuline production 
from dopamine 
 
 
 
benzylisoquinoline 
alkaloid biosynthesis 
from reticuline  
[29] 
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1.3. Exploiting Microbes for Biochemical Production 
Microorganisms have been used in industrial biotechnology for decades. Bacteria, 
yeast, and fungi are predominant platforms for this purpose. A few of the earliest 
discoveries of microbial potential to making chemicals date back to the production of 
yogurt and cheese using probiotic microbe genus Lactobacillus  [30],  and production of 
the antibiotic, penicillin from the ascomycetes fungal genus, Penicillium [31]. Microbes 
have since been engineered to make numerous industrially relevant chemicals. In 
microbial metabolic engineering, E. coli and S. cerevisiae are used extensively as cellular 
factories to produce a diversity of commodity and specialty chemicals that can be 
produced in a renewable, eco-friendly manner.  The potential to engineer metabolic 
pathways in these microbes is driven by the genetic toolbox that enables engineering, 
heterologous expression from well-characterized promoters with tunable strength and 
inducibility, and their natural propensity to grow and thrive [32-36].  
 
1.3.1. Metabolic Engineering of Conventional Microbes 
 Advancements in metabolic engineering are driven by the ability to efficiently 
engineer microbes by developing biosynthetic pathways using nature’s remarkable 
catalysts called enzymes. Having robust gene expression platforms and being able to 
fine-tune the expression of enzymes in a biosynthetic pathway is what contributes to 
improving the efficiency of metabolic pathways. While developing these novel pathways, 
a microbe’s native regulatory mechanisms needs to be considered. The native regulatory 
mechanisms enable cells to maintain homeostasis that can occur on either a transcription, 
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translation or metabolite level. While identification of these bottlenecks is crucial, having 
a library of genetic tools with various expression capabilities can alleviate issues at nodes 
to elegantly engineer foreign pathways with high efficiency. 
As a result, E. coli and S. cerevisiae have both been established as safe, 
conventional microbes to produce industrially relevant chemicals. Butanol, for example, 
is a chemical feedstock that has gained much attention as a next-generation biofuel 
replacement to ethanol due to higher energy content and lower volatility. Previous 
attempts to produce improve butanol using Clostridium have been unsuccessful due to 
difficulty in genetically manipulating clostridial strains [37]. However, in recent years, it 
was demonstrated that 1-butanol can be produced in E. coli at titers as high as 30 g/L and 
70% to 88% of its theoretical maximum via anaerobic fermentation [38]. Similar 
metabolic engineering feats have been accomplished with the production of 1,3-
propanediol in E. coli attaining titers of 135 g/L and productivity of 3.5 g/L/h in a 10 L 
fed-batch reactor [1].  
Saccharomyces cerevisiae has also been explored as a robust metabolic 
engineering platform to produce several chemicals relevant to industry [39, 40].  The 
development of an extensive genetic toolbox has enabled efficient production of natural 
compounds by transferring product-specific enzymes or entire metabolic pathways from 
other biological systems that either grow slow or are genetically intractable [41, 42]. 
Even though quantification metrics such as yields, titers and productivities may not 
always be up to par for industrial production, this microbe is best at demonstrating the 
ability to produce value-added specialty chemicals. Terpenoids, alkaloids, flavonoids and 
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non-ribosomal peptides synthesis are some examples where biosynthetic pathways have 
been successfully constructed in S. cerevisiae.  
Terpenoids are the largest class of naturally occurring molecules. The production 
of terpenoids has already been patented in the plant, Arabidopsis thaliana [43]. Although 
structurally diverse, terpenoids can be synthesized from two isoprene precursors, 
isopentenyl pyrophosphate (IPP) and dimethylallyl diphosphate (DMAPP). The 
modification of IPP and its derivates to produce more complex terpentine molecules has 
been demonstrated in S. cerevisiae. One such molecule is artemisinic acid, a precursor to 
the antimalarial drug, artemisinin [44]. Polyketides are yet another molecule where 
structural complexity precludes chemical synthesis as an economically feasible route for 
large-scale production. S. cerevisiae has proven to be a promising host for pathway 
engineering complex polyketides because it already has already been leveraged to 
produce large amounts of fungal polyketides such as 6-methylsalicylic acid [45].   
 
1.3.2 Genetic Regulation for Conventional Microbes 
The development of genetic tools to fine-tune strength and timing of expression is 
what enables much of the metabolic engineering accomplishments in a microbe. The 
expression of an enzyme in a cell is determined by two biological processes, transcription 
and translation. Transcription is the genetic level control of expression that deals with 
controlling how much mRNA is produced from a gene. The primary step of transcription 
occurs at the promoter where specific proteins bind to upstream of the gene of interest to 
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regulate the amount of the gene that is transcribed by RNA polymerase II. Therefore, at 
the base of enzyme expression is transcriptional regulation via promoters.  
Promoter regulation is the most commonly studied approach to regulating gene 
expression. In both, E. coli and S. cerevisiae, a large library of promoters have been 
identified, studied and engineered for new properties [46-49]. Since eukaryotic gene 
regulation is the basis of this dissertation, a perspective on S. cerevisiae promoters and 
promoter engineering will be summarized. Native promoters are extensively well 
characterized in the microbe from constitutive to inducible [50]. Table 1.2 summarizes 
some of the commonly used native promoters in S. cerevisiae. 
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Table 1.2. Commonly used promoters used in metabolic engineering of S. cerevisiae [50-
52]. * represents a subset of promoters from genes that are involved in global regulatory 
processes for cell survival. Other similar promoters can be found from genes involved in 
the expression of ribosomal proteins and chaperone proteins in S. cerevisiae. 
Constitutive Native Promoters 
Promoter Enzyme Function 
PPGK1 3-phosphoglycerate kinase 1,3-bisphosphoglycerate 
to 
glycerate 3-phosphate 
PTDH3 Glyceraldehyde- 3-phosphate 
dehydrogenase 
(GAPDH) 
Glyceraldehyde 3-phosphate 
to 
D-glycerate 1,3-bisphosphate 
 
PTPI1 Triosephosphate isomerase Dihydroxyacetone phosphate 
to 
D-glyceraldehyde 3-phosphate 
PENO2 Phospho-pyruvate hydratase 2-phosphoglycerate 
to 
phosphoenolpyruvate (PEP) 
PADH1 Alcohol dehydrogenase Alcohol 
to 
ketones 
*PTEF1 Translational elongation factor EF-1 
alpha (TEF1-α) 
Delivery of aminoacyl-tRNA to 
ribosome 
*PTEF2 Translational elongation factor EF-2 
alpha (TEF2-α) 
Delivery of aminoacyl-tRNA to 
ribosome 
Inducible Native Promoters 
PGAL1/GAL10 Galactokinase/UDP-glucose-4-
epimerase 
UDP Galactose 
to 
UDP-Glucose 
PCUP1 Copper thionein (Metallothionein) Chelates copper at high 
concentration 
PHXT7 High-affinity hexose transporter Active at low glucose 
concentration 
PADH2 Alcohol dehydrogenase 2 Repressed in glucose 
PPHO5 Repressible acid phosphatase Active under low inorganic 
phosphate 
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1.3.3. Promoter Engineering – A Page from the Conventional Yeast 
 Predictable expression from promoters is necessary for rational design and 
optimization of microbial cell factories; however, the use of native promoters in this 
context can be challenging because most promoters exhibit complex expression patterns. 
The complexity is a result of having spatially distributed regulatory motifs on a single 
promoter that recruit transcription factors to regulate transcription in response to changes 
to the environment (pH, temperature), nutrients (carbon, nitrogen) or cell physiology 
(early vs. late phase) etc. The PIS1 gene in S. cerevisiae is an essential gene for de novo 
synthesis of the phospholipid, phosphatidylinositol and has been reported to have 
differential responses to fermentable versus non-fermentable carbon sources [53]. In 
addition, the PIS1 promoter has regulatory regions for transcriptional factor ScROX1p, 
that represses promoters under hypoxic conditions [54]. Promoters form ScACC1, and 
genes involved in oxidative stress response have also shown similar complexities with 
multiple regulatory motifs on the promoter eliciting complex regulation to carbon 
conditions [55, 56].  
The complexity of native regulatory systems, therefore, motivates the need to 
develop better promoters with predictable and defined expression patterns that can be 
then used to engineer more optimized metabolic processes. Engineering promoters in S. 
cerevisiae serve as the basis for understanding how yeast promoters function.  Promoter 
engineering is an umbrella term used to describe many facets of developing new 
promoters.  
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One method is using error-prone PCR to create a library of random mutations on 
the native promoter and then screen for promoter function using a reporter gene (Figure 
1.1). This has been demonstrated with PTEF1 (Table 1.2). Two hundred promoter mutants 
were screened that varied in expression strength from very weak to promoters two-fold 
stronger than the native promoter [57]. This approach to promoter engineering is efficient 
when high transformation efficiencies are attainable enabling a larger, more diverse 
library of mutants.  
 The other approach to promoter engineering in S. cerevisiae is based off rational 
design. By fusing modular elements, the core promoter and Upstream Activating 
Sequences (UASs), a library of “hybrid” promoters can be engineered (Figure 1.1). 
Variable levels of promoter inducibility and strength are achieved by changing the type 
and number of UAS sequences. In S. cerevisiae the authors showed that strongest 
constitutive native promoter, PTDH3 (Table 1.2), was made almost three-fold stronger by 
fusing disparate constitutive UAS elements from other promoters upstream of the native 
PTDH3 [58]. Galactose-inducible hybrid promoters spanning a fifty-fold dynamic range in 
galactose was demonstrated by fusing tandem ScGal4p binding upstream of a core 
promoter [58]. Finally, the catabolite repression of PGAL1 was alleviated by placing 
constitutive UAS sequences upstream of the inducible promoter [58]. 
 Hybrid promoters are effective tools but the challenge lies in identifying UASs in 
native promoters. Determining UASs in yeast has traditionally relied on truncations of 
promoters fused to a reporter gene (Table 1.2). The loss of transcription activity is then 
correlated to a potential UAS element in the native promoter [59-61]. However, with 
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today’s high throughput technologies such as Chip-Seq and large transcription factor 
database for S. cerevisiae, the process of identifying transcription factor binding sites 
(TFBs) surpasses single promoter analysis to scanning all variations of the binding motifs 
in the genome [62].  
 One of the more interesting developments of S. cerevisiae hybrid promoter 
engineering is next-level regulation such as chimeric systems, fusing yeast UASs with 
bacterial operons to engineer dynamic regulation (Figure 1.1). Tet repression in a 
galactose-inducible promoter has been tested to investigate how number and positioning 
of tet repressor sites in the core promoter of a galactose-inducible promoter can affect 
gene expression [63]. Similarly, an E. coli FadR operator placed in the core promoter 
region of a yeast promoter fused to different UASs (inducible and constitutive) shows 
how dynamic promoter regulation can be used to only turn on metabolic pathways once 
there is sufficient buildup of the fatty acid precursor, relieving FadR repression to turn on 
the yeast promoter [64]. Studying these types of hybrid promoter systems in S. cerevisiae 
provides novel insight to building efficient metabolic circuits in eukaryotes and would 
better inform strategies for genetic tool development in newer, non-conventional 
microbes.  
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Figure 1.1. Schematic of three promoter engineering strategies used in S. cerevisiae. The 
heuristic approach is a more fundamental strategy for identifying promoter regions called 
Upstream Activating Sequences (UASs). Results from the first two methods can then be 
applied to experiments aimed at (1) determining specific transcription factors and binding 
motifs (2) developing tunable and dynamic hybrid promoters for metabolic engineering. 
 
 
1.4. Non-Conventional Microbes in Biotechnology 
In the past two decades, microbial engineering has mostly relied on conventional 
microbes for synthetic biology because of its genetic tractability and ease of genome 
editing. The development of bioinformatic tools during the same time enabled engineers 
to screen for suitable enzyme candidates to create pathways for target products. But, as 
biomolecular engineers, our goal is to develop a sustainable chemical engineering process 
within a biological context. In doing so, we are interested in two general parameters, 
successful transition of an engineered strain from the benchtop to a bioreactor and 
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meeting key performance indicators, yield (mass of product / mass of substrate), titer 
(mass of product / reaction volume), and productivity (mass of product / reaction volume 
/ time). Reaching such metrics for commercial feasibility can be challenging because 
synthetic circuits via heterologous pathways are not as reliable and robust as native 
pathways due to the microbe’s innate regulation. This could lead to additional issues such 
as co-factor imbalances and allosteric inhibition that would need to be teased out using 
high throughput proteomics and metabolomics [65, 66].  
 Exploiting newer non-conventional microbes with capabilities to innately produce 
desired products has become increasingly popular in industrial biotechnology. This 
transition is greatly facilitated by tremendous advancements in synthetic biology over the 
past few years. Now, large-scale genome sequencing has become relatively inexpensive 
and coupled with the library of bioinformatic tools, developing genome-scale metabolic 
models for novel microbes has become more feasible and reliable. This has resulted in 
the exploration of non-model microbes to produce a wide variety of industrially relevant 
chemicals (Table 1.3). With little engineering efforts, sustainable production capacities 
can be achieved. Non-conventional microbes are also able to grow on less-traditional 
feedstocks to produce value-added products. This ability is very beneficial for not only 
developing economically feasible biochemical processes but also contributing to a 
cleaner environment by feeding on substrates found in waste streams. Amongst non-
conventional yeasts, Yarrowia lipolytica leads the efforts to demonstrate the importance 
of exploring novel microbes for industrial biotechnology.  
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Table 1.3. Highlight of non-conventional microbes used for production of a wide range of 
industrially relevant products utilizing mainly non-traditional feedstocks 
Microbe Feed Product Titer (g/L) Ref. 
Aspergillus niger Corn stover Citric acid 100 [67] 
Rhodosporidium 
toruloides 
Sucrose Fatty alcohols 8  [68] 
Kluyverimyces marxianus Wheat Straw Ethanol 36 [69] 
Trichosporon oleaginosus Resorcinol Lipids 1.64 [70] 
Yarrowia lipolytica Glycerol Erythritol 220 [71] 
Yarrowia lipolytica Xylose Citric acid 80 [72] 
Yarrowia lipolytica Glycerol Citric acid 32 [73] 
Xanthomonas campestris Cassava 
starch 
Xanthun gum 17 [74] 
 
1.5. Yarrowia lipolytica: An Industrial Front Runner for Non-Conventional Microbes 
The non-conventional oleaginous yeast, Y. lipolytica, has been used in industry 
for the past 60 years. Its broad applications include single cell protein production, citric 
acid production, and cell biomass as animal feed [75, 76]. Advances in synthetic biology 
and metabolic engineering have increased the overall utility of microorganisms by 
enabling custom built genetic engineering tools allowing for the manipulation of 
metabolism to produce valuable chemicals. The oleaginous property of Y. lipolytica 
allows this yeast to naturally accumulate lipids greater than 20% of dry cell weight [75]. 
This trait along with continued improvements in genetic engineering tools has led to 
increased interest in engineering this host to produce lipid-based products.  
Over the years, significant effort has been made to understand the genetics of Y. 
lipolytica and to develop novel expression systems. Transformation protocols, basic 
expression cassettes, and gene deletion tools have been established for several years [77, 
78]. More recently, episomal vectors, high expression synthetic promoters, and CRISPR-
 19 
Cas9 genome editing have been developed for use in Y. lipolytica [79-83]. This has 
resulted in accelerated metabolic engineering efforts in Y. lipolytica. In addition to high 
engineered lipid production capacities to reach titers close to 100 g/L [84], Y. lipolytica 
has been engineered to produce specific high-value products such as omega-3 fatty acids 
[85], dicarboxylic acids [86], polyhydroxyalkanoates (PHA) [87], itaconic acid [88], free 
fatty acids [89, 90], alkanes [90], esters [91], and alcohols [90, 92, 93]. 
 Efforts have also been made to engineer Y. lipolytica for utilization of alternative 
sugars such as xylose, galactose, and starch [72, 94-100]. Alternative sugar substrates 
have become increasingly abundant due to advances in lignocellulose degradation [91]. 
The native xylose pathway of Y. lipolytica has been recently elucidated, which led to 
several studies achieving robust xylose utilization [72, 94, 95, 97].  
 
1.5.1. Genetic Tool Development in Y. lipolytica 
Efficient transformation protocols in tandem with access to a fully annotated and 
sequenced genomes of Y. lipolytica strains have greatly facilitated the development of 
genetic engineering tools over the past three decades [79, 101, 102]. These genetic 
engineering tools include but are not limited to the creation of hybrid, carbon responsive, 
and inducible promoter systems alongside quick and efficient genome editing techniques. 
 
1.5.1.1. Transformation Methods for Y. lipolytica 
Original transformation methods developed for Y. lipolytica utilized a PEG-
protoplast transformation [103]. Advances to this protocol soon followed with a lithium 
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acetate (LiAc) protocol adapted from Saccharomyces cerevisiae to obtain site-directed 
integrative transformation efficiencies of up to 1x104 transformants/ug of linearized DNA 
[104]. Modifications to the LiAc transformation and development of an electroporation 
protocol superseded the above technique, allowing for highly efficient replicative 
transformation [105]. To date, the LiAc protocol is the more commonly practiced method 
for transformation of plasmids and electroporation is more efficient for transforming 
linearized integrative vectors [77, 106]. Recently, improvements to the overall 
transformation efficiency of linearized integrative DNA has been accomplished by using 
a combinatorial approach of LiAc and electroporation, with yields reaching 2 x 104 
transformants / μg of linearized DNA [107].   
Although considerable work has been done to build transformation strategies in 
this oleaginous yeast, efficiencies remain about 2 orders of magnitude lower than the 
conventional yeast, S. cerevisiae. Despite this, it has been demonstrated that given the 
current efficiencies, Y. lipolytica could still be used as a suitable host for molecular 
evolution of proteins using both rational and directed evolution strategies [108, 109]. 
 
1.5.1.2. Native Promoters and Terminators for Regulating Gene Expression 
Studies of metabolic pathways in Y. lipolytica have revealed several highly 
expressed native genes that are induced and/or repressed by different carbon sources and 
physiological conditions [110]. The best characterized native promoters are from the 
genes of Glycerol-3-phosphate dehydrogenase (G3P), isocitrate lyase (ICL1), 3-oxo-acyl-
CoA thiolase (POT1), aceto-acetyl-CoA thiolase (PAT1), the acyl-CoA oxidases (POX1-
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POX6), extracellular lipase 2 (LIP2), and alkaline extracellular protease (XPR2). A list of 
the native promoters commonly used and their responsiveness to different carbon 
conditions are summarized in Table 1.4.  
In the scope of gene regulation, terminators are another important regulatory point 
since the sequences dictate completion of transcription and determine the half-life of 
synthesized mRNA. The terminator from the gene encoding cytochrome c oxidase from 
S. cerevisiae (ScCYC1t) is a commonly used terminator sequence in Y. lipolytica 
alongside native Y. lipolytica terminators [80-83, 95, 111, 112]. The use of short synthetic 
terminators to improve gene expression has also been explored in Y. lipolytica recently 
[112]. The synthetic terminator designs were first constructed in S. cerevisiae and 
translated into Y. lipolytica to attain a 2-fold improvement relative to the native TEF 
terminator of Y. lipolytica.  Terminators and promoters can interact to form loops that 
regulate gene expression [113] however, this phenomenon has not been explored in Y. 
lipolytica.  
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Table 1.4. Commonly used native promoters for constitutive and native inducible 
expression in Y. lipolytica [110, 114-118] 
Substrate(s) Induced Promoter Systems Repressed Promoter Systems 
Glycerol 
Glycerol-3-phosphate 
dehydrogenase (PG3P) 
Translation Elongation Factor-
1α (PTEF1) 
Acyl-CoA-oxidase 2 (PPOX2) 
3-oxo-acyl-CoA thiolase 
(PPOT1) 
Glucose 
Glycerol-3-phosphate 
dehydrogenase (PG3P)  
Acyl-CoA-oxidase 2 (PPOX2) 
3-oxo-acyl-CoA thiolase 
(PPOT1) 
Oleic acid 
Ricinoleic acid 
methyl ester 
n-Decane 
Acyl-CoA-oxidase 2 (PPOX2) 
Isocitrate lyase 1 (PICL1) 
3-oxo-acyl-CoA thiolase 
(PPOT1) 
Translation Elongation Factor-
1α (PTEF1) 
Glycerol-3-phosphate 
dehydrogenase (PG3P) 
Ethanol 
Acetone 
Cytochrome P450  
(PICL1) 
Acyl-CoA-oxidase 2 (PPOX2) 
Isocitrate lyase 1 (PICL1) 
Glycerol-3-phosphate 
dehydrogenase (PG3P) 
 
1.5.1.3. Hybrid Promoters for Regulating Gene Expression 
Native promoters in Y. lipolytica have been used to control metabolic pathways, 
however, the regulation associated with these promoters can be complex and exhibit 
unpredictable behavior. Furthermore, the need to construct both strong and varied 
promoter strengths for metabolic and pathway engineering is the desired outcome that 
cannot be met exclusively by native promoters. Over the past decade, there have been 
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several lines of work aimed at developing and characterizing the next generation hybrid 
promoters that confer very high and tunable expression [119-121]; however, hybrid 
promoters that have programmed regulatory behavior have not been reported. 
Hybrid promoters are created in Y. lipolytica by deconstructing the native 
promoters to identify upstream activating sequences (UAS) that confer transcriptional 
activation and creating repeats of these sequences in tandem to accomplish high levels of 
transcription. One commonly used UAS in Y. lipolytica is the UAS1B that was first 
isolated from the complexly regulated XPR2 promoter [122]. Functional dissection of the 
XPR2 promoter was used to identify the UAS1B sequence that was devoid of regulation 
by pH, nitrogen and peptone levels [123]. Placing 4 UAS1B elements tandemly in front 
of a minimal LEU2 core promoter containing a TATA box demonstrated the first efforts 
at creating a constitutive, synthetic hybrid hp4d promoter that conferred stronger 
transcriptional activation to the native PXPR2 [123, 124]. Since then, UAS1B elements 
have been used in tandem to create promoter libraries that exhibited more than a 400-fold 
increase in transcriptional levels relative to core promoters, effectively bypassing 
enhancer limitations associated with natural eukaryotic promoter systems [82]. We 
recently described that the UAS1B elements, while constitutive with respect to nitrogen, 
elicit carbon source-dependent regulation of expression with oleic acid being able to 
create the strongest transcriptional activation. Expression from the UAS1B hybrid 
promoters with glucose in the media is strong, albeit weaker than oleic acid. Using 
glycerol as a carbon source confers very weak transcriptional activation [80].   
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An interesting feature of the UAS1B hybrid promoters is that they are growth 
phase-dependent promoters. These promoters confer limited in gene expression during 
cell growth, or exponential phase, but increase significantly during late exponential / 
early stationary phase [80, 124]. This characteristic can be beneficial for heterologous 
protein production when segregating cell growth and protein expression. This segregation 
can contribute to cell productivity and alleviate toxic effects associated with heterologous 
protein expression. The UAS1B hybrid promoter would be less than optimal for 
metabolic engineering efforts to rewire pathways for substrate utilization, as the desired 
outcome, in this context, would be early phase enzyme expression while nitrogen is not 
depleted in the media. For this purpose, strong constitutive promoters from genes TEF1-α 
and RPS7 in Y. lipolytica is better suited [125]. 
Another widely used constitutive activator sequence used to create hybrid 
promoters is UAS(TEF), which was systematically dissected from truncations of the 
native TEF promoter [121]. These elements also demonstrated that tandem usage leads to 
a 4-fold increase in expression relative to the TEF (404) promoter. Other interesting 
features of the UAS (TEF) elements were the earlier growth phase transcriptional 
activation and a more consistent expression level independent of the carbon substrate 
(sucrose, glucose, glycerol and oleic acid) used compared to the UAS1B elements [121]. 
The discovery of UAS elements, which have become important modular tools for 
significantly improved gene expression in Y. lipolytica, have aided metabolic engineering 
and heterologous protein production efforts. However, there is little known to date about 
the regulatory sequences embedded within these sequences. A conceptual understanding 
 25 
of the enhancers and/or repressors within these elements could enable the development of 
smaller and more tightly regulatable/inducible hybrid promoters. The only example of a 
hybrid promoter designed from tandem enhancer sequences in Y. lipolytica is the use of 
Alkane Responsive Element 1 (ARE1) [126]. An n-decane inducible hybrid promoter 
could be designed by using tandem ARE1 sequences upstream of a minimal core 
promoter.  
The work described this dissertation uses a heuristic approach to develop a fatty 
acid inducible promoter from fatty acid inducible native YlPOX2 (YALI0F10857g) 
promoter. We revealed more than one UAS region in the POX2 promoter and used 
tandem repeats of the different UASPOX elements to create a tunable hybrid promoter 
devoid of carbon catabolite repression [116].  More recently, an erythritol/erythrulose 
hybrid promoter was developed from identified UAS elements in the erythrulose kinase 
(YlEYK1) gene (YALI0F1606g) of Y. lipolytica [127]. The approach to identifying UASs 
in the native promoter was different to what was shown with the POX2 promoter. Here, 
the nucleotide sequence of the EYK1 promoter from different Yarrowia clades was 
aligned to discover two conserved motifs. Mutational studies of the conserved motifs 
revealed that these sites were responsive to erythritol and erythrulose [127]. Tunable 
expression was demonstrated using tandem repeats of the UASEYK1.  
Kozak sequences present proximal to the ATG initiator codon could serve as 
another modular genetic component to control expression. These small sequences play a 
major role in the initiation of translation in eukaryotic systems [128, 129]. A commonly 
used Kozak sequence in Y. lipolytica that confers strong ribosome recognition affinity is 
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CCACC [130, 131]. Other modified Kozak sequences used for enhanced translational 
include AC(A/C)AAA [132, 133] and a CACA sequence [134]. In most examples of 
potential Kozak sequences used in Y. lipolytica, it is desired to have an A in the +3 
position. A separate study showed that there was a strong bias towards having A/G at the 
-3 position and an A/C in the -2 position amongst 47 eukaryotic species [135]. However, 
more experimental data is required to determine whether this downstream consensus 
sequence improves the efficiency of translational initiation in Y. lipolytica. 
 
1.5.1.4. Genome Editing Capacity for Yarrowia lipolytica 
Double-stranded break (DSB) repair in yeast can occur via homologous 
recombination (HR), single strand annealing (SSA), and non-homologous end-joining 
(NHEJ) mechanisms such as micro-homology mediated end joining (MMEJ) and 
illegitimate recombination (IR) [136-138]. A comparative genetic analysis with DNA 
repair proteins in S. cerevisiae revealed that hemiascomycetous species such as Y. 
lipolytica would predominantly utilize the NHEJ pathway for DSB repair [139]. Previous 
studies aimed at using HR for genome editing and repair required up to 1 kb of 
homologous flanking fragments for site-directed gene insertion [140]. Long homologous 
flanking regions are required to yield ~ 50% for site-specific insertion frequency in Y. 
lipolytica. Otherwise, exogenous DNA would integrate randomly into the genome to 
repair DSB. This suggests that NHEJ is dominant over HR, although the two repair 
mechanisms are known to work independently in yeast [141].  
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To improve the frequency of HR in Y. lipolytica, the core component of the NHEJ 
pathway, the ku70 / ku80 heterodimer, was knocked out [142, 143]. In both papers cited 
above, the ∆KU70 strain alone led to decreased transformation efficiencies but improved 
HR frequencies with 1 kb flanking homologies on both ends. Meanwhile, reducing the 
length of the flanking homology from 1000 bp to 50 bp did not have a dramatic effect HR 
frequencies, reducing it from 56% to 43%, respectively [142]. The use of short homology 
lengths (~50-40 bp) for homologous recombination has been demonstrated by using 
hydroxyurea to arrest and thereby enrich the cells in S-phase cells. This led to gene 
targeting frequencies between 4-9% in comparison to the untreated cells, where no 
targeted integration was observed [144]. 
Further improvements to HR efficiency for genome integration could be 
accomplished by using the CRISPR-Cas9 mediated system from Streptococcus pyogenes 
in Y. lipolytica [83]. Using CRISP-Cas9 directed HR, targeted gene integration occurred 
higher than 64% in the wildtype while in the ∆KU70 strain, the frequency was 100%. 
Meanwhile, studies have shown low dependency of HR frequency to genomic loci [105, 
143, 145].  
The examples above describe improvements on strategies to perform scarless 
single copy integrations in Y. lipolytica. The use of an auxotrophic marker for selection of 
genome integration makes screening easy; however, the number of marker genes are 
limited in Y. lipolytica. In some instances, conserving the selectable marker is of interest 
for future applications and therefore one must rescue the marker post-integration. For this 
purpose, the Cre-Lox system has been explored in this yeast species [140]. The selectable 
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marker in the disruption cassette is flanked by the LoxP/ LoxR sites which are 34 bp 
sequences containing 13 bp identical, inverted repeats separated by an 8 bp spacer [146]. 
Activation of the heterologous bacteriophage Cre-recombinase allows for the excision of 
the selectable marker after screening for site-directed integration, enabling for the marker 
to be used again. This editing mechanism, however, leaves a genomic scar but the 
CRISPR-Cas9 genome editing mechanism is a scar-free. An alternative means of marker 
recovery is to replace the selectable marker with an inactive gene by HR [85]. Using this 
method, single copy and multicopy integrations are possible. For multicopy integrations, 
the rDNA or zeta sites, which are repetitive DNA regions dispersed across the genome of 
Y. lipolytica can be targeted using flanking DNA regions homologous to these site to 
achieve as high as 30 copies of the gene per cell. [147, 148] Figure 1.2 summarizes the 
different modules of genetic engineering that have been investigated in Y. lipolytica. 
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Figure 1.2. General modules applied towards the development of genetic tools and 
genome editing. A. At the promoter level, genetic tools can be engineered by constructing 
strong hybrid responsive or inducible systems. Kozak sequence modifications enable 
improved post-transcriptional expression. Furthermore, engineering synthetic promoters 
could help to improve mRNA stability and half-life, thereby improving expression levels. 
B. CRISPR Cas9 for knockouts and homologous recombination of DNA at high 
efficiencies. Homology mediated recombination requiring the use of large flanking DNA 
homologies are most efficient in ∆ku70 strain. C. Multi-copy integration performed using 
zeta docking sites, rDNA sites or restoring URA3 function by multi-copy integration 
DNA fragments containing URA3 alleles with the gene of interest [118]. 
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1.6. Metabolic Engineering in Yarrowia lipolytica 
  Lipid accumulation and degradation are two processes that are innately superior 
in Y. lipolytica. Further engineering of these two natural processes has been promising to 
produce biofuels and fatty acid derived bioproducts. This host has already been 
engineered to produce a number of key products via engineering its native oleaginous and 
lipolytic capabilities (Table 1.5) and therefore understanding the engineering scope of 
lipid accumulation and degradation is important to understanding how novel products can 
be produced using these pathways. 
 
Table 1.5. Production of lipids and lipid-derived biochemicals in Y. lipolytica. 
 
 
1.6.1. Engineering Advanced Oleaginous Capabilities 
Lipid accumulation can be induced by nitrogen limited conditions or by high 
carbon to nitrogen (C/N) ratios. It is proposed that nitrogen exhaustion leads to increased 
activity of AMP deaminase (YlAMPD), which decreases the concentration of cytosolic 
AMP. The activity of AMP-dependent isocitrate dehydrogenase (IDH) is therefore 
inhibited, resulting in the accumulation of isocitrate. Citrate generated from accumulated 
Products Maximum Titer (g/L) Reference 
TAG Lipids 99 g/L [84] 
Free Fatty Acids (FFA) 10.4 g/L [149] 
Alcohols 2.15 g/L [91] 
Alkanes 23.3 mg/L [91] 
Fatty Acid Ethyl Esters (FAEE) 142.5 mg/L [91] 
Polyhydroxy Alkanoates (PHAs)  1.11 g/L [150] 
Itaconic Acid 4.6 g/L [88] 
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isocitrate by aconitase then exits the mitochondria and is cleaved by cytosolic ATP-
citrate lyase (YlACL1) for the generation of acetyl-CoA [151, 152]. From the metabolic 
overview in Figure 1.3., the first committed step of fatty acid synthesis is the 
carboxylation of acetyl-CoA to malonyl-CoA by acetyl-CoA carboxylase (YlACC1). 
NADPH generated by malic enzyme (ME) provides the reducing power for fatty acid 
synthesis. However, recent research has demonstrated that for Y. lipolytica, the pentose 
phosphate pathway is the major source for NADPH generation [153, 154]. When acetate 
is used as a substrate, NADPH for fatty acid synthesis is produced through 
gluconeogenesis and the oxidative pentose phosphate pathway [155]. A recent study 
showed no significant change in the YlIDH expression during lipid accumulation. 
However, the gene encoding isocitrate lyase (ICL), which is involved in converting 
isocitrate to glyoxylate, was observed to be strongly up-regulated in Y. lipolytica [156].  
 32 
Figure 1.3. Lipid biosynthesis in Y. lipolytica. Triacylglyceride (TAG) biosynthesis in Y. 
lipolytica. GPD1: glycerol-3-phosphate dehydrogenase, GUT2: glycerol-3-phosphate 
dehydrogenase, ACL: ATP-citrate lyase, ACC1: acetyl-CoA carboxylase, ME: malic 
enzyme, DGA1&2: diacylglycerol acyltransferase, TGL3&4: triacylglyceride lyase, 
PEX10: peroxisomal biogenesis factor, POX1-6: Peroxisomal Acyl-CoA Oxidase, MFE: 
β-oxidation multi-function enzyme 
 
TAG synthesis in Y. lipolytica involves three acyltransferases. The first step is the 
incorporation of fatty acyl-CoA into glycerol-3-phosphate (G3P) by glycerol-3-phosphate 
acyltransferase (YlGPAT), forming lysophosphatidic acid (LPA). LPA and fatty acyl-
CoA can be converted to phosphatidic acid (PA) by lysophosphatidic acid acyltransferase 
(YlLPAT). The phosphate group is then removed from PA to form diacylglycerol (DAG) 
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by phosphatidic acid phosphatase (YlPAP). The last step of TAG synthesis is conducted 
by one of two types of diacylglycerol acyltransferases that incorporate an acyl group into 
a DAG. Diacylglycerol acyltransferase (YlDGA1) transfers an acyl group from acyl-CoA 
to a DAG, while diacyltransferase (YlPDAT) transfers an acyl group from a phospholipid 
to a DAG. 
Early attempts to improve lipid accumulation focused on redirecting the carbon 
flux towards the glycerol pathway by deleting GUT2, preventing the reaction of glycerol-
3-P to DHAP, and thereby generating more precursor glycerol-3-P for TAG synthesis. In 
this study, lipid degradation through β-oxidation was also hindered by deletion of POX1-
6 which encode six acyl-coenzyme A oxidases [157]. In Y. lipolytica, DGA1 which 
encodes the DGA1 enzyme, and DGA2, encoding the DGAT2 enzyme are the only genes 
contributing to the acylation of DAG. The latter gene is suggested to be the major 
contributor to TAG synthesis. However, DGA1 showed great potential in acyltransferase 
activity when expressed in the quadruple mutant strain under a strong constitutive 
promoter [158]. A push-and-pull strategy was developed by overexpression of both ACC 
and DGA1 to enable high levels of lipid accumulation. Double expression of ACC and 
DGA1 under the control of a strong TEF-intron promoter carries out the first and last step 
of TAG synthesis, providing an enhanced driving force to redirect the carbon flux toward 
lipid synthesis, resulting in an increased lipid content of 41.4% [159]. A further 
enhancement of lipid accumulation was achieved by simultaneous expression of SCD 
(delta-9 stearoyl-CoA desaturase) gene, ACC1, and DGA1. SCD was identified as rate 
limiting step and target for the metabolic engineering of lipid synthesis pathway by 
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reverse engineering the mammalian cellular obese phenotypes. The high flux created by 
overexpression of ACC and DGA1 is encouraged and sustained by preventing allosteric 
pathway inhibition. Overexpression of SCD enables the conversion of saturated to 
monounsaturated fatty acids, providing increased sequestration of the pathway products 
towards a lipid sink. Moreover, the engineered strain obtained other favorable phenotypes 
including fast growth, high sugar tolerance, and lipid productivity up to 22 g/l/d [160]. 
Several efforts have focused on redirecting carbon flux to fatty acid synthesis by 
modifying glucose repression regulators. Disruption of the MIG1 gene, encoding a 
transcriptional regulator that binds to several glucose repression genes, enhanced 
lipogenesis through depression of several genes relevant to lipid synthesis including 
GPD1, ICL, ME1 and ACL1, and through repression of β-oxidation genes including 
MFE1 [161]. Another glucose repression regulator Snf1 from the Snf1/AMP-activated 
protein kinase (AMPK) pathway was identified as a lipid accumulation regulator. 
Deletion of SNF1 led to the accumulation of lipid up to 2.6-fold higher than those of the 
wild-type [162]. Disruption of β-oxidation has been explored to prevent TAG 
degradation. Pex10p, encoded by the PEX10 gene, is involved in peroxisome biogenesis. 
Deletion of PEX10 in an eicosapentaenoic acid (EPA) producing strain, resulted in 
inactivation of β-oxidation and increased total lipid accumulation as well as EPA 
production [85].  
The MFE1 gene is another target for disruption of β-oxidation. Coupling deletion 
of MFE1 and improvement of G3P synthesis increased both de novo and ex novo TAG 
synthesis [163]. Combinatorial multiplexing of several lipogenesis targets, including 
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deletion of both MFE1 and PEX10 genes, overexpression of DGA1, and restoration of a 
complete leucine biosynthetic pathway, generated a significantly lipogenic strain with a 
lipid content of 74% [164]. This study also demonstrated that lipid accumulation could be 
uncoupled from nitrogen starvation and established links between leucine-mediated 
signaling and lipogenesis. In Y. lipolytica, the only source of cytosolic acetyl-CoA is 
from splitting citrate by ACL when the TCA cycle is repressed under nitrogen-limited 
conditions. Therefore, uncoupling lipid accumulation and nitrogen starvation can also be 
achieved by rewiring the acetyl-CoA pathway. Five alternative cytosolic acetyl-CoA 
pathways were engineered separately, including the pyruvate-acetate route, pyruvate-
aldehyde route, pyruvate formate lyase, acetyl-CoA shuttling pathway, and nonoxidative 
pentose-phosphate pathway [91]. The engineered strains not only show improved lipid 
production but were also less sensitive to C/N ratio regulation. TGL3 and TGL4 are 
intracellular lipases responsible for the degradation of TAG in the lipid body. Deletion of 
the TGL3 gene has a positive effect on preventing the degradation of TAGs in the later 
phases of lipid accumulation, and thus increased the overall lipid titer [165]. By 
combining TGL3 knockout with overexpression of a heterologous DGA1 (R. toruloides) 
and DGA2 (Claviceps purpurea), 77% lipid content and 0.21 g/g lipid yield were 
achieved in a batch fermentation.    
Aside from rational metabolic engineering efforts, a rapid evolutionary metabolic 
engineering approach linked with a floating cell enrichment process was used to develop 
highly lipogenic strains. This screen led to a strain with a mutation of the succinate 
semialdehyde dehydrogenase, UGA2, achieving a high lipid content of 78% [166], and 
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suggesting an important role of gamma-aminobutyric acid assimilation in lipogenesis. 
Another evolved strain had a mutant MGA2 protein, Mga2p, that served as a regulator of 
desaturase gene expression, and exhibited high lipid content with elevated unsaturated 
fatty acid levels. The mutant MGA2 regulator resulted in a drastically altered 
transcriptome, with glycolysis upregulated and the TCA cycle downregulated. This 
suggested that imbalance between glycolysis and the TCA cycle could serve as a driving 
force for lipogenesis [167]. 
 
1.6.2.  Understanding FA Metabolism in Y. lipolytica 
The process of fatty acid degradation for energy is β-oxidation and it primarily 
occurs within specialized organelles known as peroxisomes (Figure 1.4). The number, 
size, and content of peroxisomes vary with environmental and genetic stimuli. Some β-
oxidation has also been reported to occur within the mitochondria [168]. The peroxisomal 
β-oxidation cycle consists of five major steps. First, the substrate of interest, often a fatty 
acid (FA), is transported into the peroxisome with the aid of Acyl-CoA Binding Proteins 
(ACBP) [168]. During transport, the FA is acetylated by the two peroxisomal acyl-CoA 
Synthases (PXA1/ PXA2) in an ATP-dependent reaction [169]. The newly acylated fatty 
acid is then desaturated by acyl-CoA oxidases (POX) at the vinyl position, consuming 
FAD+ and producing H2O2 as a byproduct. Yarrowia lipolytica has six POX genes 
(POX1-POX6) which have been shown to different chain length and substrate 
specificities [170]. The newly formed desaturated FA-CoA ester is then hydrated across 
the double bond by Multi-Function Enzyme 2 (MFE2 – C domain) (encoded by the 
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MFE1 gene) such that the addition of a hydroxyl occurs at the β-carbon position, forming 
a 3-hydroxyacyl-CoA intermediate. From here, the MFE2 enzyme (A/B domains) acts 
again to oxidize the 3-hydroxy intermediate to 3-ketoacyl-CoA and forms NADH in the 
process. Finally, the 3-ketoacyl-CoA is cleaved at the alpha carbon by peroxisomal 3-
oxyacyl-thiolase (POT1), releasing a molecule of acetyl-CoA and producing a fatty acyl-
CoA which is two carbons shorter than the substrate that entered the cycle. From this 
point, the product that is now 2 carbons shorter, can loop back into the cycle beginning 
with the POX reaction. 
 
Figure 1.4. β-oxidation in Y. lipolytica. The enzymes involved in β-oxidation in Y. 
lipolytica. ACBP:  Acyl-CoA Binding Proteins, ACS:  acyl-CoA synthase, POX1-POX6:  
peroxisomal acyl-CoA oxidases, MFE2: multi-function enzyme 2, POT1:  peroxisomal 3-
oxoacyl-CoA thiolase, PhaC: polyhydroxyalkanoate synthase [118]. 
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1.6.3. Advancing Metabolic Engineering of Alcohols and Other Oleochemicals 
 Recently several groups have begun producing other oleochemicals including 
alcohols, alkanes, and esters [91-93]. Medium and long-chain alcohols are used as 
moisturizers in cosmetics as well as lubricants and surfactants. Alcohol production in Y. 
lipolytica is typically achieved using a fatty acyl-CoA reductase and aldehyde reductase 
or carboxylic acid reductase (CAR) and aldehyde reductase. The bifunctional fatty acyl-
CoA / aldehyde reductase from Tyto alba (TaFAR1) was used to enable the production of 
hexadecanol [92]. The deletion of the fatty alcohol oxidase (FAO1) gene from Y. 
lipolytica and increasing the copy number of the Tafar1 gene lead to a ~5-fold increase in 
titers. Deletion of the DGA1 gene responsible for TAG synthesis and the introduction of 
5 copies of the Tafar1 gene led to a titer of ~690 mg/L from 160 g/L glucose after 6 days. 
The production of 1-decanol was demonstrated using the FAR from Arabidopsis 
thaliana using a previously engineered Y. lipolytica for C8–C10 medium chain fatty acids 
[93]. The deletion of the PEX10 gene while expressing FAR greatly increased 1-decanol 
titers by preventing peroxisome formation and thus alcohol degradation. A number of 
fatty acyl-ACP thioesterase (FAT) enzymes were also tested to release fatty acids from 
biosynthesis. The FAT enzyme from Cuphea palustris yielded the best decanol titers 
(550 mg/L). The majority of the decanol (~90%) was found to be secreted outside the cell 
and into the media. 
More recently, a range of oleochemicals was produced by targeting various 
pathways to the different organelles involving fatty acid biosynthesis and degradation 
[91]. Fatty acid ethyl ester (FAEEs) production was achieved by expression of 
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acetyltransferase, AtfA, from Acinetobacter Baylyi. When targeting this enzyme to the 
ER or Peroxisome, 136 mg/L and 111 mg/L of FAEE was produced, respectively, 
whereas only 7 mg/L was produced when targeted to the cytosol. Alkanes were produced 
using a similar organelle targeting approach by expressing the aldehyde-deformylating 
oxygenase (ADO) and CAR. Up to 23 mg/L of fatty alkanes were made by expressing 
CAR from Mycobacterium marinum and ADO from Prochlorococcus marinus. Alcohol 
production has also been demonstrated in E. coli were also produced by expression of E. 
coli fatty acyl-CoA synthetase, FadD, and Marinobacter aquaeolei FAR. In yeasts, 
however, the highest scale-up titers are reported in a 3 L bioreactor for Y. lipolytica, 
reaching 2.15 g/L. 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
† A part of this chapter is published in AIMS Bioengineering 2016, 3(4), 493-514, with co-authors Gabriel 
Rodriguez, Difeng Gao, Michael Spagnuolo, Lauren Gambill, and Mark Blenner 
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CHAPTER TWO 
 
ENGINEERING PROMOTER ARCHITECTURE IN YARROWIA LIPOLYTICA 
 
 
Abstract 
 
Eukaryotic promoters have a complex architecture to control both the strength and 
timing of gene transcription spanning up to thousands of bases from the initiation site. 
This complexity makes rational fine-tuning of promoters in fungi difficult to predict; 
however, this very same complexity enables multiple possible strategies for engineering 
promoter strength. Here, we studied promoter architecture in the oleaginous yeast, 
Yarrowia lipolytica. While recent studies have focused on upstream activating sequences, 
we systematically examined various components common in fungal promoters. Here, we 
examine several promoter components including upstream activating sequences, 
proximal promoter sequences, core promoters, and the TATA box in autonomously 
replicating expression plasmids and integrated into the genome. Our findings show that 
promoter strength can be fine-tuned through the engineering of the TATA box sequence, 
core promoter, and upstream activating sequences. Additionally, we identified a 
previously unreported oleic acid-responsive transcription enhancement in the XPR2 
upstream activating sequences, which illustrates the complexity of fungal promoters. The 
promoters engineered here provide new genetic tools for metabolic engineering in Y. 
lipolytica and provide promoter engineering strategies that may be useful in engineering 
other non-model fungal systems. 
† A version of this chapter is published in ACS Synthetic Biology 2015, 5, 213-223, with co-authors Lauren 
Gambill, Spencer Smith, and Mark Blenner. 
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Introduction 
The complexity of eukaryotic promoter architecture is fundamental for the diverse 
pattern of gene expression that can be obtained from a relatively small number of 
transcription factors (TFs) [171-173]. Even in eukaryotes as exhaustively studied as S. 
cerevisiae, fine-tuned and predictive promoter design has been elusive.[58, 174, 175] As 
a result, metabolic engineering in eukaryotes has relied on a small number of well-
defined endogenous promoters, such as the GAL1-10, TEF, and LEU2 promoters [176-
178]. This problem is exacerbated by recent progress towards utilizing non-model yeasts 
from biochemical production [179-182]. In order to push titers, yields, and productivities 
to their limits, reaction fluxes need to be well-balanced, and even responsive to 
intermediate metabolite concentration [183-186]. Such advanced metabolic engineering 
strategies may be enabled if promoters were designed from the bottom up to have specific 
transcriptional activities. Central to the development of finely tuned promoters is a better 
understanding of how different promoters’ elements influence promoter strength. 
This work focuses on engineering promoters for the oleaginous and lipolytic 
hemiascomycetes yeast Yarrowia lipolytica.  Y. lipolytica has long been studied as a 
model organism for dimorphism and as an alkane metabolizing yeast [187, 188]. It is also 
known to metabolize diverse substrates including fatty acids, triacylglycerides, glucose, 
and glycerol [189]. As an oleaginous yeast, it is able to accumulate greater than 20% of 
its mass as neutral lipids. Recent efforts to increase the lipid content of these cells grown 
on glucose have been successful, with resulting strains engineered to produce up to 90% 
w/w [160, 190]. As these lipids are useful precursors for biofuels, fatty acids, and fatty 
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alcohols, Y. lipolytica has gained attention as a useful industrial microbe for the 
production of omega-3 oils, ricinoleic acid, and triacylglycerides [85, 191]. Recent efforts 
have greatly improved de novo production of TAGs for conversion to biodiesel [160, 
190]. Other products produced include single cell protein, citric acid, lipase, lycopene, 
and -ketoglutarate [192-196].  
Overexpression of endogenous or heterologous enzymes to form new metabolic 
pathways requires functional promoters. Endogenous promoters are frequently used 
because promoter architecture in eukaryotes can be complex and transcriptional 
responses can be difficult to predict [197, 198]. Endogenous promoters used for 
overexpression include TEF1, FBA1, TDH1, GPM1, LEU2, POX2, XPR2. These 
promoters are typically over 1000 bp long and were identified by analysis of genomic and 
gene expression data. Unfortunately, this precludes tuning the level of gene expression 
since promoter strength is fixed by the endogenous promoter architecture. Without 
additional engineering, endogenous promoters cannot produce transcripts at levels higher 
than naturally occurring. Furthermore, the complex regulation of endogenous promoters 
is often ignored and can complicate metabolic engineering efforts.  
The promoter strength is determined by several factors, including the TATA box, 
core promoter sequence, proximal promoter sequences, and enhancer regions in the 
upstream activating sequences (UAS) (Figure 2.1C). The most attention has been given to 
engineering hybrid promoters, built by combining repeats of UASs with downstream 
minimal promoters comprised of truncated promoters [81, 82, 199]. Madzak et al. [200] 
showed the promoter of extracellular protease (XPR2) can be described as two regions: 
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UAS1 and UAS2, with UAS2 being closer to the start codon and UAS1 being farther 
from the start codon. The endogenous XPR2 promoter is regulated by the media pH and 
nitrogen content. When only UAS2 was used to drive the expression of XPR2, the same 
pH and nitrogen regulation was observed. On the contrary, when only UAS1B, a 90 bp 
region of UAS1 was used to drive expression, transcription was independent of pH and 
nitrogen indicating regulatory features of the UAS were localized to UAS2, while UAS1 
was a general amplifier of the downstream promoter. Blazeck et al.[82] made tandem 
repeats of UAS1B to drive expression of GFP from two minimal constitutive promoters, 
TEF and LEU. Increasing the number of repeats monotonically and cooperatively 
increased the transcription from the downstream core promoter. UAS repeats have been 
shown to be genetically stable in Y. lipolytica [82]. This modular architecture suggests 
that promoter strength and induction properties should be predictably engineerable using 
defined UASs, however, considerably less attention has been given to the TATA box, 
core promoter, and proximal promoter sequences.  
In this study, we have taken a systematic look at the promoter architecture in 
order to engineer a new panel of hybrid promoters for metabolic engineering 
applications. We chose to study promoter structure in the context of autonomously 
replicating plasmids for two reasons. First, it allows us to study promoter architecture in 
the absence of epigenetic effects that commonly influence expression profiles in 
chromosomal DNA; and secondly, plasmids are useful vehicles for rapid testing of 
metabolic engineering strategies. We made several truncations to the acyl CoA oxidase 
(POX2) endogenous promoter and built hybrid promoters. We characterized a new 
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substrate responsiveness from the XPR2 UAS1B sequences and showed that UAS1B 
enhancers are more induced by oleic acid compared to glycerol or glucose. We also tuned 
promoter strength through engineering of the TATA box and the proximal promoter 
regions. While TATA box engineering resulted in similar effects in different promoters, 
the proximal promoter sequences did not appear modular. In sum, these studies have 
helped elucidate the importance of each of the regions comprising the overall promoter 
architecture.
 
Figure 2.1. Promoter architecture. (A) Eukaryotic promoters contain a core promoter 
sequence that may have a TATA box, a proximal promoter sequence, and enhancer 
sequences located farther upstream. (B) Hybrid promoters were created by placing eight 
UAS1B sequences (UAS1B8) upstream of a promoter. The promoter consists of a core 
promoter and 5′ truncations of the native promoter to identify regulatory sequences 
upstream of the proximal and core promoter. Humanized Renilla reinformis GFP was 
used as a reporter to characterize promoter strength. (C) Different UAS, proximal, TATA 
box, and core promoter sequences tested throughout the course of this study. The 
promoter components are ordered from top to bottom in decreasing strength. 
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Experimental Procedures 
Chemicals and Enzymes 
All chemicals were purchased from Sigma unless otherwise stated. All restriction 
enzymes, DNA ligases, and DNA polymerases used for cloning and PCR were purchased 
from New England Biolabs (NEB) unless otherwise stated. Plasmid minipreps, PCR 
purifications, and gel extractions were done using the QIAprep spin miniprep kit and 
QIAquick PCR purification and gel extraction kit (Qiagen). Genomic DNA from Y. 
lipolytica was extracted using the E.Z.N.A. yeast DNA kit (Omega Biotek). All 
oligonucleotides and gBlocks were purchased from IDT. 
 
Strains and Cultures 
DH10β cells (NEB) were used for cloning and propagation of plasmids in 
Luria−Bertani (LB) media supplemented with 100 μg/mL ampicillin. Y. lipolytica strain 
PO1f (MATa leu2−270 ura3−302 xpr2−322 axp1) was used for GFP expression studies. 
Transformed was cultivated at 28 °C and 215 rpm in 20 mL volumes using 250 mL 
baffled flasks with YSC-LEU selective media consisting of 6.7 g/L YNB without amino 
acids (Difco), 0.69 g/L CSM-LEU (MP Biomedicals). Data in Figure 6 was collected in 2 
mL volumes grown in 14 mL culture tubes under the same rotational speed and 
incubation temperature. The carbon source for YSC-LEU media contained either 2% 
(w/v) glucose (Sigma), 2% (v/v) glycerol (Fisher Scientific), or 2% (v/v) emulsified oleic 
acid (EMD Millipore) in 0.1% (v/v) Tween 80. Agar plates for post-transformation 
applications in E. coli and Y. lipolytica were prepared by adding 15 g/L agar to either LB 
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or YSC-LEU media, respectively. Y. lipolytica transformations were done using the 
lithium acetate method as described previously [106]. 
 
General Plasmid Construction 
Procedures for restriction enzyme digestions and PCR amplification were 
performed as recommended by supplier protocols. Ligations were incubated at room 
temperature for 20 min using T4 DNA ligase prior to transformation into DH10β E. coli 
using the heat shock method. Post-ligation transformants were grown overnight in LB 
media supplemented with 100 μg/mL ampicillin. All vectors used in this study were 
derived from a skeletal plasmid containing a centromeric site and autonomous replicative 
sequence (CEN/ ARS) pSL16-cen1-1(227) [173]. A gBlock containing a multiple cloning 
sites (MCS), hrGFP, and CYC1 terminator was synthesized (Supplementary Table 2.1) 
with flanking 5′ BamHI and 3′ HindIII restriction sites and ligated into the pSL16-cen1-
1(227) skeletal vector to create pSL16-cen1-1(227)-MCS-hrGFP-CYC1t. Eight tandem 
repeats of UAS1B elements were PCR amplified from pUC-UAS1B8-TEF(136) [82] 
using primer pair F1/R1 (Supplementary Table 2.1). The F1 mutagenesis forward primer 
was used to introduce a BstBI restriction site and mutate the SphI site adjacent to 5′ of the 
UAS1B sequences, while the reverse primer retained the SphI site. The PCR amplified 
UAS1B8 fragment was ligated into the pSL16-cen1-1(227)-MCS-TEF(136)-hrGFP-
CYC1t to create pSL16-UAS1B8-TEF(136)-hrGFP.  
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Construction of POX2 Promoter Truncation Plasmids 
The native POX2 promoter, POX2 (2147 bp), and subsequent truncations, POX2 
(1591 bp), POX2 (513 bp), POX2 (438 bp), POX2 (147 bp), and POX2 (100 bp), were 
PCR amplified from PO1f genomic DNA using primer pairs F2/R2, F3/R2, F4/R2, 
F5/R2, F6/R2, and F7/R2, respectively (Supplementary Table 2.2). The POX2 promoter 
truncations were ligated in place of the TEF(136) promoter using restriction sites 
SphI/AscI to make a series of POX2 hybrid promoters, pSL16-UAS1B8-POX2 (x bp)-
hrGFP. Unless otherwise stated, all hybrid promoter constructs utilized 5′ SphI and 3′ 
AscI sites for ligation into the pSL16-UAS1B8- TEF(136)-hrGFP vector by replacing the 
TEF(136) minimal core promoter. To create a series of vectors containing truncations of 
the native POX2 promoter without the UAS1B elements, the series of POX2 promoter 
truncations were PCR amplified from PO1f genomic DNA using primer pairs F8/R2, 
F9/R2, F10/R2, F11/R2, F12/R2, and F13/R2 (Supplementary Table 2.2). The forward 
primers had a 5′ flanking XmaI site for ligation into the pSL16-cen1-1(227)-MCS-
hrGFP-CYC1t vector to create the series of pSL16-POX2 (x bp)-hrGFP vectors.  
 
Construction of Hybrid Core Promoter Plasmids 
Four hybrid core promoter systems were constructed using core promoters of the 
TEF, LEU2, POX2, and PAT1 genes. Primer pairs F14/R3 and F15/R4 were used to 
amplify the TEF (111 bp) and LEU2 (78 bp) core TATA promoters, while synthesized 
oligonucleotide pairs F16/R5 and F17/R6 (Supplementary Table 2.2) were annealed to 
make the core TATA promoters, POX2 (48 bp) and PAT1 (61 bp), respectively. These 
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promoters were digested and ligated into pSL16-UAS1B8-TEF-hrGFP in place of the 
TEF(136) promoter to construct the hybrid core promoters, pSL16-UAS1B8-POX2 (x 
bp)-hrGFP.  
 
Construction of Hybrid TATA Box Promoter Plasmids 
 
The TATA box in TEF core hybrid promoter was replaced with the POX2 and 
LEU2 TATA box motifs using mutagenesis forward primers F18 and F19 paired with R3. 
The template used for PCR was pSL16-UAS1B8-TEF (111 bp)-hrGFP. Mutations to the 
TATA box in the POX2 core promoter to substitute in the TEF and LEU2 TATA motifs 
were accomplished by purchasing synthesized oligonucleotides F20/R7 and F21/R8, 
respectively. pSL16-UAS1B8-POX2 (2147 bp)-hrGFP was digested to remove the POX2 
(2147 bp) promoter, and the abovementioned annealed oligos were ligated in its place. 
Sequence and ligation-independent cloning (SLIC) [201] was used to replace the TATA 
box of the native POX2 promoter with the canonical TEF and the LEU2 TATA motifs. 
The vector template was pSL16-POX2 (2147 bp)-hrGFP. Primer pairs F22/R9 and F23/ 
R10 were used for the TEF TATA substitution, whereas F23/ R11 and F24/R10 were 
used to make LEU2 TATA motif substitutions (Supplementary Table 2.2). The base 
vector for mutagenesis and PCR amplification was pSL16-POX2 (2147 bp)-hrGFP.  
 
Construction of Hybrid Proximal Promoter Plasmids 
The effect of the proximal sequence in the TEF minimal core promoter was tested 
by placing proximal motif upstream of the POX2 and LEU2 core promoters, respectively. 
 49 
Two separate gBlocks containing the respective core promoters and the 26 bp proximal 
sequence 5′ of the TEF core promoter, F25, and F36 were purchased. To test the effect of 
various TATA box associations with the TEF proximal sequence, gBlocks of the POX2 
core promoters with modified TATA boxes containing the TEF proximal sequence (F32 
and F33) were also purchased (Supplementary Table 2.2). SLIC was used to insert the 
oligonucleotides into a SphI/AscI double-digested pSL16-UAS1B8-POX2 (2147 bp)- 
hrGFP vector.  
 
Construction of UAS1B8 Hybrid Promoters for Genome Integration 
Hybrid promoter cassettes with TATA box modifications were made for 
integration into the leu2 locus of Y. lipolytica Δku70. The Δku70 strain has previously 
been shown to improve the efficiency of homologous recombination events.51 pSL16-
cen1-1(227) was digested with AatII to insert a 500 bp front-end homology to the leu2 
locus and new restriction site, AvrII, in the vector. The 500 bp front-end homology was 
PCR amplified from the Y. lipolytica genome using SLIC primer pairs F26/R12 
(Supplementary Table 2.2). The new vector containing the frontend homology was 
digested with HindIII-HF to insert a 500 bp back-end homology to the leu2 locus and a 
new restriction site, MfeI. The 500 bp back-end homology was PCR amplified from the 
Y. lipolytica genome using SLIC primer pairs F27/R13 (Supplementary Table 2.2). The 
new vector was termed pSL16-cen1-1(227) [LEU2 homologous ends]. The three hybrid 
TEF core promoter cassettes containing the TEF, LEU, and POX2 TATA boxes, 
respectively, were digested with BstBI and AatII, and an insert containing the LEU2 
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promoter, gene, and terminator was PCR amplified from the Y. lipolytica W29 genome 
using SLIC primer pairs F28/R14 and inserted into the double-digested vectors above 
(Supplementary Table 2.2). The purpose of this step was to remove the centromeric 
CEN1-1 DNA sequence that makes the plasmid replicative. These three vectors were 
then doubled-digested with AatII and HindIII to add in an insert containing leu2 
homologous ends that were PCR amplified from pSL16-cen1-1(227) [LEU2 homologous 
ends] using primer pairs F27/R12 (Supplementary Table 2.2). Integration at the leu2 
locus was verified by PCR and DNA sequencing.  
 
Construction of Vectors Containing Three Tandem UAS(TEF) Elements 
A pUC vector was used to first make three tandem UAS(TEF)#2 sequences33 
prior to transferring these elements into a pSL16 hybrid vector. The UAS(TEF) from the 
first UAS(TEF) element was PCR amplified from the Y. lipolytica PO1f genome using 
SLIC primer pair F29/R15 (Supplementary Table 2.2) and inserted into pUC-
UAS1B8(TEF136) (Addgene no. 44380) double-digested with SphI and BamHI to 
remove the 8UAS1B elements, creating pUC-UAS(TEF)#1. The second UAS(TEF) 
element was PCR amplified from the Y. lipolytica PO1f genome using SLIC primer pair 
F30/R16 (Supplementary Table 2.2) and inserted into the pUC-UAS(TEF)#1 vector 
double-digested with NdeI and BamHI to create pUC-UAS(TEF)#2. Finally, the third 
UAS- (TEF) element was PCR amplified from the Y. lipolytica PO1f genome using SLIC 
primer pair F30/R17 (Supplementary Table 2.2) and inserted into the pUC-UAS(TEF)#2 
vector double-digested with NdeI and EcoRI to create pUC-UAS(TEF)#3. The three 
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tandem UAS(TEF) elements were digested out of the pUC-UAS(TEF)#3 vector using 
SphI/BstBI and inserted into the double-digested pSL16-UAS1B8-TEF(TATA)-hrGFP, 
pSL16- UAS1B8-TEF(LEU2 TATA)-hrGFP, and pSL16-UAS1B8- TEF(POX2 TATA)-
hrGFP core promoter hybrid cassettes to create counterpart vectors containing 
3UAS(TEF) elements. 
 
Flow Cytometry 
Humanized Renilla reinformis GFP (hrGFP), codon optimized for Y. lipolytica, 
was used as the fluorescence reporter protein to measure promoter strength. 
Transformants from selective media plates were first propagated in 2 mL precultures for 
48 h prior to inoculating 10 mL cultures at an OD600 of 0.3. The cultures were grown 
under constant agitation for 48 h, which was reported as the optimal incubation time for 
high expression levels.32 Prior to flow cytometry analysis, cultures were grown in 
glucose and glycerol and were spun at 12000xg for 2 min and resuspended in 0.1 M 
phosphate-buffered saline (PBS) at pH 7.4. Cultures grown in emulsified oleic acid were 
spun at 12 000gfor 2 min and suspended in YSC-LEU containing 5% (v/v) Tween 80. 
The resuspended pellet was agitated by vigorous shaking prior to centrifuging the sample 
at 12 000gfor 1 min and resuspending the pellet in 0.1 M PBS, pH 7.4. All samples were 
kept on ice during sample preparation and analysis. Flow cytometry analysis was 
performed using the BD Accuri C6 flow cytometer (BD Biosciences) with the standard 
detector, FL1 filter (533/30), used to capture fluorescence from the GFP fluorophore. The 
VIRTUALGAIN module in the BD Accuri C6 software was used to adjust peak position 
and account for normalizing gains across samples during analysis. Population gates were 
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applied to account for the mean fluorescence from the GFP expressing population and 
negate autofluorescence.  
 
Quantitative Reverse Transcription PCR (qRT-PCR) 
 Transformants grown under different carbon source conditions were subject to 
RNA extraction 48 h post-growth. The transformants across each of the selected cultures 
were normalized to an OD600 of 5 prior to RNA extraction procedures. The cells were 
pelleted, and total RNA was extracted using the E.Z.N.A yeast RNA kit (Omega Biotek). 
RNA extracts were placed in aliquots and stored at −80 °C until further use. For absolute 
RT-qPCR, a two-step protocol was employed. 500 ng of total RNA was used in cDNA 
synthesis that was performed using gene-specific priming with maxima reverse 
transcriptase (Thermo Scientific). 1.5 μL from the cDNA synthesis mix was subject to 
qPCR with the Maxima SYBR Green/Fluorescein qPCR master mix (Thermo Scientific). 
qPCR was performed in biological triplicates from the cDNA mix in a 96-well plate 
using a CFX Connect real-time (Bio-Rad). The primer pair, GFPF/ GFPR, used in RT-
qPCR is listed in Supplementary Table 2.2. A standard curve was developed using a 
linearized vector containing the hrGFP gene to relate Cq values to copy number. This 
calibration curve was used to calculate mRNA copy numbers of qPCR analyzed samples. 
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Results 
Oleic Acid Inducible Enhancers Are Upstream in the Native POX2 Promoter 
While the whole POX2 promoter has proven to be useful for heterologous 
expression in Y. lipolytica, there is little known about the mechanism or localization of 
elements that confer oleic acid responsiveness in this relatively large promoter. To 
identify such oleic acid response elements (OREs) in the promoter, a series of 5′ deletions 
were made to the endogenous POX2 promoter, based on homology to S. cerevisiae 
OREs. These promoter truncations were placed upstream of a humanized R. reinformis 
GFP (hrGFP) reporter gene to quantify expression via cellular fluorescence (Figure 
2.1A). The significant drop in fluorescence was observed from the POX2 (1591 bp) to the 
POX2 (513 bp) promoter. This indicates that most of the OREs reside in this 1 kb 
window, significantly upstream of the TATA box, where the preinitiation complex (PIC) 
is known to form (Figure 2.1A) in RNA polymerase II promoters.  
 
UAS1B Sequences Act in a Distance-Dependent Manner 
The UAS1B element in Y. lipolytica has previously been shown to be a 
constitutive transcriptional amplifier that is independent of the nitrogen content and pH of 
the media [199] and fusion of greater than four UAS1B elements in tandem could lead to 
a cooperative and significant amplification [199]. We combined eight tandem UAS1B 
(UAS1B8) repeats with truncations of the POX2 inducible promoter system and observed 
the strongest expression from the shortest POX2 truncations. Several short POX2 
promoter truncations (100, 147, and 438 bp) resulted in minimal GFP fluorescence; 
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however, when they were combined with UAS1B8, these promoters were stronger than 
longer hybrid POX2 promoters. We observed that the UAS1B8 sequences conferred 
weaker transcriptional amplification as they were moved farther away from the gene 
(Figure 2.2B). A significant decrease in fluorescence is observed from the UAS1B8-
POX2 (513 bp) to the UAS1B8-POX2 (1591 bp) hybrid promoter, which is an opposite 
effect to what was observed with the truncations of the native promoter.   
 
Figure 2.2. Truncated POX2 promoters and hybrid POX2 promoters. (A) Length of 5′ 
truncations of the native POX2 promoter (gray; left) and oleic acid induced fluorescence 
from the corresponding truncations of the endogenous POX2 promoter (right). (B) Eight 
UAS1B elements (orange) fused upstream of the 5′ POX2 promoter truncations (gray) to 
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create a series of POX2 hybrid promoter systems (left) and oleic acid induced 
fluorescence (black) from the corresponding hybrid POX2 promoter constructs (right). 
 
Core Promoter Sequence Modulates Expression Level 
A complete understanding of the mechanism for TFIID-dependent transcription 
and TSS localization in yeast promoters is still unclear; therefore, a range of TATA 
promoters containing different distributions of predicted initiator sequences were used in 
this study. Transcriptional effects from the types of initiator sequences (Supplementary 
Figure 2.1) and distances from TATA box still remain to be fully elucidated in yeast 
TATA-containing promoters [202]. Our hybrid POX2 promoter studies indicate that 
UAS1B8 sequences placed upstream of the core promoter truncated down to the TATA 
box still result in high levels of transcription and therefore we hypothesized that these 
sequences can similarly amplify other core promoters. The UAS1B8 elements were fused 
upstream of core promoters from the PAT1, POX2 inducible promoters and the TEF1-α, 
LEU2 constitutive promoters. The core promoters constructed in this chapter are 
designated as the truncated promoter sequence to a functional TATA box (Figure 2.3A), 
which acts as the binding site of the PIC in TATA-containing promoters [202]. The 
functional TATA boxes in these promoters were identified by scanning the promoter 
sequence between 40 and 100 bp from the start codon [203]. GFP reporter expression and 
quantitative PCR results indicate that, indeed, the UAS1B8 sequence enhances 
transcription from all core promoters tested and that transcript levels scale with core 
promoter strength, with TEF1 being the strongest and PAT1 and LEU2, the weakest. We 
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also observed that the TEF1 core promoter is the longest functional core promoter 
(Figure 2.3A), whereas the shortest core promoter (POX2) had similarly high expression.  
 
UAS1B from XPR2 Confers Substrate-Specific Responsiveness 
The UAS1B sequence was originally described as lacking regulation by media 
conditions when compared to the full XPR2 promoter; however, an investigation of 
UAS1B hybrid promoter strength when using different carbon sources was not performed 
[199]. We compared the expression levels of GFP by flow cytometry and qPCR of 
cultures grown in either YSC media containing glucose, glycerol, or oleic acid. Oleic acid 
substrate resulted in the highest levels of promoter activation. UAS1B8 hybrid promoters 
were less activated in glucose and were minimally activated in glycerol. All four 
promoter systems exhibited a similar trend in substrate-specific responsiveness, largely 
following the pattern of core promoter strength (Figure 2.3B, C).  
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Figure 2.3. UAS1B8 enhancers are oleic acid responsive. (A) Core promoter sequences 
of TEF, POX2, LEU2, and PAT1 shows the variability of the TATA box sequence. (B, 
C) Substrate-specific transcriptional responsiveness (fluorescence, B; absolute qPCR, C) 
from the various hybrid core promoter constructs. 
 
TATA Box Sequence Has a Large Influence on Expression Level 
To study the effect of TATA elements on transcriptional regulation, we chose 
TATA boxes as 8 bp sequences, with 2 additional bases downstream of the 6 bp core 
TATA box from four sequentially different Y. lipolytica promoters. The TEF promoter 
contains a TATAAA[AG] sequence that is reported to be one of the strongest TATA box 
sequences in S. cerevisiae, while the LEU2 TATA box sequence, TATATA[TA], is also 
considered to be a strong sequence for TFIID binding, albeit to a weaker extent than the 
TEF TATA box [204]. Expression from these hybrid promoters was strong (Figure 2.4A, 
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B, C). The POX2 TATA box sequence, TATACTTATATA, is not prevalent or highly 
uncommon in S. cerevisiae promoters; however, in Y. lipolytica, we observed strong 
expression from this hybrid promoter as well. When these TATA boxes were applied to 
the native POX2 promoter, we observed small changes in expression strength strongly 
suggesting that the strong UAS elements are predominantly important to confer strong 
expression (Figure 2.4D). 
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Figure 2.4. TATA box sequence impacts promoter strength. (A) Schematic of 8 bp TATA 
box mutations in the TEF (purple) and POX2 (lilac) hybrid core promoters. The 
consensus TEF TATA box, TATAAAAG, was substituted with lower affinity binding 
TATA boxes from the LEU2 and POX2 promoters. Furthermore, the POX2* TATA box 
was replaced with the LEU2 and the consensus TEF TATA box. (B) Qualitative 
representation of fluorescence strength from hybrid core promoters containing different 
core TATA boxes. (C) Fluorescence profiles for substitutions of the TATA boxes in the 
hybrid core promoters of POX2 and TEF. (D) Fluorescence profiles for when the TATA 
box from the endogenous POX2 (2147 bp) promoter was substituted with the TEF and 
LEU2 TATA boxes. * Indicates that a weaker, truncated version of the fully functional 
POX2 TATA box (TATACTTATATACC) was used in these experiments to create a 
series of hybrid promoter constructs with varying degrees of strength. 
 
 
TEF Proximal Promoter Sequence Enhances Expression of Engineered Promoters 
A comparison of the oleic acid-induced expression between the hybrid UAS1B8-
TEF (136 bp) and UAS1B8-TEF (111 bp) transformants revealed that the UAS1B8-TEF 
(136 bp) showed a significant increase in fluorescence (Figure 2.5B). The difference 
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between the two constructs is a 26 bp fragment adjacent to the 5′ end of the TATA box in 
the TEF core promoter. We wanted to understand if this proximal sequence could be used 
in a modular fashion for transcriptional enhancement in other TATA box containing 
promoters. We placed the TEF proximal sequence upstream of the hybrid POX2 core 
promoter containing a fully functional TATA box, UAS1B8-POX2 (TEF proximal) 
(Figure 2.5A). An insignificant increase in fluorescence was observed from this 
engineered promoter in comparison to the UAS1B8-POX2 (55 bp) construct without the 
TEF proximal sequence (Figure 2.5C), suggesting proximal sequences affect 
transcription in a nonmodular manner. The exact mechanism for how proximal sequences 
can enhance transcription is not well-understood and is likely context-dependent. To 
investigate this, we constructed UAS1B8 hybrid promoters containing the TEF proximal 
sequence upstream of TEF, LEU2, or POX2 core promoters. This data shows that the 
relative increase in transcriptional activity due to the TEF proximal sequence was 
insignificant for POX2 core promoters, higher in LEU2 core promoters, and highest in 
TEF core promoters (Figure 2.6A). Additionally, we showed that the TEF proximal 
sequence continues to exert no significant transcriptional enhancement when paired with 
the POX2 core promoter regardless of TATA sequence (Figure 2.6B), suggesting that 
proximal sequences interact with the core promoter sequence downstream of the TATA 
sequence. It is important to note that the effect of TATA sequence on GFP expression 
was preserved. 
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Figure 2.5. Proximal promoter sequences impact promoter strength but are not modular. 
(A) Schematic of TEF minimal core promoter with proximal promoter sequences 
adjacent to the core promoter. The schematic also shows insertion of the TEF proximal 
promoter motif directly upstream of the POX2 core promoter (UAS1B8-POX2 (TEF 
Proximal)). (B) Comparison of hrGFP fluorescence from TEF promoter including the 
proximal promoter sequence, including just the core promoter, and truncated past the 
TATA box. (C) Comparison of hrGFP fluorescence from POX2 core promoter TEF and 
native proximal sequence (TEF proximal and 100 bp) with core promoter (55 bp) and 
truncation (42 bp) that lacks the TATA box 
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Figure 2.6. Modularity of the TEF proximal sequence in different promoter 
environments. (A) Comparison of hrGFP fluorescence from UAS1B8 hybrid promoters 
containing the TEF, LEU2, or POX2 core promoter with and without the TEF proximal 
sequence shows different levels of transcription enhancement based on core promoter 
sequence. (B) Comparison of hrGFP fluorescence from UAS1B8 hybrid promoters with 
POX2 core promoter sequence with and without the TEF proximal sequence shows that 
changing the TATA sequence does not alter the interaction between TEF proximal 
sequence and core promoter sequence. 
 
 
Utility of the TATA Box Mutations in Different Episomal and Genomic Contexts 
We investigated the utility of the TATA elements in transcriptional regulation of 
RNA polymerase II promoters. In hybrid promoters with three tandem repeats of 
UAS(TEF) and a TEF core promoter, the effect of TATA box sequences from TEF, 
LEU2, and POX2 followed the trend observed in hybrid promoters using UAS1B8 from 
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XPR2 (Figure 2.7A). Regardless of the type of UAS element used, the strongest 
expression levels were observed from the TEF TATA consensus box, followed by the 
LEU2 TATA box and the POX2 TATA box. The relative expression strengths among the 
TATA box modifications translate well across the UAS(TEF)3 and UAS1B8 elements, 
with the TEF hybrid core promoter containing the canonical TATAAAA box showing an 
approximately greater than 2-fold increase in comparison to the TEF hybrid core 
promoter with the LEU2 TATA motif. We also observed that the absolute promoter 
strength dropped approximately 2-fold when integrated into the genome, consistent with 
previous work showing lower expression of integrated promoters [205]. The relative 
differences in strength among the hybrid promoters with different TATA boxes follow 
the same trend in expression observed in UAS1B8 an UASTEF3 containing hybrid 
promoters. The TEF core promoter containing the TEF TATA box is still the strongest 
expressing system, followed by the LEU2 TATA box and the POX2 TATA box (Figure 
2.7B). The decrease in promoter strength upon integration is consistent with additional 
repression of promoter strength due to genomic context. 
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Figure 2.7. Modularity of the TATA box in different promoter environments. (A) hrGFP 
fluorescence from UAS(TEF)3 hybrid promoter containing TEF core promoter with 
either TEF, LEU2, or POX2* TATA box shows the same trend in promoter strength 
compared to identical episomal expression with UAS1B8 hybrid promoters. (B) hrGFP 
fluorescence from a UAS1B8 hybrid promoter containing TEF core promoter with either 
TEF, LEU2, or POX2* TATA box shows the same trend in promoter when integrated 
into the genome at the leu2 locus. 
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Table 2.1. Summary of promoters built from different component sequences 
UAS TYPE PROXIMAL 
SEQUENCE 
TATA 
SEQUENCE 
CORE 
PROMOTER 
EXPRESSION 
STRENGTH 
TATA modifications in TEF hybrid promoters (Episomal Expression) 
UAS1B8 NONE TEF TEF ++++ 
UAS1B8 NONE LEU2 TEF +++ 
UAS1B8 NONE POX2* TEF ++ 
UAS(TEF)3 NONE TEF TEF ++++ 
UAS(TEF)3 NONE LEU2 TEF +++ 
UAS(TEF)3 NONE POX2* TEF ++ 
TATA modifications in TEF hybrid promoters (Genomic Expression) 
UAS1B8 NONE TEF TEF +++ 
UAS1B8 NONE LEU2 TEF ++ 
UAS1B8 NONE POX2* TEF + 
TATA modifications in POX2 hybrid promoters (Episomal Expression) 
UAS1B8 NONE POX2 POX2 +++ 
UAS1B8 NONE TEF POX2 ++++ 
UAS1B8 NONE LEU2 POX2 +++ 
UAS1B8 NONE POX2* POX2 + 
TATA modifications in native promoters (Episomal Expression) 
POX2 POX2 POX2 POX2 + 
POX2 POX2 TEF POX2 + 
POX2 POX2 LEU2 POX2 + 
CORE PROMOTER modifications in hybrid promoters 
UAS1B8 NONE TEF TEF ++++ 
UAS1B8 NONE LEU2 LEU2 +++ 
UAS1B8 NONE POX2 POX2 +++ 
PROXIMAL SEQUENCE modifications in hybrid promoters 
UAS1B8 TEF TEF TEF +++++ 
UAS1B8 TEF LEU2 LEU2 ++++ 
UAS1B8 TEF POX2 POX2 +++ 
UAS1B8 TEF LEU2 POX2 +++ 
UAS1B8 TEF TEF POX2 ++++ 
Comparison of hybrid promoters 
UAS1B8 NONE TEF TEF ++++ 
UAS1B8 NONE POX2 POX2 +++ 
UAS1B8 NONE LEU2 LEU2 +++ 
UAS1B8 NONE PAT1 PAT1 ++ 
 
Discussion and Conclusion 
  Table 2.1 summarizes the library of promoters with varying degrees of expression 
that can be engineering by investigating promoter architecture. There are several 
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components that can be used to fine-tune promoter strength and responsiveness. This 
chapter explores the contribution from each of these promoters to transcription.   
The role of UASs sequences to promoter activation is studied in the context 
proximity to the core promoter and responsiveness to carbon. The native POX2 promoter 
is the most commonly described oleic acid inducible promoter in Y. lipolytica [110]. The 
inducibility and expression strength of the endogenous POX2 promoter have been well-
characterized, and it has been used to drive inducible heterologous protein expression in 
Y. lipolytica [206, 207]. Although the promoter is weak, there is no understanding of 
where these UAS elements exist on the native promoter. From truncations, we observed 
that most of the ORE sites exist in a ~1000 bp region on the POX2 promoter. The lack of 
concordance between truncation data and predicted ORE sites is consistent with the 
observations of Poopanitpan et al. that showed predicted S. cerevisiae OREs in Y. 
lipolytica were nonfunctional [208]. Instead, the genetics of Y. lipolytica appear to be 
more closely related to filamentous fungi such as Aspergillus nidulans instead of S. 
cerevisiae.  
In eukaryotes, enhancer sequences are located several hundred to thousands of 
kilobases upstream from a transcriptional start site (TSS). These sequences are 
hypothesized to recruit TFs to the TSS through a looping mechanism, suggesting that 
their position relative to the TSS is important for function. Tandem repeats of upstream 
activating sequences (UAS1B) from the XPR2 promoter have previously been used to 
create hybrid promoters (Figure 2.1B) that amplify downstream minimal promoter 
transcriptional activity [200]. Placing 8 tandem UAS1B sequences upstream of the POX2 
 67 
truncation showed that as these sequences moved further away from the core promoter, 
the expression strength became weaker, elucidating that there is a distance dependence of 
UAS sequences for transcriptional activation. Interesting, we observed an increase in 
expression between the UAS1B8-POX2 (513 bp) and UAS1B8-POX2 (1591 bp) which 
correlated well with the increase in the expression between POX2 (513 bp) and POX2 
(1591 bp) further supporting the potential for OREs in this ∼1 kb POX2 promoter 
fragment. These experiments suggest that transcriptional factors from enhancer regions of 
different promoter systems can work cooperatively to amplify transcription. 
In addition to amplifying transcription, the UAS1B sequence from the XPR2 
promoter contains elements that are highly responsive to regulation by oleic acid, in 
contrast to the notion that they are not regulated by media conditions. This observation 
underscores the need to be cautious about the possibility of unintended promoter 
regulation when engineering eukaryotic promoters. 
Regulation at the core promoter level in eukaryotic systems can be complex as 
there are several elements within the core promoter that modulate promoter activity and 
strength. For example, in S. cerevisiae promoters, core promoters of both constitutive and 
regulated genes confer the highest activity when the sequence has a low G/C content, 
with T-rich motifs upstream of the TSS and A-rich motifs downstream of the TSS [209]. 
Such conditions are better suited for RNA polymerase II scanning downstream of the 
TATA box and selecting the most suitable TSS to initiate transcription. Our selection of 
TATA-containing core promoters in Y. lipolytica took into account sequences of varying 
degrees of G/C content, with the TEF1-α core promoter containing the lowest G/C 
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content (∼39%) and the PAT1 promoter having the highest percentage (∼49%) (Figure 
2.3A). Core promoters from POX2 and LEU2 both contain a G/C content that is 
approximately 43%. The TEF core promoter exhibits the strongest transcription while the 
PAT1 core promoter shows weakest expression but these promoters also contain 
distinctly different TATA elements that need to be considered. These results show that 
that promoter strength is a complex function of elements near core promoter sequence 
and distance of UAS sequences from the core promoter.  
Distance from the TATA box and the core promoter strength can be used to fine-
tune transcriptional levels, leading not only to multiple transcription levels but also to 
redundant transcriptional levels, as seen for UAS1B8-LEU2, UAS1B8-POX2, and 
UAS1BTEF (Figure 2.3B). However, to fully elucidate the role of initiator sequences in 
core promoters, we would need to test these sequences independently of the TATA boxes 
used as different TATA boxes can elicit different transcription strengths making it 
difficult to interpret the role of initiator sequences.  
The TATA box is perhaps the most studied component of the eukaryotic promoter 
and is well-appreciated for its role determining the strength of eukaryotic core promoters, 
for example, in S. cerevisiae synthetic GAL4 enhanced promoter systems [210]. Two 
well-studied consensus core TATA boxes, TATAAA and TATATA, have previously 
been shown to have a high affinity to TFIID binding both in vitro and in vivo in S. 
cerevisiae, with the former being the strongest [204]. Furthermore, the nucleotide 
sequence that is immediately downstream TATA element has been shown to strongly 
affect transcription levels. Therefore, to test TATA elements, we considered 2 bp 
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downstream of the 6 bp elements we considered TATA boxes based on comparison to S. 
cerevisiae sequences. The TATA motif from the TEF promoter showed strongest 
transcriptional strength while a mutation of one TATA box in the POX2 promoter that 
houses two TATA elements severely weakened transcription. This raises interesting 
questions about the most optimal TATA sequence for Y. lipolytica, which can be studied 
by increasing the sequence space from what we initially considered a TATA element in 
this study.   
Modifications of the TATA box across hybrid promoters containing different 
UAS element types showed that expression from the different TATA boxes is 
independent of the UAS elements used to enhance expression. This suggests that 
promoter strength and therefore expression can be tuned using TATA box modifications 
independent of the type of enhancer used. To determine if the TATA box promoter 
tuning strategy would translate to engineered promoters integrated into the genome, 
hybrid UAS1B8-TEF core promoter cassettes containing the TATA box modifications 
were integrated into the genome at the leu2 locus and similar trends were observed, 
albeit, weaker than the hybrid promoter. This demonstrates the importance of strong 
UASs to amplify the variations of base transcription from TATA elements.  
There was less success, however, in attaining predictable expression strength by 
translating proximal sequences from one core promoter to another. A potential reason for 
this lack of modularity is that the proximal sequence works cooperatively with the 
surrounding DNA sequences to provide a favorable nucleosome-depleted region near the 
TSS. In constitutive promoters, the DNA directly upstream of the TSS is typically 
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nucleosome-depleted, whereas upstream of regulated promoters are more occupied [211]. 
A simple analysis of the POX2 and TEF core promoters clearly shows that, in addition to 
TATA box variability, there is a significant difference in the distribution and localization 
of the predicted yeast initiator sequences [212-214] and length of each core promoter 
(Supplementary Figure 2.1). We were unable to find any potential S. cerevisiae 
homologous transcriptional factors that could be associated with binding to the 26 bp 
proximal sequence. 
This study has generated several new plasmids useful for episomal expression of 
genes in Y. lipolytica. We have identified a region of the native POX2 promoter that 
contains oleic acid responsive enhancers, we have shown that UAS1B8 repeats from 
XPR2 are sensitive to the carbon source, and we have examined the effect of the different 
core promoter and proximal promoter sequences on regulating transcript levels. We have 
also shown that by engineering different components of the promoter architecture a series 
of vectors with varying degrees of expression can be obtained (Table 2.1). Our study has 
shown that eukaryotic promoter engineering approaches can be focused at the enhancer 
region, at proximal sequences, the TATA box, and the core promoter, leading to a diverse 
and finely tunable level of gene expression. Future efforts to incorporate other responsive 
enhancers may lead to promoter engineering approaches that can finely tune both the 
transcription level as well as the environmental signal needed to activate transcription. 
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CHAPTER THREE 
DEVELOPMENT OF A STRONG YET TUNABLE FATTY ACID INDUCIBLE 
PROMOTER IN YARROWIA LIPOLYTICA 
 
 
Abstract 
The engineering of Yarrowia lipolytica to accumulate lipids with high titers and 
productivities has been enabled with a handful of constitutive promoters for pathway 
engineering. However, the development of promoters that are both strong and lipid 
responsive could greatly benefit the bioproduction efficiency of lipid-derived 
oleochemicals in oleaginous yeast. In this study, we sought to engineer a fatty acid-
regulated hybrid promoter for use in Y. lipolytica. We identified a 200 bp upstream 
regulatory sequence in the peroxisomal acyl CoA oxidase 2 (POX2) promoter. Further 
analysis of the promoter sequence revealed a regulatory sequence, that when used in 
tandem repeats, led to a 48-fold induction of gene expression relative to glucose and 4-
fold higher than the native POX2 promoter. To date, this is the strongest inducible 
promoter reported in Y. lipolytica. Taken together, our results show that it is possible to 
engineer strong promoters that retain strong inducibility. These types of promoters will 
be useful in controlling metabolism and as fatty acid sensors.  
 
 
 
† A version of this chapter is published in Biotechnology Journal 2017, 12(10), 1-11, with co-authors Ian 
Wheeldon, and Mark Blenner. 
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Introduction 
Metabolic engineering of microorganisms for bioproduction greatly benefits from 
transcriptional control of native or heterologous genes [215, 216]. Precision control of 
gene expression enables rapid pathway optimization [217]. To that end, significant work 
has been put into developing libraries of promoters with predictable strength for a 
number of microorganisms [32, 215, 218]; however, in even well-characterized 
eukaryotes, such as Saccharomyces cerevisiae, the toolkit of promoters remains small 
compared to bacteria. Given the benefits of metabolic engineering in yeast [219, 220], 
additional focus on expanding the yeast promoter toolkit is warranted. Random 
mutagenesis of promoters has resulted in only modest improvements in promoter strength 
[215]. Similarly, it has been quite simple to identify loss-of-strength mutations in 
promoters [215, 218]. Rational approaches to increasing promoter strength have focused 
on hybrid promoters, where heuristically identified, well-defined DNA elements called 
upstream activating sequences (UASs) are placed in front of a core promoter sequence 
and can be used in a modular fashion to tune transcription strength [80-82, 199, 221]. 
While improving the strength of yeast promoters has been successful, the toolkit is 
currently lacking many options for inducible promoters.   
 Libraries of constitutive promoters with different strength can be used to tune 
gene expression; however, the expression level is statically set.  Inducible promoters are 
useful genetic tools for metabolic engineering because, in addition to the benefits of 
being able to tune the transcriptional output, the expression level can be changed 
dynamically by metabolites or inducers. Inducible promoters can be especially important 
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to improve the carbon flux efficiencies in a metabolic process by separating the growth 
phase from the production phase of a cell [222, 223]. Additionally, if the excess 
production of an enzyme or a product is toxic to the cell, it would be beneficial to have 
production switched off so cell growth would not be inhibited until the desired biomass is 
made [184, 186]. Inducible promoters used in metabolic engineering of yeast have largely 
been endogenous promoters responsive to small molecules such as copper, methionine, 
tryptophan, and phosphate [224-227]. Unfortunately, these promoters exhibit complex 
regulation patterns and are of modest strength at best. One notable exception is the Gal 
promoter from S. cerevisiae, which is both strongly repressed by glucose and strongly 
activated by galactose [224]. An upstream regulatory sequence (URS) from the GAL1-10 
promoter has been used with a strong endogenous promoter, TDH, to confer galactose 
inducible control of the TDH promoter to create an inducible chimeric promoter [228]. 
Recently, a tryptophan inducible TDH promoter was engineered, using a mutant ARO80 
transcription factor and tandem repeats of the URSARO9, resulting in promoters that are 
both strong and induced by tryptophan [229].  
In recent years, there has been an increase in genetic tools for metabolic 
engineering in the oleaginous yeast, Y. lipolytica. The advancement of genetic tools [80, 
82, 83, 230] has enabled metabolic engineering in this microorganism to produce a 
significant amount of FAs [89] and lipids [190, 231, 232] from different substrates [95, 
233, 234]. Given the relative weakness of endogenous promoters, hybrid promoters have 
had great success in heterologous gene expression [82]. This success stems from the 
ability to tune expression strengths in hybrid systems. Whereas high expression is often 
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desired [190], the option to tune transcriptional strength to lower levels can be critical to 
attaining optimal heterologous protein production [235]. An important set of hybrid 
promoters developed in Y. lipolytica contain the UAS1B element originally derived from 
the nitrogen and pH regulated XPR2 promoter [199, 200]. When used in tandem, the 
UAS1B elements provide enhancement in expression independent of nitrogen level and 
pH [81, 82, 199]. Another hybrid promoter used for metabolic engineering contains 
UASTEF from the constitutive promoter of the translation elongation factor 1-α (TEF1-α) 
gene [81]. Strong expression of genes is enabled by hybrid promoters; however, the 
current set of strong hybrid promoters is limited. Although tunable in expression strength, 
hybrid promoters sometimes elicit carbon source dependent regulation from the UAS, as 
was previously demonstrated using the POX2 UAS1B [80]. While this property might be 
used to create regulated promoters, the inducibility is neither rational nor tightly 
regulated. There has only been one report of a rationally designed inducible hybrid 
promoter in Y. lipolytica. This alkane inducible promoter was constructed from repeats of 
an alkane response element, but confers relatively weak expression when grown on 
alkanes [114, 115, 120, 236]. Therefore, development of hybrid promoters that are 
inducible to a biomolecule that is both readily metabolized in Y. lipolytica and acts as a 
precursor molecule for the synthesis of several other important biomolecules is desirable. 
Fatty acids are ideally suited for this task. 
The native promoters from the peroxisomal acyl-CoA oxidase 2 (POX2), 
peroxisomal 3-ketoacyl-thiolase (POT1), and lipase 2 (LIP2) genes are commonly used 
as fatty acid inducible systems for metabolic engineering [117, 148, 206, 207, 237-239]. 
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While the expression strength of the inducible promoter of POX2 has previously been 
characterized as strong [110, 148, 240], we show that the POX2 promoter is relatively 
weak compared to the beta-actin promoter and engineered hybrid promoters. In this work, 
we performed a series of truncations to identify fatty acid-responsive UASs and URSs 
that were combined to construct a library of hybrid promoters. A URS, called R1, was 
initially found to be critically important for fatty acid responsiveness and promoter 
strength. The amplifying effect of the R1 sequence was shown to be synergistic with a 
UAS, called A1. Tandem repeats of the R1 sequences from the POX2 promoter were 
used to create a strong fatty acid inducible system. This new hybrid promoter was 
approximately four-times the strength of the native POX2 promoter and smaller in size. 
This promoter had a 48-fold oleic acid induction of expression relative to glucose. The 
promoter was also induced by other fatty acids and lipids but remained strongly repressed 
in glycerol and glucose. Stronger inducible promoters were engineered by placing tandem 
R1 sequences upstream of either the TEF1-α promoter minimal promoter or the TEF1-α 
intron promoter, achieving expression levels greater than 10-fold higher than the native 
POX2 promoter. The hybrid promoter described here is the first engineered and strongest 
fatty acid inducible promoter system for Y. lipolytica.  
 
Experimental Procedures 
Strains & Culture Conditions 
Plasmid propagation was performed using Escherichia coli DH10β competent 
cells (NEB). Transformations in  E. coli were performed using standard methods [241].   
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strain PO1f (ATCC MYA-2613; MATa leu2−270 ura3−302 xpr2−322 axp) was 
purchased from ATCC.  Transformations were done using the lithium acetate method as 
previously described with a minor modification for cell propagation after the 
transformation [80]. Briefly, following the heat shock step, the cells were mixed with 800 
µL of 0.1 M lithium acetate, spun down at 6,000 x g for 2 minutes (4°C) and re-
suspended in 100 µL of 0.1 M LiAc buffer prior to inoculating 2 mL cultures that were 
grown in 14 mL culture tubes. All cultures were grown at 215 rpm and 28 °C. 
Transformations and growth were performed in biological triplicates.  was grown in 
Yeast Synthetic Complete media without leucine (YSC-LEU) comprised of 6.7 g/L yeast 
nitrogen base (YNB) without amino acids (Difco) and 0.69 g/L CSM-LEU (Sunrise 
Science Products). Carbon substrates used for characterization during the construction of 
the hybrid promoter were 2% (v/v) oleic acid (EMD Millipore) emulsified in 0.05% (v/v) 
Tween 80, and 2% (w/v) D-glucose. Other substrates that were used to characterize the 
substrate responsiveness of the hybrid promoter were all added at 30 mM, an equimolar 
concentration equivalent to 2% (v/v) oleic acid. These substrates include glycerol, 
linoleic acid (Alfa Aesar), triolein (Tokyo Chemical Industry), chicken fat (Animal 
Coproducts Research and Education Center, Clemson University) and n-decane. In cases 
where two carbon substrates were used, each was added at a final concentration of 15 
mM. The hydrophobic substrates in the dual carbon experiments were emulsified with 
Tween 80 at a final concentration of 0.05% (v/v). 
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Promoter and Plasmid Design 
All primers used to create the hybrid promoters designed in this study are 
presented in Supplementary Table 3.1. Unless otherwise stated, sequence and ligation 
independent cloning (SLIC) [201, 242] was used for cloning, and all PCRs were 
performed from genomic DNA. The base vector used for cloning was pSL16-CEN1-
UAS1B8-POX2(100 bp)-hrGFP. [80] Our previous work identified a large region of the 
POX2 promoter that was important for POX2 promoter fatty acid responsiveness (-1590 
bp to -513 bp) [80]. Within this region, we made periodic truncations using the primer 
pairs described in Section 1 of Table 3.1. The truncated POX2 promoter PCR fragments 
were inserted between the SphI/AscI restriction sites using SLIC. Hybrid promoter 
systems containing UAS1POX2 and UAS2POX2 (A1A2), UAS2POX2 and UAS3POX2 (A2A3) 
and UAS1POX2 and UAS3POX2 (A1A3) were constructed by performing a three-piece 
SLIC with each UAS and the base vector as described in Section 2 of Table 3.1. To 
construct A1A2A3, the A2 fragment was PCR amplified and inserted into the A1A3 
vector at the MfeI site, as shown in Section 3 of Table 3.1. Inserts A1R1 and A1R1A2R2 
were PCR amplified from genomic DNA and inserted in the base vector A1A3 digested 
with AvrII / SphI.  Promoters containing URS1POX2 (R1) and URS2POX2 (R2) were 
constructed by PCR and cloned in between the SphI and AscI sites of the base vector 
(Section 4 of Table 3.1). The R1 sequence was inserted between into A2A3 and A1A3 
respectively using the MfeI site (Sections 5 and 6 of Table 3.1). Additional R1 sequences 
were inserted to make A1(R1x2)A3 and A1(R1x3)A3 (Section 7 and 8 of Table 3.1). 
Construction of the R1A3 plasmid required the R1A3 insert be PCR amplified from the 
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A1R1A3 vector and inserted into the A1R1A3 base vector digested with AvrII / SphI. 
A1R1A1R1A3 was created by PCR amplifying the A1R1 sequence from gDNA and 
inserting it into the A1R1A3 vector digested with MfeI. To create the fatty acid inducible 
hybrid promoter containing the TEF(136) (Section 9 of Table 3.1), TEF(136)-hrGFP was 
PCRed from a previously constructed vector [243] and the A3 fragment was PCRed from 
the POX2 promoter. These fragments were inserted into a MfeI / AscI-digested hybrid 
fatty acid vector (Section 8 of Table 3.1). Construction of the fatty acid inducible 
promoter containing the TEF-intron utilized the same strategy instead, in this case, the 
TEF-intron-hrGFP vector had to first be constructed as described in Sections 10 and 11 of 
Table 3.1. The vector constructed in Section 11 of Table 3.1 was then used as the 
template to PCR the TEF-intron-hrGFP.  
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Table 3.1. Detailed list of vectors and primers used to construct hybrid promoters tested 
in this study.    
 Starting Vector Restriction 
Enzymes 
Primer 
Pair(s) 
Final Vector(s) 
1 pSL16-UAS1B8-
POX2(100 bp)-hrGFP 
SphI / AscI F1 / R1 
F2 / R1 
F3 / R1 
F4 / R1 
F5 / R1 
F6 / R1 
F7 / R1 
F8 / R1 
F9 / R1 
POX2(1590 bp)-hrGFP 
POX2(1390 bp)-hrGFP 
POX2(1190 bp)-hrGFP 
POX2(990 bp)-hrGFP 
POX2(790 bp)-hrGFP 
POX2(540 bp)-hrGFP 
POX2(513 bp)-hrGFP 
POX2(430 bp)-hrGFP 
POX2(100 bp)-hrGFP 
2 pSL16-UAS1B8-
POX2(100 bp)-hrGFP 
XmaI / SphI F10 / R2 
F11 / R3 
F12 / R4 
F13 / R5 
F10 / R6 
F11 / R5 
A1A2-POX2(100bp)-
hrGFP or  
A1A2 
A2A3-POX2(100bp)-
hrGFP or  
A2A3 
A1A3-POX2(100bp)-
hrGFP or  
A1A3 
3 A1A3  MfeI F11 / R4 A1A2A3-POX2(100bp)-
hrGFP or A1A2A3 
4 A1A3 AvrII / SphI  F10 / R11 A1R1-POX2(100bp)-
hrGFP or 
A1R1 
5 A1A3 AvrII / SphI F10 / R12 A1R1A2R2-
POX2(100bp)-hrGFP or 
A1R1A2R2 
6 pSL16-UAS1B8- SphI / AscI F10 / R3 A1R1A2-POX2(100bp)-
hrGFP or A1R1A2 
 POX2(100bp)-hrGFP  F12 / R5 A2R2A3-POX2(100bp)-
hrGFP or A2R2A3 
7 A2A3 MfeI F15/ R7 A2R1A3-POX2(100bp)-
hrGFP or A2R1A3 
8 A1A3 MfeI F16 / R7 A1R1A3-POX2(100bp)-
hrGFP or A1R1A3 
9 A1A3 MfeI F22 / R13 A1R1A1R1A3-Pox2(100 
bp)-hrGFP or 
A1R1A1R1A3 
9 A1R1A3 MfeI F17 / R7 A1(R1x2)A3-
POX2(100bp)-hrGFP or 
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A1(R1x2)A3 
10 A1R1A3 AvrII / SphI F21/ R5 R1A3-POX2(100bp)-
hrGFP or 
R1A3 
11 A1(R1x2)A3 MfeI F17 / R7 A1(R1x3)A3-
POX2(100bp)-hrGFP or 
A1(R1x3)A3 
12 A1(R1x3)A3 MfeI / AscI F18 / R8 
F19 / R9 
A1(R1x3)A3-
TEF(136bp)-hrGFP 
13 pSL16-UAS1B8-
TEF(136)-hrGFP 
PstI / NheI gBlock® pSL16-UAS1B8-TEF-
intron 
14 pSL16-UAS1B8-TEF-
intron 
BtgZI F20 / R10 pSL16-UAS1B8-TEF-
intron-hrGFP 
15 A1(R1x3)A3-
POX2(100bp)-hrGFP or 
A1(R1x3)A3 
MfeI / NheI F18 / R8 
F19 / R9 
A1(R1x3)A3-TEF-intron-
hrGFP 
 
 
RNA Extraction and Quantitative PCR 
RNA extractions were performed on cell cultures that were grown until mid-
exponential phase. Prior to RNA extraction, all cell cultures were normalized to an 
OD600 of 10 and 1 ml was used for the extraction using the Omega Biotek RNA 
Extraction Kit with the optional DNaseI digestion step. qPCR was done using the CFX 
Manager real-time machine from Bio-Rad. In accordance with MIQE guidelines, 
standard curves for quantification of hrGFP and beta-actin were created and the 
efficiency of each primer pair was calculated. Two housekeeping genes, beta-actin and 
TEF1-α were used as reference genes to initially validate analysis method. An equal mass 
of RNA from each of the samples was loaded. Protocols for qPCR conditions are 
described in protocols provided by the qPCR kit supplier. A relative quantification 
method was used to determine GFP expression. Standard curves were used to calculate 
copy numbers for the above-mentioned genes taking into account priming efficiency. The 
 81 
ratio of GFP mRNA copy number to beta-actin mRNA copy number was used to quantify 
changes in expression strength for the different POX2 promoter truncations. qPCR was 
used to measure GFP expression instead of flow cytometry because of its higher 
sensitivity.  
 
GFP Fluorescence Analysis 
 During the development of the POX2 promoter, fluorescence spectroscopy with 
the Biotek Synergy MX fluorescence spectrophotometer was the method of choice for 
characterization of promoter strength. Cells grown in glucose were spun down at 6000 x 
g (4 °C) for 2 minutes and re-suspended in 0.1 M Phosphate Buffered Saline (PBS) (pH 
7) while cell cultures from oleic acid were spun down, washed once with 0.1 M PBS 
containing 5% (v/v) Tween 80 and re-suspended in 0.1 M PBS. All cell cultures were 
grown for 36 hours, between mid and late exponential phase, where OD600 values across 
the samples were similar. The harvested cells were placed in 96 well plates and serial 
dilutions of the cells were performed to obtain an average fluorescence (Ex. 485 nm and 
Em. 510 nm). Serial dilutions were performed to obtain a fluorescence value in the linear 
range of detection without changing the gain for each experiment. The same gain was 
used for all measurements. The BD Accuri® C6 Flow Cytometer was used for promoter 
characterization with different carbon sources. In all flow cytometry measurements, 
20,000 single cell events were counted and fluorescence was measured using the GFP 
channel. VirtualGain® was used to normalize the gain across all samples post-analysis. 
Fluorescent cell populations were gated and the same gate was used across all samples 
analyzed in each day. To obtain the specific mean fluorescence, the mean fluorescence of 
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the non-fluorescent cells was subtracted from the mean fluorescence of the gated 
fluorescent cells. 
 
Results 
Identification of Fatty Acid Responsive Upstream Sequences in the POX2 Promoter 
  The most common approach for identifying UASs and URSs by measuring 
expression strength determined by a reporter gene from truncated promoters [81, 221, 
244-246]. Such a description of the promoter architecture provides information about 
important DNA sequences in the promoter but leaves unanswered questions about the 
nature of these sequences and how they contribute to gene regulation patterns. 
Nevertheless, in systems such as Y. lipolytica, our lack of understanding of gene 
regulation prevents a more informed promoter engineering strategy a priori.  
  We previously made truncations to the POX2 promoter and identified a large 
region upstream (1590 bp) of the POX2 gene that is required for measurable transcription 
in glucose-free oleic acid media [80]. As a result, we chose to make truncations from the 
5’ end of the POX2(1590 bp) promoter at 200 bp intervals (Figure 3.2A). Our rationale 
for choosing these particular truncations was based on the identification of putative Por1p 
binding sites (Figure 3.1A). Por1p (YALI0D12628p) is a Y. lipolytica homolog of the 
fatty acid-responsive FarA transcriptional factor in Aspergillus nidulans [208, 247]. 
Homologs for S. cerevisiae fatty acid-responsive transcription factor Oaf1p do not exist 
in Y. lipolytica or other oleaginous yeast. Therefore, the well-studied S. cerevisiae 
regulatory system does not inform our work. 
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Quantitative PCR was used to detect changes in transcriptional profiles resulting 
from POX2 truncations (Figure 3.2B). In YSC-LEU media with oleic acid, there is a 
general decrease in expression strength with truncations moving towards to the core 
promoter. A four-fold decrease in mRNA copy number was observed between POX2 
(1590 bp) and POX2 (1190 bp), suggesting the presence of an activating sequence we 
call UAS1POX2 or A1. Another significant change in mRNA transcript was observed 
between POX2 (990 bp) and POX2 (540 bp); therefore, we call this region UAS2POX2 or 
A2. A smaller drop in expression was observed between POX2 (438 bp) and the core 
promoter, POX2 (100 bp), defining a third activating sequence, UAS3POX2 or A3. This 
truncation strategy also enabled us to identify regions in the native POX2 promoter where 
a single 200 bp truncation lead to a three-fold increase of transcriptional activity, as seen 
between the POX2 (1190 bp) and POX2 (990 bp) promoters. We call this upstream 
regulatory sequence URS1POX2 or R1. A similar repressor sequence was observed for the 
truncation between POX2 (540 bp) and POX2 (438 bp), albeit to a weaker extent than 
R1, that we call URS2POX2 or R2. Using this truncation strategy, we were able to map 
sequences in the native POX2 promoter that were potential fatty acid-responsive 
activating sequences and other sequences that appeared to behave as repressor sequences, 
although further investigation was required. 
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Figure 3.1. Identification of activating and regulatory sequences in the POX2 promoter. 
(A) Identification of hypothetical POR1p binding sites in the POX2 native promoter that 
were used to guide rational 5’ truncations. (B) Schematic of systematic truncations were 
made to the native POX2 promoter to identify DNA fragments containing hypothetical 
fatty acid-responsive transcription factor binding sites. (C) Changes in truncated 
promoter strength were monitored with real-time PCR measurements of GFP mRNA 
relative to control beta-actin. Activating sequences (A1, A2, A3) were defined as those 
resulting in loss of transcriptional activity when truncated. Regulatory sequences (R1, 
R2) were defined as those resulting in either gain or constant transcriptional activity 
when truncated. The data are the average of mRNA copy number relative to beta-actin 
determined from biological triplicates. The error bars are the standard deviation of 
biological triplicates.   
 
Discovery of a Fatty Acid Inducible Upstream Regulatory Sequence from POX2 
By performing promoter truncations, 3 UASs and 2 URSs were identified in the 
native POX2 promoter. Our initial hypothesis was that by removing URSs, equivalent to 
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combining the 3 UASs, would increase the fatty acid inducible expression. Furthermore, 
we reasoned the loss of UASs unimportant for fatty acid-regulated transcription would 
not greatly impact transcription. To test these hypotheses, we constructed promoters with 
various combinations of UAS in tandem (Figure 3.2A), expecting to obtain a promoter 
more strongly induced by oleic acid. When all three UASs were combined (A1A2A3), 
expression in YSC-LEU with oleic acid was diminished compared to the full native 
POX2 promoter (Figure 3.2B), suggesting the URSs might have a more complex role 
than could be predicted by the truncation experiments. This idea will be explored in 
section in the results following this section. When A3 was removed, resulting in promoter 
A1A2, transcription was further decreased, suggesting an important role for the A3 
sequence. By restoring the A3 sequence and removing the A1 to create promoter A2A3, 
expression strength recovered to a value closer to that of the native POX2 promoter, 
further validating the importance of A3. When A2 was removed, resulting in promoter 
A1A3, gene expression was now comparable to the native POX2 promoter, suggesting 
that the A2 is dispensable and actually inhibitory in the context of these hybrid 
promoters. The A1A2 hybrid promoter that lacks the A3 sequences confers the weakest 
expression while A1A3, which is half the size of the native promoter, confers the 
strongest expression. These results suggest that the A1 and A3 sequence combine to 
provide an essential function for the A1A3 promoter. It should be noted that two tandem 
copies of the either A1 or A3 were tested and expression was significantly weaker than 
the native POX2 promoter (Supplementary Figure 3.1). Furthermore, these UAS 
sequences elicited a positional dependence as switching the order of A1A3 to A3A1 
 86 
resulted in a significant drop in fluorescence (Supplementary Figure 3.1), suggesting 
again that substantial complexity exists in these systems. All promoters showed almost 
no expression when cells were cultured in YSC-LEU with glucose (Figure 3.2B). 
From the initial 5’ truncation data, removal of either the R1 or R2 sequences 
conferred an increase in transcriptional activation suggesting their role as repressor 
sequences. However, because of the unexpected results from 5’ truncations, we created a 
series of 3’ truncations (Figure 3.2C). Promoter A1R1A2R2 has oleic acid-induced 
transcription similar to but lower than POX2 (Figure 3.2D), indicating the importance of 
A3. Further truncation to create A1R1A2 resulted in increased transcription, producing 
GFP similar to the POX2 promoter. This result is consistent with our previous findings 
that R2 is a regulatory sequence that acts as a repressor. The relative unimportance of the 
A2 sequence is further confirmed by oleic acid-induced expression from A1R1, which is 
similar to A1R1A2.    
By comparing the results in Figure 2B and D, it became clear R1 also exhibited 
complex behaviors not predicted by the original truncation experiment. These data 
suggest that R1 can act as an activator when placed after the A1 sequence, contrary to the 
repression observed when the A1 sequence was removed from the native POX2 promoter 
during our truncation experiments (Figure 3.1). The same amplifying effect of the R1 
sequence was not observed when the R2 sequence was placed in its natural position 
between the A2 and A3 sequences in promoter A2R2A3 (Supplementary Figure 3.1). The 
R1 sequence, when placed between the A2 and A3 sequences (A2R1A3) also did not 
confer strong activation of the promoter (Figure 3.2D), suggesting that there is a 
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synergistic effect between the A1 and R1 sequence. The R1A3 promoter shows lower 
expression than A1R1, however, the difference is not statistically significant. The results 
here demonstrated the importance of the R1 sequence as an enhancer element when 
paired with the A1 and perhaps A3 sequence. This is also suggested by the A1R1 data in 
Figure 3.2D. To support this hypothesis, we created promoter A1R1A3, which combines 
the synergistic effects of A1R1 and the A3 sequence. This promoter was nearly three-fold 
stronger than the native POX2 promoter and serves as the foundation for building even 
stronger fatty acid inducible promoters.  
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Figure 3.2. Discovery of the R1 UAS from the POX2 promoter. (A) New promoters were 
designed by combining parts of the POX2 promoter upstream of the POX2 core 
promoter. Activating (A1, A2, and A3) sequences were previously identified by 5’ 
truncations. (B) Promoter strength is determined by expression of hrGFP and measured 
as mean fluorescence of an equal number of transformed cells grown in YSC-LEU with 
either glucose or oleic acid. Glucose samples are shown on the left and oleic acid on the 
right. A1 and A3 are important for oleic acid responsiveness, while A2 appears 
dispensable. (C) New promoters were designed by combining 5’ and 3’ truncations of the 
POX2 promoter upstream of the POX2 core promoter. Activating (A1, A2, and A3) 
sequences previously identified by 5’ truncations. Regulatory (R1 and R2) sequences 
were previously defined by 5’ truncations. (D) Promoter strength quantified by 
expression of hrGFP shows the R1 sequence results in strong expression in oleic acid 
media compared to glucose media. Glucose samples are shown on the left and oleic acid 
on the right. The R1 sequence appears to work synergistically with the A1 sequence. The 
data are the average of mean fluorescence measurements from biological triplicates. The 
error bars are the standard deviations of biological triplicates. 
 
Engineering a Strong Fatty Acid Inducible Hybrid Promoter 
Including the R1 in between the A1 and A3 sequences to form hybrid promoter 
A1R1A3 resulted in strong oleic acid activation compared to the native POX2 promoter 
and was a logical starting point to design a stronger fatty inducible promoter. Based on 
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previous hybrid promoter work [81, 82, 248], we hypothesized that we could increase the 
oleic acid inducible transcriptional activation using tandem repeats of the R1 sequence. 
Therefore, hybrid promoters containing 0-3 copies of the R1 sequences were created 
(Figure 3.3A) and compared to the native POX2 promoter. The addition of each copy of 
the R1 sequence increased gene expression induced by oleic acid while the expression in 
glucose remained significantly and equally repressed, demonstrating the oleic acid 
inducible nature of the R1 sequence (Figure 3.3B). Addition of the first R1 sequence 
created a 2-fold increase in expression while subsequence additions of R1 sequences lead 
to about a 4-fold improvement in expression strength compared to the native POX2 
promoter. Furthermore, we were able to improve the fold induction in oleic acid to 48-
fold in the A1(R1x3)A3 hybrid promoter compared to the 19-fold induction in the native 
POX2 promoter (Figure 3.3C). Another promoter, (A1R1)x2A3 was created and had 
similar expression levels in oleic acid media as well as similar fold induction (Figure 
3.3B, C). Given its larger size compared to A1(R1x3)A3, we chose to move forward with 
the smaller promoter. This new inducible hybrid promoter demonstrates the ability to 
engineer a tightly regulated oleic acid inducible switch and to tune the transcriptional 
output of the activated promoter.   
The A1(R1x3)A3 promoter is already comparable in strength to strong hybrid 
promoters containing UAS1B8 and the POX2 core promoter (Supplementary Figure 3.2). 
We have previously shown that the strength of a hybrid promoter can be tuned by 
manipulating the modular elements of the promoter [80]. We demonstrate additional 
improvements to the A1(R1x3)A3 promoter by replacing the weaker POX2 core 
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promoter with the stronger TEF(136) and TEF-intron core promoter (Supplementary 
Figure 3.2A), resulting in an additional two-fold and a three-fold increase in expression, 
respectively (Supplementary Figure 3.2B). Engineering the modular core promoter 
element allows us to tune the induction strength over a 10-fold range of expression; 
however, the increased expression in glucose led to a reduction in the fold induction 
(Supplementary Figure 3.2C). The core promoter is likely to exhibit some level of 
regulation mediated by regulatory TFs that bridge URS and the core promoter [249].  
 
Figure 3.3. Engineering a strong fatty acid inducible hybrid promoter. (A) Schematic of 
hybrid promoters constructed with tandem repeats of the POX2 R1 sequence and A1R1 
sequence. (B) Promoter strength is determined by expression of hrGFP and measured as 
mean fluorescence of an equal number of transformed cells. Glucose samples are shown 
on the left and oleic acid on the right. (C) Promoter induction using oleic acid as the 
carbon source relative to glucose as carbon source. In (B) and (C) the data are the average 
of mean fluorescence measurements from biological triplicates. The error bars are the 
standard deviation of biological triplicates.  
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The A1(R1x3)A3 Hybrid Promoter is a Fatty Acid Sensor 
To better understand how different substrates affect transcription from the 
A1(R1x3)A3 hybrid promoter, we used flow cytometry to measure hrGFP expression 
controlled by A1(R1x3)A3 and compared it to the native POX2 promoter. Figure 4A 
shows that while both promoters were activated by various fatty acids (oleic and linoleic 
acid) and lipids (triolein and chicken fat), the inducible hybrid promoter A1(R1x3)A3 is 
consistently stronger than the native POX2 promoter. Linoleic acid elicited the highest 
transcriptional response for both promoters (Figure 3.4A). In all fatty acid and lipid 
substrates, the A1(R1x3)A3 promoter is two-to-four-fold stronger than the POX2 
promoter (Figure 3.4B). Tween 80 was used as an emulsifier for fatty acid media and on 
its own does not elicit strong transcriptional activation. 
When glucose, glycerol, or n-decane are used as the sole carbon source, the 
hybrid promoter remains strongly repressed, with only basal transcriptional activity 
similar to the native POX2 promoter. In media containing both glucose and oleic acid, the 
native POX2 promoter remained repressed, while the A1(R1x3)A3 hybrid promoter was 
strongly activated, suggesting the hybrid promoter is not catabolite repressed. 
Interestingly, in media containing both glycerol and oleic acid, both the native POX2 
promoter and the A1(R1x3)A3 hybrid promoter were more strongly activated than oleic 
acid alone. The mechanism underlying this synergy remains unclear, however, a similar 
behavior was reported for the Lip2 promoter [117]. 
 92 
 
Figure 3.4. Substrate responsive induction of the A1(R1x3)A3 hybrid promoter. (A) 
Promoter strength was measured by hrGFP expression using flow cytometry. The 
A1(R1x3)A3 hybrid promoter is most strongly induced by linoleic acid and is strongly 
repressed by glucose and glycerol. Interestingly a combination of glycerol and oleic acid 
synergistically activated the hybrid promoter. (B) Fatty acids and mixtures of fatty acids 
with other carbon sources more strongly activate the hybrid promoter A1(R1x3)A3 
compared to the native POX2 promoter. In (A) and (B), the data are the average of mean 
fluorescence measurements from biological triplicates. The error bars are the standard 
deviation of biological triplicates.  
 
Fatty Acid Induction of the A1(R1x3)A3 Hybrid Promoter 
In order to use the A1(R1x3)A3 promoter as an fatty acid inducible promoter, we 
grew cells to stationary phase in YSC-LEU glucose media and then induced the 
A1(R1x3)A3 promoter by titrating oleic acid into the media, at concentrations ranging 
from 0.25% (v/v) to 8%(v/v). The induction was measured using fluorescence 
spectroscopy. At all concentrations tested within this range, we observe nearly identical 
induction profiles of the hybrid promoter. This suggests the A1(R1x3)A3 promoter can 
be induced at oleic acid concentrations as low as 0.25% (v/v) during the stationary phase 
(Supplementary Figure 3.3).  
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Given the high sensitivity of the hybrid promoter, we determined if other fatty 
acids would similarly induce the hybrid promoter at this low concentration. We used 
0.25% (v/v) of oleic (OA), linoleic (LA), arachidonic (ARA), and eicosapentaenoic 
(EPA) acids in YSC-LEU to induce the hybrid promoter in the stationary phase. The 
hybrid promoter is strongly and similarly induced by the different fatty acids (Figure 
3.5A-D) while glucose did not induce GFP expression (Figure 3.5E). The fatty acid 
induction profiles for the A1(R1x3)A3 promoter, when induced at stationary phase with 
EPA, appears stronger than other fatty acids, however, the error associated with these 
stationary phase measurements makes the difference of low statistical confidence.  
 
Figure 3.5. Inducibility of the A1(R1x3)A3 hybrid promoter by different fatty acids. 
Cells were grown to stationary phase with glucose and induced by the addition of 0.25% 
(v/v) of fatty acid. Induction was monitored over 20 hours using a fluorescence plate 
reader. Fatty acids used in this experiment include: (A) oleic acid (OA, 18:1), (B) linoleic 
acid (LA, 18:2), (C) arachidonic acid (ARA, 20:4 ω-6), (D) eicosapentaenoic acid (EPA, 
20:5 ω-3) and (E) Glucose as a control shows no induction. The data are the average of 
mean fluorescence measurements from biological triplicates. The error bars are the 
standard deviation of biological triplicates.  
 
Discussion and Conclusion 
Our work has resulted in the development of a fatty acid inducible hybrid 
promoter for Y. lipolytica. UAS and URS sequences were initially identified using a 
rational truncation strategy; however, our subsequent experiments resulted in different 
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conclusions about the roles of the A1 and R1 sequences when tested in isolation of the 
native POX2 promoter. Therefore, the truncation approach is useful in identifying 
functionally important sequences of promoters, but in this case, fails to correctly identify 
how these sequences will work in different contexts. This analysis showed that the R1 
sequence contains a fatty acid response element and that it acts synergistically with the 
A1 sequence. Hybrid promoters with tandem repeats of the R1 sequence lead to increased 
transcriptional strength in oleic acid media (four-fold stronger than native POX2) while 
maintaining tight repression in glucose media (48-fold induced by oleic acid). These 
hybrid promoters are strongly activated by a variety of long chain fatty acid and lipids. 
Interestingly, the engineered hybrid promoter is not catabolite repressed in contrast to the 
native POX2 promoter and carbon metabolism promoters [227, 250-252].  
The only comparable work in Y. lipolytica focuses on alkane responsive elements 
(AREs). Prior studies have identified a URS in the ALK1 gene (responsible for alkane 
oxidation in alkane metabolism) that contains an ARE that binds the Yas1p/Yas2p TFs 
[120]. A hybrid promoter containing three copies of the ARE1 sequence were placed 
upstream of the LEU2 core promoter, resulting in 6-fold activation on n-decane 
compared to glucose. By comparison, the A1(R1x3)A3 promoter is 48-fold activated by 
fatty acids compared to glucose. While differences in assay methods prevent a direct 
comparison of the strength of these two promoters, we have shown alkane promoters are 
significantly weaker than the beta-oxidation promoters (Supplementary Figure 3.4). This 
finding opens opportunities to engineer additional responsive hybrid promoter tools for Y. 
lipolytica.    
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Enabled by a deeper understanding of its genetics, there has been more work 
engineering strong inducible promoters in S. cerevisiae. For example, the most well 
studied inducible yeast promoter is the Gal1-Gal10 system. It exhibits remarkably low 
basal transcription in glucose-containing media and activated up to four orders of 
magnitude by galactose. These levels of regulation are determined by the combination of 
six repressing operator sites that overlap four Gal4p binding sites [253]. Analogously, 
further improvements to our fatty acid-responsive hybrid promoter may be possible once 
the TFs that bind to the R1 sequence of POX2 are identified. 
We demonstrated that combining the hybrid promoter containing R1 repeats with 
other core promoters, including the TEF(136) and TEF-intron core promoters increased 
both the basal level expression and the induced expression. This result was expected in 
light of work combining different S. cerevisiae UAS sequences. For example, combining 
a constitutive UAS from CYC1 with the Gal1 or Gal10 promoter elements resulted in 
galactose regulated expression [228]. Stronger hybrid promoters were engineered by 
placing the UASgal upstream of weak core promoters (pLEU and pCYC) leading to 
glucose repression and galactose activation; however, when UASgal was placed upstream 
of strong core promoters (pTEF and pTDH3), a higher level of basal expression in 
glucose was observed [58]. This study also directly used individual Gal4p binding sites to 
further tune and enhance promoter regulation. More recently, ultra-strong and tryptophan 
regulated promoters were created by placing 5 UASaro sequences upstream of the TDH 
core promoter [229]. These promoters were 1.7-fold stronger than the TDH promoter and 
had 14-fold induction by tryptophan. Future efforts to increase promoter strength and 
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maintain strong inducibility would benefit from an additional focus on upstream 
sequences, transcription factor binding sites, and less emphasis on strong core promoters.     
UASs and URSs from native promoters have traditionally been identified through 
truncation studies [81, 200, 244]. While this method proves to be a solid foundation for 
identifying the parts needed for hybrid promoters, it fails to always capture the 
complexity of eukaryotic transcription regulation, which is controlled by the association 
of multiple transcriptional factors to their cognate binding sites [254, 255]. Because of 
the heuristic way in which UASs and URSs are identified, they are inherently subject to 
context-dependent behaviors. Our work demonstrates the difficulty encountered as a 
result of this disconnect. The UAS/URS sequences contain multiple and often 
overlapping transcription factor binding sites enabling higher strength transcription or 
regulation of transcription [228]. Unlike S. cerevisiae, there are few studies on Y. 
lipolytica TFs or transcription factor binding site motifs, and at least with respect to fatty 
acid metabolism, TFs in S. cerevisiae do not always have homologs in Y. lipolytica. To 
date, there has been only one transcription factor associated with fatty acid regulation. 
Deletion of the POR1 gene causes some growth defect on oleic acid and a reduction in 
POX2 mRNA expression [208]. As POR1p is a homolog of FarA from A. nidulans, 
POR1p may bind a similar DNA sequence. Putative POR1p binding sites were found in 
the R1 region, suggesting a significant role of POR1 in regulating the A1(R1x3)A3 
promoter. A better understanding of TFs and their binding sites may lead to a more direct 
identification UAS/URS sequences and more rapid design of regulated hybrid promoters.  
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 The A1(R1x3)A3 promoter is induced by a several different long chain fatty 
acids, including OA, LA, ARA, and EPA. Interestingly, stationary phase induction 
(Figure 3.5) of this promoter was nearly identical for OA, LA, and ARA, whereas when 
cells were grown on the fatty acids (Figure 3.4), LA more strongly induced the promoter. 
EPA caused the greatest induction of the hybrid promoter, which was unexpected since 
EPA is not synthesized by Y. lipolytica. When measuring induction during growth, the 
hybrid promoter was not repressed by glucose or glycerol when co-fed oleic acid, 
consistent with recent observations for the native Lip2 promoter;  however, the PO1f 
strain used in our study does not co-utilize glucose and oleic, so the results shown by 
Sassi et al. [117] showing Lip2 promoter induction was strongest with a 40/60 mixture of 
glucose and oleic acid (w/w), are not likely to work in all strains. These works do suggest 
a potential strategy for fatty acid inducible gene expression when using glucose or 
glycerol as a substrate.  
The fatty acid-regulated hybrid promoter created in this study represents a 
significant advance in the toolkit for engineering. We demonstrated the identification of a 
URS, R1, and its construction into a fatty acid-regulated promoter significantly stronger 
than the native POX2 promoter. We also showed that the hybrid promoter design can 
lead to the tuning of both the transcriptional output as well as the inducibility of the 
promoter. This promoter system is one of the strongest identified and is the strongest 
inducible promoter for Y. lipolytica. This regulated promoter has great promise for use as 
a sensor for strain engineering applications, for dynamic regulation of heterologous gene 
expression, or as an inducible promoter for toxic genes. We anticipate further 
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development of regulated and strong promoters to expand the genetic engineering tools 
available for Y. lipolytica.    
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CHAPTER FOUR 
USING DNA ACCESSIBILITY AS A ROBUST APPROACH TO ENGINEER NOVEL 
HYBRID INDUCIBLE PROMOTERS 
 
Abstract 
Inducible promoters are powerful genetic tools in metabolic engineering as they 
allow for an added layer of control of metabolic processes. In the yeast, Yarrowia 
lipolytica, these types of promoter systems are poorly characterized. Here, we 
investigated a novel mechanism to engineer hybrid inducible systems by measuring 
changes in DNA accessibility that can result from the interaction of regulatory 
transcription factors with DNA and chromatin structure. The Acyl CoA oxidase 2 
promoter (POX2) in Y. lipolytica is one of the best understood inducible systems, 
activated by fatty acids and repressed by either glucose or glycerol. The DNA binding 
sites of the POR1p transcription factor were mapped to the native POX2 promoter. These 
binding sites were found at the edges of regions where changes in DNA accessibility was 
visible under induced and non-induced conditions. The functionally important binding 
sites on the POX2 promoter were elucidated via site-directed mutagenesis studies. The 
role of POR1p and CFU1p, both implicated in the regulation of beta-oxidation genes, 
were knocked out. The findings presented here provide new insight into the development 
of hybrid, tunable inducible promoters in a more robust and efficient manner. 
 
¥ This work will be included in a future publication with co-authors Scott Anglin, Sara Edgecomb, and 
Mark Blenner. 
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Introduction 
Advancements in synthetic biology have revolutionized the field of microbial cell 
factories for sustainable chemical production. The ability to efficiently screen, sequence 
and annotate genomes of new microbes has enabled the shift from traditional hosts such 
as Escherichia coli and Saccharomyces cerevisiae to non-conventional microbes bearing 
unique native traits. The growth of Trichosporon oleaginosus on aromatics to accumulate 
lipids [70] or the ability of Y. lipolytica to tolerate many environmental factors, above all 
pH [256] or grow on hydrocarbons such as alkanes to produce lipids [257] are a few 
examples of superior features of non-conventional yeasts. 
With recent success in developing genome editing tools, [83, 140, 230], 
engineering metabolic pathways and developing stable strains in Y. lipolytica has become 
easier. Making these pathways efficient requires tunable expression of enzymes to guide 
flux of metabolites. To date, only a handful of hybrid promoters exist to enable this 
process [80-82, 116, 127, 217]. The most commonly used hybrid promoters are 
constitutive providing one dimension of control that is expression strength. If we are to 
improve pathway efficiencies, more means to control enzyme expression by selectively 
inducing enzymes at different times during growth is important. This can be 
accomplished with inducible promoters. 
Inducible promoter systems have gained interest as a “next-level” genetic tool that 
can be used to modulate expression strength and control the timing of expression. By 
doing so, these systems can significantly improve the efficiency of microbial engineering 
processes [258, 259]. In Y. lipolytica, tunable and inducible promoters are poorly 
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understood because there is insufficient knowledge on promoters that demonstrate 
inducibility. Furthermore, transcription factors and mechanisms for regulation of such 
promoters are not known. Understanding how inducible promoters work could motivate 
rational engineering of novel metabolite and non-metabolite hybrid inducible promoter 
systems.  
To date, strategies to engineer hybrid promoters have relied on heuristic methods 
such as truncating the promoter from either the 5’ or 3’ end and coupling it to a reporter 
gene coding for beta-galactosidase or green fluorescent protein to quantitatively measure 
the expression strength [81, 116, 122, 221]. Any loss or gain in reporter activity from 
truncations was used to identify the promoter regions as either an enhancer or repressor 
sequence. Heuristic approaches can fail for two reasons. First, there is the likelihood of 
truncating within the regulatory region of the promoter that can affect the affinity of a 
transcription factor to the binding domain. This approach also does not account for 
complex regulatory mechanisms typical of eukaryotic promoters resulting from the 
interaction of two or more transcription factor binding sites [260, 261]. Second, heuristic 
approaches do not account for DNA accessibility that results from dynamic changes in 
histone modifications to regulate gene expression, which is covered below.   
In this chapter, we describe a new method for the development of next-generation 
inducible, yet tunable promoter systems by investigating changes in DNA accessibility of 
the promoter on the genome under conditions that induce or repress gene expression. 
Nucleosomes are a basic unit of DNA packaging in eukaryotes, made up of 147 bp of 
DNA wrapped by an octamer of core histones, H2A-H2B dimers flanking two core H3-
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H4 histone tetramers [262, 263]. The final arrangement of eukaryotic DNA is a 
supercoiled structure called chromatin that is comprised of multiple nucleosomes 
separated by short linker fragments [264]. The role of nucleosomes in the genome has 
been well studied over the years. Structurally, nucleosomes bring about the first level of 
genomic compaction, which is 180 bps and then facilitates self-assembly into higher-
order compaction of DNA inside the nucleosome [265, 266]. This structural arrangement 
protects DNA from damage and the positioning of nucleosomes plays a crucial role in 
transcriptional regulation and DNA replication [267-269].  
DNA and histone methylation is known to influence nucleosome position and 
structure, thereby regulating transcription. CpG DNA methylation represses promoters by 
either recruiting transcriptional repressors to bind to the methyl CpG moiety [270] or 
inhibiting binding of transcriptional activators from binding to the promoter region [271]. 
Histone methylation of arginine (R) and lysine (K) residues play a key role in 
transcriptional regulation by altering chromatin organization. The methylated amino acids 
K4, K9, and R19 on histones H3 or H4 can either cause transcriptional activation of 
repression at the promoter of genes [272, 273].  In S. cerevisiae, H3K4, H3K36, and 
H3K79 methylation correlates with transcriptional activation [274]. Histone acetylation is 
also associated with transcriptional regulation. Remodeling of the PHO5 and PHO8 
promoters in S. cerevisiae were initiated by acetylation of the H2B histone, which 
recruits ATP-dependent remodelers to evict the nucleosomes creating a nucleosome-free 
region (NFR) for transcriptional activation by PHO4 [275, 276]. Similarly, other histone 
 103 
modifications can cause nucleosome “sliding” or “loosening” to enable transcriptional 
activation (Figure 4.1) [277].   
 
Figure 4.1. Three mechanisms by which nucleosome remodeling can occur to 
accommodate transcription factor binding. Mechanisms A and B rely on trans factors 
(TF) like ATP-consuming chromatin remodelers that cause either (A) complete 
nucleosome disassociation or (B) sliding events. In mechanism C, nucleosome structure 
is altered via histone-modifying enzymes. Acetylation of amino acid residues via histone 
acetyltransferases (HATs) increases the electronegative charge of the histone residue 
causing repulsion between DNA and histones, leading to a “loosening” effect of the 
nucleosome thereby making it more accessible to transcription factors. The process is 
reversible by histone deacetylases (HDACs) [277].    
 
Nucleosome sliding is a well documented mechanism in S. cerevisiae [278-280]. 
There are essentially two models that have been proposed to explain how this occurs, the 
twist diffusion and the loop/ bulge propagation model [281]. In brief, the twist diffusion 
model explains a stepwise movement of a single base pair from the linker that shifts into 
the nucleosomal DNA space causing the nucleosomes to twist or untwist to accommodate 
the change [282]. Meanwhile, with the loop/ bulge propagation model, larger segments 
from the linker are transferred to the nucleosome DNA space creating a loop that causes 
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the histone core to quickly diffuse to the opposite end to remain wrapped [283]. The 
detached nucleosome DNA can now be exposed to transcriptional regulators. This 
mechanism relies on the intrinsic dynamic nature of nucleosomes. Once the proteins bind 
to the DNA, it can control the level of nucleosome occupancy at their sides [284].  
The affinity of transcription factors to DNA binding sites is another influence on 
transcription regulation. The PHO84 promoter of S. cerevisiae contains five copies of the 
PHO4p binding site dispersed across its promoter and not all motifs bear similar 
affinities. Mutational analysis of the 6 bp binding motifs revealed that only three motifs 
are important for transcriptional activation, but only two are necessary for full regulation 
of the PHO84 gene [285]. The regions flanking PHO4p binding motifs affected its 
binding affinity. Therefore, even though some binding sites may be positioned in NFRs, 
if these sites have a low binding affinity, no transcriptional activation will be observed 
until the high-affinity sites are relieved from nucleosome compaction under phosphate 
starvation conditions. Figure 4.2 depicts a model for how chromatin may influence gene 
expression by differentially regulating the accessibility of the PHO4 binding sites on the 
promoter. Similar remodeling mechanisms have been shown in other S. cerevisiae 
promoters such as GAL1, SUC2, and CUP1 [286, 287].  
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Figure 4.2. Model depicting transcription factor affinity and nucleosome positioning on 
differentially regulating PHO binding motifs [277]. Red arrows represent transcription 
and thickness of arrows represent the strength of transcription. X represents no 
transcription. As nucleosome occupancy reduces in and around transcription factor 
binding sites, high-affinity binding sites (red) become more accessible to PHO4 binding 
resulting in some transcription activation. The same is not true for low-affinity sites 
(blue) that require high levels of nucleosome depression to have a cooperative effect with 
high-affinity binding sites and elicit strong transcriptional activation. 
 
As described above, each transcription factor can have an inherent affinity to the 
DNA and yet its binding probability be affected by competition with nucleosomes. 
Therefore, to understand how nucleosomes are affected by transcription factors, it would 
be ideal to study a system where all transcription factors regulating a promoter are 
known. Understanding the effect of specific transcription factors on nucleosome 
positioning can be leveraged to building hybrid promoters regulated via transcription 
factor-mediated nucleosome remodeling. This is one interesting application for next-level 
hybrid promoters to modulate gene expression, however in Y. lipolytica, this is not 
possible because there is no well-established promoter with known regulatory elements 
or an understanding of the mechanisms that dictate nucleosome positioning.  
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Another application for studying nucleosome positioning is to identify Upstream 
Activating Sequences (UASs) rapidly, promoting the development of hybrid promoters 
with tunable strength and inducibility. We hypothesize that UASs can be identified by 
observing nucleosome repositioning during transition from repression to induction. The 
POX2 promoter in Y. lipolytica is a good platform to establish design principles since our 
previous work have already elucidated critical activator regions in the native promoter 
[116] that can be mapped to the nucleosome profile. The mapping suggested that the 
putative transcription factor binding sites from POR1p [208] align to regions adjacent to 
significant changes in nucleosome occupancy observed between oleic acid and glucose 
samples. This suggests some remodeling may be occurring in POX2 regulation. Of the 
four 6 bp binding sites in the POX2 promoter, three mapped near highly nucleosome 
occupied regions while the fourth site did not. Mutation to the putative POR1p binding 
motifs revealed that two of the three sites that mapped to occupied regions were crucial 
for full transcriptional activation. Knockout of POR1p and CFU1p, two transcriptional 
factors implicated in the regulation of beta-oxidation caused a significant loss in GFP 
expression from the native POX2 promoter. The POX2 promoter in the knockout strain, 
PO1fΔpor1Δcfu1, generally had higher DNA occupancy throughout the promoter. 
Although the profiles of DNA accessibility between the wild-type and knockout strain 
had similarity trends, the knockout strain had widened nucleosome coverage. The 
broadening of nucleosome coverage in oleic acid was more evident, particularly at the 
upstream-most site. This suggests that different mechanisms of regulation may govern 
transcription factor-promoter interactions. A comparison of the profiles between the wild-
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type and knockout strain in different carbon conditions revealed new regulatory regions 
that can be used to re-engineer the POX2 promoter, showing promising application as a 
strategy to develop other regulatable promoters in Y. lipolytica. 
 
Experimental Methods 
Chemicals and Reagents 
All restriction enzymes used in cloning were purchased from New England 
Biolabs (NEB, Ispwich, MA) unless otherwise stated. Oligos designed for all experiments 
were synthesized by Eurofins Genomics or IDTDNA. Plasmid minipreps were performed 
using the Zyppy™ Plasmid miniprep kit (Zymo Research, Irvine, CA). PCR purifications 
and restriction digest purifications were performed using the DNA Clean and 
Concentrator kit (Zymo Research). Micrococcal nuclease solution (Thermo Scientific, 
Waltham, MA) was used to prepare mononucleosomal DNA from gDNA. Digestion of 
all proteins from cell extract was performed using Proteinase K (Thermo Scientific). A 
bicinchoninic assay (BCA) (Thermo Scientific) was used to quantify protein in the cell 
lysate. RNA digestions were performed using RNase A (Thermo Scientific). gDNA 
extraction was performed using the E. Z. N. A. Yeast DNA Kit (Omega Biotek, Norcross, 
GA). 
 
Plasmids and DNA Cloning 
Construction of the base plasmid consisting of the POX2 native promoter (1540 
bp) fused to a GFP reporter gene that has been described elsewhere [80]. Mutations were 
made to the putative POR1p binding sites identified on native promoter as shown in 
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Figure 4.3. There are four putative binding sites labeled 1, 2, 3, and 4 that were found in 
the A1, R1, A2, and A3 regions identified in Chapter 3, respectively [116]. All cloning 
was performed using sequence and ligation independent cloning (SLIC) method unless 
otherwise stated. The base vector used was pSL16-POX2(1590bp)-hrGFP, harboring the 
native POX2 promoter, in this study referred to as pSL16-POX2-hrGFP. Table 4.1 
summarizes the cloning strategy used to make all vectors containing individual and 
combinatorial mutations to the POR1p binding sites. Briefly, the base vector and all 
preceding constructs containing the desired mutations were first digested with AatII to 
linearize DNA prior to PCR. The primers used for amplification of the vector can be 
found in Supplementary Table 4.1. First, four individual mutations were made to the 
POR1p binding sites in the A1, R1, A2 and A3 sequences of the native promoter. 
Combinatorial mutations were then created using these vectors as the base vectors until 
all four binding sites were mutated in the native POX2 promoter.  
 
 
 
 
 
 
 
 
 
 109 
Table 4.1: Cloning strategy to create vectors containing mutations to the respective 
POR1p binding sites in the A1, R1, A2 and A3 sequence. 
 
Transformation, Cell Culture, and Media Formulations 
Plasmid propagation and cloning were performed using E. coli DH10β competent 
cells (NEB). The heat shock transformation method was used. All transformations of Y. 
lipolytica (MATa leu2−270 ura3−302 xpr2−322 axp1) were performed using the lithium 
acetate method as previously described [106] with a minor modification to the final step. 
In brief, the cells were heat-shocked for 10 minutes at 39ºC and then mixed with 1.2 mL 
0.1M LiAc (pH 6.0) solution. The mixture was centrifuged at 3,000xg for 2 mins and the 
pellet was re-suspended in 0.1 mL of 0.1 M LiAc (pH 6.0) and 0.03 mL of the mixture 
Base Vector Mutation  Primers Final Vector 
pSL16-POX2-hrGFP 
A1 
F1/R1 
F2/R2 
pSL16-POX2  
 [A1 mutation]-hrGFP 
R1 
F1/R1 
F3/R3 
pSL16-POX2  
[R1 mutation]-hrGFP 
A2 
F1/R1 
F4/R4 
pSL16-POX2  
[A2 mutation]-hrGFP 
A3 
F1/R1 
F5/R5 
pSL16-POX2  
[A3 mutation]-hrGFP 
pSL16-POX2 
[A1 mutation]-hrGFP 
R1 
F1/R1 
F3/R3 
pSL16-POX2  
[A1R1 mutation]-hrGFP 
A2 
F1/R1 
F4/R4 
pSL16-POX2  
[A1A2 mutation]-hrGFP 
A3 
F1/R1 
F5/R5 
pSL16-POX2  
[A1A3 mutation]-hrGFP 
pSL16-POX2 
[A1R1 mutation]-hrGFP 
A2 
F1/R1 
F4/R4 
pSL16-POX2  
[A1R1A2 mutation]-hrGFP 
pSL16-POX2 
[A1A2 mutation]-hrGFP 
A3 
F1/R1 
F5/R5 
pSL16-POX2  
[A1A2A3 mutation]-hrGFP 
pSL16-POX2 
[A1R1A2 mutation]-hrGFP 
pSL16-POX2  
[A1R1A2A3 mutation]-hrGFP 
pSL16-POX2  
[R1 mutation]-hrGFP 
pSL16-POX2  
[R1A3 mutation]-hrGFP 
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was transferred into the desired auxotrophic media to propagate cell growth. The 
auxotrophic media prepared was Yeast Complete Synthetic (YSC) media – LEU using 
6.7 g/L Yeast Nitrogen Base (YNB) w/o amino acids (BD Diagnostic, Hunt Valley, MD) 
and 0.69 g/L Complete Supplement Mixture deficient in leucine (CMS-LEU) (MP 
Biomedicals, Solon, OH). Yeast Peptone Dextrose (YPD) or Oleic Acid (YPO) media 
was prepared using 5 g/L Yeast Extract (BD Diagnostics), Peptone (BD Diagnostics) and 
either 2% (w/v) Glucose (Sigma Aldrich, St. Louis, MO) or 2% (v/v) Oleic Acid (EMD 
Millipore, Burlington, MA) emulsified with 5% Tween80 (Sigma Aldrich), respectively. 
To test the effects of mutations and transcriptional factor knockouts, all cultures were 
performed in 2 mL cultures in 14 mL culture tubes. For mononucleosome extraction, 100 
mL cultures were grown in a 250 mL baffled flask.  
 
CRISPR-Cas9 to Create Knock-out Strains 
The PO1f strain was used for all experiments and further engineering. CRISPR-Cas9 
genome editing [83] was used to create all knockout strains used in this study. The 
CRISPR vector was modified to contain a NsiI restriction site used to insert the gRNAs 
of interest. gRNA oligos containing SLIC overhangs (Supplementary Table 4.2) were 
annealed together prior to cloning into the NsiI CRISPR vector that was digested with 
NsiI-HF. The strains PO1fΔpor1, PO1fΔcfu1 and PO1f Δpor1Δcfu1 contained frameshift 
mutations (Supplementary Figure 4.2). The sites for gRNA targeting sequences were 
designed using Benchling software (http://www.benchling.com) to insert the frameshift 
in 5’ region the coding sequence of the respective proteins. Verification primers shown in 
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Supplementary Table 4.2 were used to perform colony PCR and screen colonies 
containing the desired mutation and Sanger sequencing was used to verify the mutations. 
 
Mononucleosome DNA Preparation 
Adaptations were made to a mononucleosome DNA preparation protocol 
previously described for S. cerevisiae resulting in >90% mononucleosome DNA [288]. In 
brief, the respective strains were grown in either YPD or YPO until early exponential 
phase (OD600 of ~20-25) and measured using the cuvette function on the NanoDrop 
(Thermo Scientific). Cells were chilled on ice prior to centrifugation at 3,000xg and 
washed twice with 1x Phosphate Buffered Saline (PBS). The cells were then resuspended 
in nuclease digestion buffer (10 mM Tris-HCl (pH 8) and 1 mM CaCl2). For cell lysis 
with the bead beater (BioSpec Products, Bartlesville, OK), our modification was seven 
rounds of beating, each cycle for a minute with a 2-minute pause in between at 4ºC. 
Protein quantification was performed using a Bradford assay. It is essential to run an 
optimization step by varying MNase concentration to obtain a final mononucleosome 
DNA product (>90%) which can be detected and analyzed as ~146 bp on a 2% DNA gel 
run at ~80V (constant voltage, 1xTAE buffer). It should be noted that a histone 
immunoprecipitation step was not performed therefore we cannot definitively call this a 
nucleosome preparation method, rather technique that provides a DNA accessibility 
profile. 
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PCR-tiling and PCR to determine CT of each Amplification 
PCR tiling primers for the POX2 promoter were designed using the PCT Tiler 
v1.42 online tool [289]. The minimum and maximum temperature for primer annealing 
were set at 60ºC and 63ºC, respectively. The specifications for minimum and maximum 
amplicon length were 100 and 130 bps. A key parameter was designing overlapping 
primer pairs where each consecutive primer starts 30 base pairs after the beginning of the 
previous primer to obtain a good overlap between each of the primers tiling the promoter. 
This resulted in 44 primers pairs constructed for the tiling experiment (Supplementary 
Table 4.3). PerfeCTa SYBR Green FastMix (Quantabio) was used for qPCR reactions in 
the CFX Connect real-time (Bio-Rad). The reaction volume for each set-up was 20 μL 
and total primer concentration in each well was 0.4 μM. The efficiency of each primer 
was calculated using a four-point standard curve with gDNA as the template strand. The 
efficiency curves were then used to convert CT of each reaction to copy number. For each 
tiling experiment, the copy numbers were normalized to a range between 0 and 1 by 
dividing the copy number by the maximum copy number within the experimental set to 
provide a nucleosome occupancy profile between 0 and 1. 
  
Fluorescence Spectroscopy 
To test the effect of mutations on the POX2 promoter, each of the vectors 
harboring mutations as described in Table 4.1 were transformed into the PO1f wildtype 
strain and grown in YSC-LEU media containing 2% (w/v) glucose for 48 hours until cells 
reached stationary phase. Cells from a glucose culture were spun down and resuspended 
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in YSC-LEU media with 2% (v/v) oleic acid at a starting OD600 of 0.2 and allowed to 
grow for around 36 hours determined to be the optimal time for POX2 expression 
(Supplementary Figure 4.1). Cells from the oleic acid culture were spun down and 
washed once in 1xPBS containing 5% (v/v) Tween 80 to remove residual oleic acid and 
finally resuspended in 1x PBS solution (pH 7.0). After OD600 normalization across all 
cultures, 0.2 mL of the cultures were loaded into 96 well black plates and serial dilutions 
of this culture were made to calculate the fluorescence as described in the methods 
section elsewhere [116]. The excitation/emission wavelengths used were 485 / 510 nm 
with a bandwidth of 9 in the Biotek Synergy MX fluorescence spectrophotometer. Since 
the strength of the native POX2 promoter is inherently weak, the gain was set to 157 to 
obtain reliable measurements of fluorescence. To determine the effects of the 
transcription factor knockouts, the respective strains were transformed with the 
A1R1x3A3-GFP vector and grown in minimal media containing glucose until early 
stationary phase was reached. Cells were then spun down and resuspended in minimal 
media containing 2% (v/v) oleic acid and transferred into to a 48-well plate. Fluorescence 
from the GFP reporter was measured each hour with continuous shaking for 18 hours 
while the cells remained at stationary phase. For these experiments, the gain was set to 
140 since the hybrid promoter is significantly stronger than the native POX2 promoter.  
 
Screening for Growth in Oleic Acid 
PO1f wild-type and strains, PO1fΔpor1 and PO1fΔcfu1, in biological replicates, 
were grown in minimal synthetic media supplemented with 100 mg/L L-leucine (BD 
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Diagnostics) (YSC) and 2% (w/v) glucose until stationary phase. Four quadrants were 
drawn on YSC plates containing 2% (v/v) emulsified oleic acid and a second set of plates 
with 2% (w/v) glucose. Cells from stationary phase cultures were spread on each of the 
plates using an inoculating loop and grown at 28ºC for 96 hours (4 days) to observe 
growth.  
 
Results 
Nucleosome Profiling of POX2 Promoter 
 Activation of PHO promoters occur due to extensive remodeling and loss of 
nucleosome at the upstream activation sites harboring transcription factor binding sites  
causing activation of the promoters under cellular phosphate starvation. We wanted to 
investigate whether a similar remodeling process can be observed in promoters of Y. 
lipolytica. The POX2 promoter in Y. lipolytica is a fatty acid inducible promoter that is 
activated by oleic acid and repressed in either glucose or glycerol [110, 116]. The 6 bp 
putative binding site for POR1p (CCTCGG) were mapped to the POX2 promoter (Figure 
4.3). These motifs, labeled as 1, 2, 3, and 4, are located in the A1, R1, A2, and A3 UAS 
regions previously identified via a heuristic approach described in Chapter 3 [116].  
All four binding motifs are in regions of the promoter where there is low 
nucleosome density. Binding site 1 is near a region that transitions to a higher 
nucleosome occupancy in oleic acid. Meanwhile, in oleic acid, the nucleosome profile 
near binding site 2 shifts to the right, away from the binding motif. Binding site 3 is 
located in a ~90 bp nucleosome-free trough. To the far right of the binding site, however, 
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there is a significant increase and shift in nucleosome position in oleic acid. The 
nucleosome profile near motif 4 has a higher density of nucleosomes in oleic acid 
compared to glucose. At this point, it is difficult to conclude mechanisms that cause these 
transitions but note that binding sites 1, 2, and 4 are nearest to the edge of transitions in 
nucleosome occupancy between glucose and oleic acid. From PHO5 regulation, UASs do 
not have to be wrapped within nucleosomes to be inaccessible but sitting near regions of 
high nucleosome density can also prevent accessibility of transcriptional factors [226]. 
Nucleosome remodeling around the region relieves compaction and makes the binding 
site more accessible. We could hypothesize a similar mechanism to explain the shifts in 
nucleosome profiles from glucose to oleic acid.   
 
Figure 4.3. Nucleosome occupancy for native POX2 promoter in the PO1f WT strain 
grown in YP Glucose (blue) and YP Oleic acid (pink) mapped to POR1p binding sites on 
the native POX2 promoter. Putative binding sites for POR1p, 1, 2, 3, and 4 are found in 
A1, R1, A2, and A3 regions of the POX2 promoter previously mapped out [116].  Purple 
regions indicate overlap of nucleosome profile for both culture conditions. 
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Determination of High-Affinity Binding Motifs on the POX2 Promoter 
Another important factor to consider alongside nucleosome positioning is binding 
site affinity. In the S. cerevisiae PHO5 promoter, all upstream binding sites for 
transcription factor promoter activation are not bound by nucleosomes, nor do all binding 
sites share the same affinity for transcription factor binding  [285, 290]. Low and high-
affinity sites binding sites are located in the nucleosome-free linker regions and set the 
threshold for promoter activation. This provides an initial binding site for activation 
during induction although the threshold is higher for low-affinity binding sites [291].  
Having mapped the putative POR1p motifs to DNA accessibility profiles in 
glucose and oleic acid, we wanted to determine the high and low-affinity sites in the 
POX2 promoter. The palindromic CCTCGG POR1p recognition sequences were mutated 
from GC rich to AT-rich (TAAATA) (Figure 4.4A). Vectors containing a GFP reporter 
gene driven by a POX2 promoter harboring individual and combinatorial mutations were 
episomally expressed in Y. lipolytic and fluorescence was measured after 36 hours of 
growth in oleic acid. From individual mutations, sites 2 and 4 were most critical for 
expression from the POX2 promoter. Mutating site 1 or 3 had minimal effect on GFP 
expression (Figure 4.4B). Interestingly, mutating both the 1 and 2 motifs had a stronger 
effect on expression strength compared to mutation of 2 alone suggesting there is a 
dependence of binding site 1 on 2. The same effect was not observed when mutations to 
site 1 and 3 were made, resulting in approximately the same strength as the promoter 
harboring a mutation at site 1. The most striking observation, however, was the near 
complete loss in fluorescence with a mutation to sites 2 and 4, demonstrating the 
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importance of these two putative binding motifs (Figure 4.4B).  Both 2 and 4 sit in 
regions of high DNA accessibility in either glucose or oleic acid, therefore we can 
hypothesize that these motifs may have high affinity to POR1p binding.   
 
Figure 4.4. (A) Native POX2 promoter with mapped 1, 2, 3, and 4 binding motifs. 
Mutation to the POR1p consensus binding motif was changed from CG rich to AT-rich. 
(B) GFP fluorescence of POX2 promoters with individual and combinatorial mutation of 
the POR1p binding sites. The error is represented as a standard deviation of replicate size 
n=3. 
 
Screening for Transcription Factors 
Nucleosome positioning on promoters to regulate transcription is influenced by 
competition with transcription factors [292]. Therefore studying how nucleosome form 
with and without and transcription factors can elucidate mechanisms for nucleosome 
positioning to activate transcription in  a UAS region of a promoter. To first study this 
mechanism requires us to know the transcription factors and binding motifs on a UAS 
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element. We use the POX2 promoter that is the most characterized promoter system in Y. 
lipolytica where it is understood that POR1p is involved in transcriptional activatation 
and putative binding sites are known. The goal is to eventually translate our knowledge 
of nucleosome positioning in UAS regions of the POX2 promoter to identify newer UAS 
elements in other promoter systems that would enable of hybrid promoter engineering 
efforts.  
Our previous results suggest that putative binding POR1p motifs, 1, 2, and 4 are 
important for transcriptional activation. Theses motifs are found on UAS elements, A1, 
R1, and A3 used to construct a fatty acid inducible hybrid promoter four times stronger 
than the native POX2 promoter [116]. Therefore, we use the strong hybrid promoter to 
determine the significance of POR1p and identify other transcription factors necessary in 
association with POR1p to activate transcription in oleic acid.  
Our first strategy was to knockout POR1p in Y. lipolytica and investigate its effect 
on growth and transcriptional activation from the hyrid promoter harboring important 
UAS elements. The strain harboring a non-functional POR1p, PO1fΔpor1, led to partial 
growth in oleic acid (Figure 4.5A). This result complements previous work showing 
similar effects of ΔPOR1p on beta-oxidation [208]. Knocking out POR1p resulted in only 
partial loss in expression from the hybrid promoter compared to the PO1f wild-type 
(Figure 4.5C). A similar effect has been observed with the native POX2 promoter [208]. 
This suggests that POR1p may not be the only transcription factor activating transcription 
from UASs in the POX2 promoter.  
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Figure 4.5. Identification of critical transcription factors. (A) PO1fΔpor1 steaked out on 
synthetic media plates containing glucose and oleic acid shows severe growth defects in 
oleic acid. (B) No growth defects are observed in either carbon sources for PO1fΔcfu1. 
(C, D, E) GFP fluorescence experiments for strains PO1fΔpor1, PO1fΔcfu1 and 
PO1fΔcfu1Δpor1 grown in glucose until stationary phase and then induced with 2% (v/v) 
oleic acid to measure A1R1x3A3-GFP promoter strength over time. The error is 
represented as a standard deviation with replicate size n=3. 
 
Therefore, we investigated other potential coregulators of  UAS activity in oleic 
acid. The transcription factor, ADR1p, is known to be a positive regulator for 
transcription of genes encoding peroxisomal proteins [293]. The homolog of ADR1p was 
identified as CFU1p (Control of Fatty Acid Utilization) in Y. lipolytica (unpublished 
report). Our BLAST analysis showed no sequence homology of YlCFU1p to ScADR1p 
(Supplementary Figure 4.3A). The closest homology was to transcription factor, TDA9p, 
from the pentose utilizing yeast, Sugiyamaella lignohabitans, a relative to Y. lipolytica 
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[294]. However, a BLAST of YlCFU1p against the S. cerevisiae database revealed that 
the ScADR1p, chain A, containing the GATA zinc-finger binding domain shared 65% 
sequence homology to a similar domain in YlCFU1p (Supplementary Figure 4.3B). To 
date, the effect of YlCFU1p on either beta-oxidation or POX2 regulation is unknown. We 
were interested to determine whether CFU1p had any effect on the UAS elements from 
the POX2 promoter. Knocking out CFU1p did not result in any growth defect on either 
media (Figure 4.5B) and no effect on the hybrid promoter (Figure 4.5D). This suggests 
that CFU1p alone does not have an direct effect on beta-oxidation or promoter regulation.   
Eukaryotic regulation is complex and usually involves the association of more 
than one transcription factor. Therefore, we tested the effect on expression of the hybrid 
fatty acid inducible promoter in the PO1fΔpor1Δcfu1 strain. A noticeably weaker 
fluorescence signal compared PO1fΔpor1 was observed in oleic acid (Figure 4.5C). This 
may suggest that that CFU1p is a coregulator requiring POR1p as the main 
transcriptional activator in the UAS elements.  Since we were unable to get complete loss 
of fluorescence from the hybrid promoter suggests that may be other transcription factors 
involved in oleic acid activation from the UAS elements that still needs to be identified. 
Chapter 6 details experiments to deterimine these transcription factors.   
 
DNA Accessibility in Strains Devoid of Transcription Factors 
 Although, we were not able to identify all transcription factors involved in oleic 
acid activation, we identified two important transcription factors, POR1p and CFU1p, in 
combination seem to impact activity of the UASs from the POX2 promoter in oleic acid. 
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Therefore, we wanted to investigate if deleting these transcription factors would relieve 
the competition with nucleosomes and result in more identical DNA accessibility profiles 
in glucose and oleic acid. We anticipate the difference in DNA accessibility between the 
wild-type and the PO1fΔpor1Δcfu1 strain in oleic acid would enable us to identify UAS 
regions in the POX2 promoter. Using a PCR tiling array, DNA accessibility of the native 
POX2 promoter was mapped in PO1fΔpor1Δcfu1 strain (Figure 4.6).  
 With the exception of nucleosome density, as represented by the area under the 
graph, and the region between -578 bp to -278 bp, there is better overall convergence of 
the nucleosome profiles in the between the two carbon conditions in the knockout strain 
(Figure 4.6) compared to the profiles in the wildtype strain (Figure 4.3). The DNA 
accessibility near binding motif 1 is similar between oleic acid and glucose. Meanwhile, 
the nucleosome profile shift noted in the wild-type strain next to binding site 2 is less 
prominent due to better convergence of the oleic acid and glucose nucleosome data. At 
motif 4, nucleosome spread is greater and density is higher under both conditions relative 
to the wild-type.  Given that motif 4 is close to the core promoter, it would be interesting 
to investigate how the increase in nucleosome density near the core promoter would 
affect transcriptional regulation since the core promoter contains the crucial TATA 
docking site for basal transcription machinery.  
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Figure 4.6. Nucleosome occupancy for native POX2 promoter in the PO1fΔpor1Δcfu1 
strain grown in YP Glucose (blue) and YP Oleic acid (pink) mapped to POR1p binding 
sites on the native POX2 promoter. Purple regions indicate overlap of nucleosome profile 
for both culture conditions. 
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Figure 4.7. Re-engineering POX2 promoter from differences in DNA accessibility in 
glucose and oleic acid. POX2 promoter from (A) wildtype strain and (B) 
PO1fΔcfu1Δpor1 strain showing higher nucleosome occupancy in oleic acid (OA) on top 
axis and higher nucleosome occupancy in glucose on lower axis. Putative POR1p binding 
sites are mapped out to DNA accessibility profile located in previously identified UASs, 
A1, R1, A2, and A3 elements on the POX2 promoter. Grey and red regions represent 
UAS elements selected from differences in DNA accessibility between both carbon 
sources. Yellow represents POX2 core promoter.  
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Discussion and Conclusion 
The goal of this work is to determine if it is possible to predict locations of UAS 
elements in native inducible promoters by investigating changes in DNA accessibility on 
promoters under different conditions. If feasible, this method will enable quicker 
development of hybrid promoters with tunable and predictable expression. A strategy like 
this is especially beneficial for non-conventional microbes such as Y. lipolytica where 
there is a need to develop more genetic tools in spite of a limited understanding of 
transcriptional regulation of native promoters. RNA seq can be used to determine 
inducible and constitutive native promoters but does not inform us how promoters are 
regulated. Identifying short segments of UASs in long eukaryotic promoters aids in the 
engineering of better expression platforms.  
 Developing tunable promoters using DNA accessibility is a novel approach that 
has not been attempted to date. Constructing promoters in this context requires a 
mechanistic understanding of how nucleosomes re-position or displace to accommodate 
transcription factors under inducible conditions. Nucleosome positioning on promoters is 
largely influenced by DNA diversity that can favor or disfavor nucleosome formation 
[295, 296]. For example, in core promoter regions next to the TATA box, the AT-rich 
nucleotide region promotes weak base-pair interaction and facilitates DNA unwinding for 
basal transcriptional activation. The AT-rich abundance leads to a low propensity for 
nucleosome formation leading to NFRs in core promoters [297]. This is also observed in 
the tiling experiments for the native POX2 promoter where the core promoter region (-61 
to +1), being ~58% AT-rich, has a sharp drop in nucleosome occupancy (Figures 4.3 and 
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4.6). However, upstream of the promoter where transcription activators or repressors bind 
to amplify or repress genes, the understanding of molecular interplay between histones, 
nucleosome remodeling complexes, specific and non-specific TFs is less clear.  
 The POX2 promoter is one the more well-studied native fatty acid inducible 
promoters in Y. lipolytica [110, 116, 208] and is a good candidate promoter to test the 
hypothesis. POR1p has previously been shown to be important for POX2 expression in 
oleic acid is a close homolog of the fatty acid regulator FarA in Aspergillus nidulans 
[208].  Putative binding sites of the YlPOR1p were mapped on the native POX2 promoter 
in the wild-type strained tiled to determine nucleosome occupancy in glucose and oleic 
acid. The four binding sites, 1,2, 3, and 4 were in low nucleosome occupancy regions for 
both glucose and oleic acid but 1, 2, and 4 were at the edge of where transitions of 
nucleosome occupancy in oleic acid were observed, either an increase or a shift in profile. 
While it has been established that not all transcription factor binding sites bear 
similar importance to transcriptional regulation in the PHO promoters of S. cerevisiae, we 
wanted to determine which of the putative motifs contributed most to transcriptional 
activation of the POX2 promoter. Binding site 1 was interesting because mutating the site 
did not contribute to transcriptional loss although in tandem with a mutation binding site 
2 or 4 resulted in greater than a four-fold drop in strength. Mutation to 2 and 4 caused 
almost near loss of expression. These results inform us that these sites are important but 
the reasons are less clear. It would be important to determine if the mutation removes the 
POR1p binding site on the DNA or whether there are there are changes in DNA 
accessibility that makes the binding sites within the region less accessible. Nucleosome 
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profiling of the POX2 promoter harboring these mutations can answer this question. The 
region near or at binding site 1 has demonstrated cooperativity to binding motifs 2 and 4. 
This result aligns well with our previous finding that demonstrated the importance of 
UASs A1, R1 and A3, harboring sites 1, 2, and 4, respectively, to confer strong 
transcriptional activation [116]. Binding site 4, ~60 bp away core promoter, also had a 
deleterious impact on POX2 expression. Combined with the mutation to binding site 2, 
caused near loss of expression. In the future, it would be important to investigate how 
surrounding sequences could impact the affinity of the transcription factor to the binding 
site in a nucleosome independent context [285].  
Knockout studies of the POR1p and CFU1p transcription factors had different 
effects on growth and expression of the hybrid promoter. PO1fΔpor1 caused severe 
growth defects on oleic and lowered transcription output from the hybrid promoter while 
PO1fΔcfu1 had no effect. The double mutant, PO1fΔpor1Δcfu1 showed more significant 
down-regulation of the hybrid promoter but did not eliminate expression completely. 
More transcription factors would need to be screened to determine the mechanism for 
regulation. 
We observed a better convergence of the nucleosome profiles of the 
PO1fΔpor1Δcfu1 strains in glucose and oleic acid except for the 300 bp region between -
578 and -378 bps. For future work, nucleosome profiling in the PO1fΔpor1 strain in 
glucose and oleic acid is required to determine the effects ΔCFU1p has on the profile. At 
this point, the role of YlCFU1p is less understood and although, it contains a conserved 
DNA binding domain (Supplementary Figure 4.3B), whether it directly binds to the 
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POX2 promoter is unknown. Preliminary results presented here show that the CFU1p 
alone may not have a direct association with POX2 expression or growth (Figure 4.5 B, 
D) however, further work is required to elucidate its role. Similarly, YlPOR1p has not 
been shown to directly bind to the POX2 promoter in oleic acid. This is a key experiment 
needed to validate both transcription factors as nuclear receptors for oleic acid induction. 
Figure 4.7A and B presents a new analysis of DNA accessibility in the wildtype 
and PO1fΔpor1Δcfu1 strains, respectively. The calculated difference in occupancy 
between both substrates enables better visualization of which regions are more occupied 
in glucose versus oleic acid and vice versa. The objective of this analysis is to select 
regions in the POX2 promoter that could be potential UAS elements. In the grey UAS1 
region containing putative POR1p binding site 1, there is generally a lower nucleosome 
occupancy in both two carbon conditions. However, once the POR1p and CFU1p are 
knocked out in the mutant strain, PO1fΔpor1Δcfu1, we observed a bleed over of 
nucleosomes into the region. This selection of this region as a potential UAS is made on 
the hypothesis that knocking out competition from these oleic acid inducible transcription 
factors would now favor nucleosome formation in oleic acid. The transitions seen here 
may hint at one mechanism for how enhancer sites are regulated.  
UAS2 and UAS3 elements shaded in red contains putative POR1p binding sites 2 
and 3. The selection of these regions is based on the hypothesis that oleic acid-induced 
transcription would result in lower nucleosome occupancy in oleic acid than in glucose. 
Applying a similar principle helps us identify another potential UAS region (New UAS) 
that could be tested. Furthermore, we selected UAS4 based on Figure 4.4B data that 
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shows it is the most critical binding motif for transcriptional regulation and it sits in 
proximity to the core promoter. These UASs can be used to engineer a new fatty acid 
hybrid promoter that would be different to the heuristic approach applied in Chapter 3. 
Ultimately, we would like to apply this approach to dissecting new UASs from other 
promoters to engineer more hybrid promoters in Y. lipolytica. 
Here, we make predictions for new UASs based off DNA accessibility profiles 
that account for nucleosomes and transcription factor binding to the DNA. From these 
DNA accessibility profiles, it would not be possible to definitively conclude changes as a 
result of nucleosome eviction or sliding as transcription factors are also crosslinked to 
DNA. This can prevent MNase cleaving DNA at the transcription factor bound sites, 
thereby we may see more nucleosome protected regions. However, if transcription factor 
binds to DNA wrapped in a nucleosome, which has been reported as another mechanism, 
then predictions made from this dataset would be valid. At this moment, we do not know 
which mechanisms are more predominant, therefore, the work presented here needs to be 
complemented with profiling of pure mononucleosome DNA that can be achieved with 
chromatin immunoprecipitation using histone-specific antibodies [298]. This could also 
provide insight into histone modifications that contribute to transcriptional regulation.  
The work highlighted in this chapter is aimed towards developing methodologies 
towards designing new regulatable promoters using predictions from DNA accessibility. 
The nucleosome mapping approach is applied on the POX2 promoter that has previously 
been studied to identify regulatory regions (A1, R1, A2, A3) and transcription factors 
(POR1p, CFU1p) associated with FA-induced expression. The nucleosome profile of the 
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wild-type strain under the different conditions enables mapping of key binding sites with 
respect to changes in nucleosome profile. Most of the binding sites are located near or 
within regions of high nucleosome occupancy in oleic acid growth conditions. The 
importance of these binding motifs is tested using via mutational studies. Next, 
transcription factors, YlPOR1p and YlCFU1p are knocked out, leading to repressed 
expression from the POX2 promoter. The POX2 promoter was tiled in the knockout 
strain which showed a significant broadening of nucleosome profiles in oleic acid relative 
to the wild-type strain while maintaining a similar profile in glucose. The difference in 
nucleosome between oleic acid and glucose between the wild-type and knockout strain 
aids new strategies to re-engineer a hybrid promoter from POX2 elements.  
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CHAPTER FIVE 
A FATTY ACID RESPONSIVE PROMOTER USED TO GUIDE ENGINEERING OF 
FATTY ALCOHOL PRODUCTION IN THE OLEAGINOUS YEAST,  
YARROWIA LIPOLYTICA 
 
Abstract 
 Fatty alcohols are an important class of oleochemicals with a wide range of 
industrial applications from biofuels to surfactants and detergents. A microbial platform 
capable of producing biorenewable fatty alcohols may be competitive with current 
production capacities. From an engineering perspective, Yarrowia lipolytica is a 
promising microbe for fatty alcohol production because of its natural ability to synthesize 
and metabolize lipids that are precursors to fatty alcohols. The strategy described here 
utilizes a fatty acid-responsive promoter developed in Chapter 3 to detect intracellular 
pools of free fatty acids. A strain capable of producing upwards of 1 g/L intracellular free 
fatty acids was first engineered. By expressing a heterologous fatty acyl-CoA/aldehyde 
reductase from Marinobacter aquaeolei, MAACR, localized to the peroxisome, we 
produced over 530 mg/L fatty alcohols in the engineered strain, a yield close to 7.5 mg/g 
glucose. While there is more work that needs to be done to make production more 
efficient, this is first time peroxisomal targeted fatty alcohol production has been 
demonstrated in Y. lipolytica, a promising approach to produce short to medium chain 
fatty alcohols in the future.  
¥ This work will be included in a future publication with co-authors Michael Spagnuolo, Matthew 
Brabender, Cory Schwartz, Ian Wheeldon, and Mark Blenner. 
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Introduction 
Fatty alcohols are an important class of biological molecules that can range from as short 
as 4-6 carbons to as many as 22-26 carbons. Depending on the chain length, fatty 
alcohols can have a wide range of applications in industry ranging from personal care & 
cosmetics, soaps & detergents, textiles, oil, and gas. The global fatty alcohols market is 
estimated at USD 4.7 billion in 2017 and projected to reach USD 6 billion by 2022 [299].  
Traditional means to produce these aliphatic compounds via catalysis route can be 
costly and require energy-intensive reactions. Furthermore, synthesis of unique metal 
catalysts is required to produce fatty alcohols with different chain length specificities 
[300, 301]. In comparison, biological means of fatty alcohol production bypass these 
issues because in nature, several naturally occurring biocatalysts have chain length 
specificity but also enable the production of these biomolecules in a more energy friendly 
sustainable manner by utilizing cheap, cost-effective feedstock [65, 302].   
In recent years, microbes have been explored as an alternative route for fatty 
alcohol production [303-305]. S. cerevisiae and E. coli are target hosts because of the 
wide array of genetic tools, ease of genome editing, and an extensive body of literature 
that already exists well establishing the metabolic pathways. Yeast systems are more 
industrially relevant because of the ability to grow them to high density at large-scale 
fermentation, resistance to phage infections, and higher tolerance to toxic inhibitors and 
products [306].  
There are essentially two main pathways to produce fatty alcohols in yeast (Figure 
5.1). One strategy is the conversion of fatty acyl-CoA to fatty alcohol via a single four-
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electron reduction step using a bifunctional acyl-CoA / aldehyde reductase. The 
commonly used enzymes are TaFAR1 (Tyo alba), MmFAR1 (Mus musculus) and 
MAACR (Marinobacter aquaeoli) [65, 91, 92, 307]. The other strategy is to convert fatty 
acids to aldehydes via a carboxylic acid reductase (CAR) and then convert the aldehydes 
to fatty alcohols via an alcohol dehydrogenase or aldehyde reductase.  
The earliest work in S. cerevisiae relied on pushing flux to fatty acyl-CoA from 
acetyl-CoA and using a fatty acyl-CoA reductase, MmFAR1, to convert fatty acyl-CoA to 
fatty alcohol [90]. This led to almost 100 mg/L fatty alcohols and the production yield 
was 5 mg/g (glucose and galactose). Another strategy was to block triacylglycerol 
synthesis by deleting DGA1, accumulating fatty acyl-CoAs in the cytosol [308]. The fatty 
acyl-CoA was converted to fatty alcohols using a fatty acyl-CoA reductase from TaFAR1 
[308]. The authors used the word “yield” to describe titers, reporting 100 mg/L fatty 
alcohols produced in the engineered strain. If total substrate consumption is considered, 
the yield would be 1.6 g/g galactose.  
It was not until recently that d’Espaux et. al. showed significant improvements in 
fatty alcohol production. First, the push to fatty acyl-CoA from acetyl-CoA was 
engineered by overexpressing an acetyl CoA carboxylase (ScACC1), the first committed 
step in fatty acid synthesis. Proteomics revealed that this enzyme was naturally present in 
low abundance.  Many competing pathways for the fatty acyl-CoA were blocked, the 
more significant knockout being ScDGA1. A strong pull on fatty acyl-CoA pools for fatty 
alcohol production was accomplished by overexpressing MmFAR1 [65]. They 
determined that MmFAR1 was a more efficient four-electron reducing reductase than 
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TaFAR1. Titers of 1.2 g/L and yield of 70 mg/g glucose were reported (Table 5.1). This 
is the best fatty alcohol yield reported to date in S. cerevisiae using glucose as substrate. 
This experiment, however, was performed in rich YPD media, which is not suitable for 
industrial production because of its high costs, complex make up, and variable 
composition.  
The other strategy in S. cerevisiae was the conversion of free fatty acids to fatty 
alcohols. A pull towards free fatty acid production was engineering by over-expressing a 
heterologous ATP-dependent citrate lyase, MmACL1 (Mus musculus), to convert citrate 
to acetyl CoA, and then overexpressing the endogenous ScACC1p. Intracellular fatty acid 
pools were increased by blocking fatty acid activation and degradation [309]. Conversion 
of fatty acids to fatty alcohols was accomplished by overexpressing a heterologous 
Mycobacterium marinum CAR, MmCAR, an endogenous aldehyde dehydrogenase, 
ScADH5. A build-up of C18 fatty aldehydes suggested that overexpression of ScADH5 
was not sufficient, therefore, MAACR was overexpressed to contribute to more efficient 
fatty aldehyde reduction. This strategy produced only 120 mg/L fatty alcohols in shake 
flasks and a low yield of 6.3 mg/g glucose [309].   
More recently, inducible promoters have been demonstrated to fine-tune 
metabolic pathways to dynamically control fatty alcohol production. A glucose-
repressible promoter from the HXT1 gene was used to control the expression of FAA1, 
encoding for an enzyme that converts fatty acids to fatty acyl CoA. Fatty alcohol 
accumulation improved by ~41% while FFAs decreased by ~63% relative to the 
control strain [310]. In a separate study, a bifunctional reductase from Arabidopsis 
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thaliana, AtFAR, and upstream enzymes were placed under the control of a galactose-
inducible promoter. This enabled separation of growth from production and prevented 
the build-up of toxic compounds from the mevalonate pathway. The engineered strain 
produced close to 85 mg/L of C22 alcohols, about four times higher than fatty alcohol 
titers in the strain containing constitutive expression promoters [311].  
 In addition to producing fatty alcohols in high enough titers, it is important to 
design a microbial production platform that is efficient and provides the means to 
manipulate chain length specificity. The global demand for short to medium chain fatty 
alcohols (C6-C14) accounts for more than half of the fatty alcohol market volume and is 
projected to increase in the next few years [312]. This is due to the broad range of 
industrial applications for medium-chain fatty alcohols while short-chain fatty alcohols 
are specialty chemicals because they are not abundant in nature. As a result, these fatty 
alcohols have a larger global demand resulting in higher market costs. Our analysis 
shows that given the current market value for fatty alcohols and glucose, lower yields of 
short and medium chain fatty alcohols would need to be produced to “break even” on the 
cost of glucose (Table 5.1). This does not account for production and separation costs 
suggesting that we would have to produce higher than the break-even yield (Table 5.1) to 
eventually make the process economically feasible. 
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Table 5.1. Average market value of fatty alcohol based on chain length and yield required 
to meet the cost of glucose [313].  Shaded in grey is the market price for un-refined 
glucose [314]. 
Fatty Alcohol Range 
Fatty Alcohol Price 
(cents / g alcohol) 
Break-Even Yields 
(mg alcohol / g glucose) 
Short (C6-C8) 32 180 
Medium (C8-C14) 25 250 
Long (>C14) 16 400 
 
One method to create short-chain fatty alcohols is compartmentalizing the 
production pathway to the peroxisome. This strategy can be used to produce shorter chain 
fatty acids that can then be reduced to alcohols [65, 315]. In S. cerevisiae short to 
medium chain fatty alcohols (C6-C12) have been produced in the peroxisome with a high 
degree of efficiency (43 mg/g glucose) compared to other studies [315]. The other 
strategy to create shorter chain fatty alcohols is premature termination of fatty acid 
elongation by using chain length specific acyl-thioesterases that convert fatty acyl-ACP 
(Acyl Carrier Protein) to fatty acids, which can then be converted to fatty alcohols via a 
reductase. The latter strategy has been explored in Y. lipolytica to produce C10 fatty 
alcohols [93]. Y. lipolytica is a promising host for production of fatty alcohols because of 
its ability to produce lipids [157, 162, 257, 316, 317]  and fatty acids [149], which can 
serve as precursors for fatty alcohols.  
By expressing bacterial and plant acyl-ACP thioesterase, fatty acid elongation 
was terminated to produce a large abundance of C10 fatty acids [318]. Overexpression of 
native fatty acyl CoA synthase, YlFAA1, converted C10 fatty acids to fatty acyl-CoAs 
followed by AtFAR overexpression to produce upwards of 500 mg/L of C10 fatty 
alcohols in the cytosol with a yield of ~10 mg/g glucose [93]. The strain lacked 
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peroxisomes which resulted in four times weaker growth than the wildtype, W29 strain. 
We have observed that knocking out the peroxisomes in the PO1f auxotrophic strain 
causes weaker growth and slower growth rates, which for industrial purposes makes the 
strain more difficult to use. Table 5.2 summarizes other accomplishments to date of fatty 
alcohol production in Y. lipolytica and a comparison the best engineering feats in S. 
cerevisiae. The theoretical yield is calculated based on the total glucose supplied to the 
media while yield coefficient is calculated based on how much glucose was consumed. 
To date, the highest fatty alcohol production achieved from Y. lipolytica via scale 
up into a 3-L bioreactor is 2.5 g/L [91] while in 40 mL shake flask fermentations, the titer 
was 205 mg/L [91]. Various pathways were accessed for fatty alcohol production but the 
most promising strategy was pushing flux from fatty acids to fatty acyl-CoA using a 
heterologous fatty acyl-CoA synthetase from E. coli, EcFadD, and pulling on fatty acyl-
CoA pools to fatty alcohols using MAACR reductase [91].  
In this work, we compartmentalized fatty alcohols production inside the 
peroxisome that houses all enzyme necessary for beta-oxidation (Figure 5.2). This 
strategy, which has not been reported in Y. lipolytica before provides access to the 
machinery to tune fatty acid chain length by manipulating the POX1-6 genes. The native 
fatty acid synthesis pathway creates predominantly C16 and C18 fatty acids while our 
goal is to produce short and medium chain fatty alcohols (C6-C14). In addition to 
achieving chain length specification, localizing the pathway into the peroxisome allows 
spatial compartmentalization of the enzymes that facilitate the transfer of metabolites 
from one enzyme to the next. This generates a more efficient assembly line for the 
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process and has been shown in eukaryotes to increase overall metabolic output [319] and 
prevent undesired side reactions that hinder production efficiency. 
 We first localized MAACR into the peroxisome by fusing it to a peroxisomal 
targeting sequence (PTS).  The first strategy relied on increasing the cytosolic fatty acyl-
CoA pool by knocking out expression of YlDGA1. We hypothesized that this would 
create a cellular increase fatty acyl-CoA concentrations that would also translate into the 
peroxisome. The second strategy that showed more success, was increasing the 
intracellular free fatty acid pools. We accomplished this by blocking fatty acid activation 
(ΔYlFAA1) and beta-oxidation inside the peroxisome (ΔYlMFE1). The peroxisomal fatty 
acyl-CoA synthetase, YlAAL1, was kept in-tact. The fatty acid hybrid promoter reported 
the strongest GFP expression from this strain and thin layer chromatography (TLC) 
showed that >50% of the intracellular lipid content were free fatty acids. This strategy 
resulted in titers of 530 mg/L although the yield was a little over 7 mg/g glucose 
suggesting that more work needs to be done to improve the efficiency of the pathway.  
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Table 5.2. Comparison of fatty alcohol production in S. cerevisiae and Y. lipolytica. 
Highlighted in blue are peroxisomal targeted strategies for S. cerevisiae and Y. lipolytica. 
Yield coefficient is yield based on glucose consumed while yield was calculated with 
how much glucose was initially added to the media. N.R. means not reported data. 
Host 
Titer 
Shake 
Flask 
(mg/L) 
Titer 
Bioreactor  
(mg/L) 
Yield 
(mg/g glucose) 
Yield 
Coefficient 
(mg/g glucose) 
Ref. 
S. cerevisiae 1200 6000 58 70 [65] 
S. cerevisiae 330 1100 16.5 30 [320] 
S. cerevisiae 837 1300 40 43 [315] 
Y. lipolytica 690  N.R. 4.3 18 [92] 
Y. lipolytica 550 N.R. 11 N.R. [93] 
Y. lipolytica 167 N.R. 5.5 N.R. [321] 
Y. lipolytica 205 2500 3.4 N.R. [91] 
Y. lipolytica 530 N.R. 7 12 This study 
 
Experimental Methods 
Chemicals and Reagents 
All restriction enzymes used in cloning were purchased from New England 
Biolabs (NEB, Ipswich, MA) unless otherwise stated. Oligos designed for all experiments 
were synthesized by Eurofins Genomics.  Plasmid minipreps were performed using the 
Zyppy™ Plasmid miniprep kit (Zymo Research, Irvine, CA). PCR purifications and 
restriction digest purifications were performed using the DNA Clean and Concentrator kit 
(Zymo Research). Fatty alcohol and fatty acid standards were purchased from Nu-Check 
Prep. All chemicals were purchased from Sigma Aldrich unless otherwise stated. 
 
Transformation, Cell Culture and Media Formulations 
 Plasmid propagation and cloning were performed using E. coli DH10β competent 
cells (NEB). The heat shock transformation method was used. All Y. lipolytica 
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transformations were performed using the lithium acetate method as previously described 
[106] with a minor modification to the final step. In brief, post heat-shock for 10 minutes 
at 39ºC, transformed cells were mixed with 1.2 mL of 0.1M LiAc (pH 6.0) solution prior 
to spinning down at 3,000xg for 2 mins and re-suspending the pellet in 0.1 mL of 0.1 M 
LiAc (pH 6.0). 0.03 mL of the mixture was transferred into 2 mL of the desired synthetic 
media containing 6.7 g/L yeast nitrogen base (YNB) without amino acids (BD 
Diagnostics, Hunt Valley, MD) and complete synthetic media either without leucine 
(0.69 g/L CSM-LEU) or without leucine and uracil (0.67 g/L CSM-LEU-URA) (Sunrise 
Science Products, San Diego, CA). The cells were precultured in media containing 20 g/L 
glucose and grown in culture tubes to propagate cell growth for 40-48 hours. The cells 
were then transferred into their respective auxotrophic cultures at an initial OD600 of 0.2.  
For fatty alcohol production, experiments were performed in synthetic culture 
media containing 1.7 g/L YNB without amino acids and ammonium sulfate (Difco) and 
CSM-LEU or CSM-LEU-URA. Final ammonium sulfate concentrations in the culture 
were 2.5 g/L and 5 g/L to accomplish C:N molar ratios 60:1 and 30:1, respectively. Each 
of the cultures contained 80 g/L glucose. Total culture volume was 20 mL grown in 50  
mL baffled flasks. The cultures were overlaid with a 10% (v/v) dodecane layer to capture 
fatty alcohol excreted and prevent volatilization [322]. Cells were grown at 215 rpm for 5 
days prior to harvesting cells for fatty alcohol quantification. 
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Plasmids and DNA Cloning 
 The TEF(404)-Intron and AAL1 were cloned into pSL16-cen1-1(227) ARS/CEN 
with a URA3 selection marker using primer pairs F1/R1 and F2/R2.  To create the 
MAACR-PTS vector, the plasmid pSL16-UAS1B8-GFP-ScCYC1t referenced in Chapter 
2 was digested with BssHI/NheI to clone a PCR amplified MAACR-PTS using SLIC 
primers F3/R3. Primers can be found in Supplementary Table 5.1. For intracellular fatty 
acid detection, a plasmid containing A1R1x3A3-GFP (created in our lab) harboring a 
leucine auxotrophic was transformed in each of the strains. 
 
CRISPR-Cas9 to Create Knockout Strains 
The base strain used for all subsequent knockouts was PO1f (MATa leu2−270 
ura3−302 xpr2−322 axp1). CRISPR-Cas9 [83] was used to create the knockouts strains 
described in this chapter. The gRNA sequences used to create each knockout can be 
found in Supplementary Table 5.1. CRISPR-Cas9 / gRNA cassettes were made using a 
base vector that was redesigned to contain a NsiI cut sight where all subsequent gRNA 
were cloned by using SLIC. The design of the modified CRISPR vector containing the 
NsiI cloning site was described in Chapter 4. Table 5.3 highlights the strains engineered 
for fatty alcohol production and intracellular fatty acid reporter experiments. The 
POf1Δfao1 strain was created as the base strain for all fatty alcohol experiments. gRNA 
oligos were first annealed together prior to using SLIC to clone the gRNA sequence into 
CRISPR vector digested with NsiI. The same strategy was used to create all strains 
except for the PO1fΔpex10 and PO1fΔmfe1Δfaa1Δpex10 where two gRNA sequences 
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were used to remove the PEX10 gene instead creating a frameshift mutation. First, two 
separate plasmids were cloned containing gRNA sequences that cut upstream and 
downstream of PEX10. The annealed gRNA oligonucleotides were F8/R8 and F9/R9, 
respectively.  Next, the CRISPR plasmid harboring the gRNA sequence that cuts 
downstream of PEX10 was PCR amplified using primer pairs F10/R10 to obtain the 
SCR1-tRNA-gRNAPEX10down-tracrRNA. This insert was cloned into the CRISPR 
vector containing the gRNA that cuts upstream of PEX10 that was digested with a single 
enzyme XmaI, placing the second gRNA sequence in the same expression cassette 
harboring the first gRNA sequence. Sanger sequencing was used to verify screened 
colonies post-transformation. A greater than 50% cut efficiency of the CRISPR system 
was achieved using this strategy. 
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Table 5.3. List of engineered strains used for fatty alcohol production and tested for 
intracellular fatty acid production. Not in study – reported in Supplementary Figure 5.1. 
Fatty alcohol production strains 
PO1f (Wild Type) Not tested 
PO1fΔfao1 + MAACR (leucine) Not tested 
PO1fΔfao1 + MAACR (leucine) + AAL1 (uracil) In study 
PO1fΔdga1Δfao1 + MAACR (leucine) In study 
PO1fΔdga1Δfao1 + MAACR (leucine) + FAA1 (uracil) In study 
PO1fΔdga1Δfao1 + MAACR (leucine) + TGL4 (uracil) In study 
PO1fΔmfeΔfaa1 + MAACR (leucine) In study 
PO1fΔmfeΔfaa1 + MAACR (leucine) + AAL1 (uracil) In study 
Intracellular fatty acid sensor strains 
PO1f (Wild Type) Not tested 
PO1f + hrGFP FA sensor (leucine) In study 
PO1fΔdga1 + hrGFP FA sensor (leucine) In study 
PO1fΔmfe1 + hrGFP FA sensor (leucine) In study 
PO1fΔmfe1 + hrGFP FA sensor (leucine) + FAA1 (uracil)  Not in study 
PO1fΔpex10 + hrGFP FA sensor (leucine) In study 
PO1fΔfaa1 + hrGFP FA sensor (leucine) In study 
PO1fΔmfeΔfaa1 + hrGFP FA sensor (leucine) In study 
PO1fΔmfeΔfaa1Δpex10 + hrGFP FA sensor (leucine) In study 
PO1fΔmfeΔfaa1 + hrGFP FA sensor (leucine) + AAL1 (uracil) In study 
PO1fΔmfeΔfaa1 + hrGFP FA sensor (leucine) + DGA1 (uracil) Not in study 
PO1fΔmfeΔfaa1 + hrGFP FA sensor (leucine) + TGL4 (uracil) Not in study 
 
Fluorescence Spectroscopy for Intracellular Fatty Acid Detection 
The Biotek Synergy MX fluorescence spectrophotometer was used for all 
fluorescent studies. Cells were inoculated into 48-well plates containing 0.250 mL of 
synthetic media prepared as described above. The spectrophotometer was set to gain 140 
with fast orbital shaking. Cells were grown in plates and for ~60 hours past stationary 
phase with cell growth and fluorescence measured every hour using an 
excitation/emission wavelength 485/510 nm and a bandwidth of 9. 
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Total Lipid and Free Fatty Acid Extraction 
To identify and quantify lipids in cell biomass, extracted cellular lipids were 
transesterified to FAMEs as described previously with minor modifications [95]. Briefly, 
1 mL cell culture was harvested and spun down at 13,000 rpm for 3 minutes at 25 °C. 
100 L glyceryl triheptadecanoate at a concentration of 2 mg/mL methanol was added to 
the cell pellet as an internal standard. Lipids were transesterified to FAMEs with 500 μL 
of 0.5 N sodium methoxide followed by 30 min of vortexing at 2,000 rpm. The solution 
was neutralized with 40 μL sulfuric acid. FAMEs were extracted by adding 850 μL 
hexane followed by 20 min of vortexing at 2,000 rpm. The mixture was centrifuged for 1 
min at 8,000 rpm, and 800 μL of the organic layer was collected for GC-FID analysis. 
For free fatty analysis, the blot on the TLC plate (Millipore, Burlington, MA) is scraped 
off and run subject to the same fatty acid methylation and quantification process as 
described in this section.  
 
Thin Layer Chromatography for Determination of Percentage Lipid Classes 
 Cell cultures, normalized to OD600 of 17, were collected and centrifuged. The 
same extraction protocol was employed for cellular lipid and fatty alcohol extraction as 
described in the fatty alcohol methods section below with a minor modification. At the 
final step, instead of re-suspending the sample in ethyl acetate, the dried lipid extract was 
re-suspended in 0.1 mL hexane to be run on TLC. A protocol for silica plate-based thin 
layer chromatography has been described before [323, 324]. TLC plates were activated 
by heating the plate immediately before use for 10 min at 105 °C to remove the water. 
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The solvent system was prepared by thoroughly mixing hexane/diethyl ether/acetic acid 
(70/30/1, v/v) and poured into the chamber to a level up to approximately 1 cm from the 
bottom.  The chamber was closed to enable solvent saturation. A pencil line was drawn 
on the plate approximately 2 cm from the bottom. The lipid sample was then applied to 
the plate using either a microsyringe or a sample applicator device incubated at room 
temperature for 1-2 min to allow for the hexane to evaporate. The plate was quickly 
placed inside the saturated chamber, standing vertically and submerged in ~ 1cm of 
solvent. At the end of separation (once the solvent has migrated to the top of the plate), 
the plate was dried by passing gently passing nitrogen gas over the plate. The plate was 
then placed in a chamber containing crystal of iodine (non-destructive) for several 
minutes until yellow or brown spots appear. A pencil was used to demarcate lipid regions 
of interest for further processing. An image of the chromatogram was analyzed using the 
Image J software [325] to determine proportions of the lipid fractions on the plate.  
 
Fatty Alcohol Extraction 
 Ten mL of culture from each flask were spun down in centrifuge tubes at 3000xg 
for 10 minutes. The dodecane overlay (top layer) was extracted and directly used in GC-
FID analysis to determine fatty alcohols in the dodecane layer. To extract fatty alcohols 
from the supernatant, 2 mL of ethyl acetate was added to 10 mL of the supernatant in a 
closed glass vial and allowed to shake for 2 hours. The mixture was then incubated at 4ºC 
overnight to facilitate separation of both layers. One mL of ethyl acetate was extracted 
for GC-FID analysis. To extract fatty alcohols from the cell pellet, 10 mL of cell culture 
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was centrifuged and washed once with 1xPBS (Sigma) to prevent any carry-over from 
the supernatant. Fatty alcohol, including lipids, were extracted as described before [159, 
326]. Briefly, cells were resuspended and in 1 mL of 2:1 (v/v) Chloroform: Methanol 
mixture and vortexed at 5000xg for 1 hour. The mixture was spun down and 0.9 mL of 
the liquid was extracted.  0.225 mL of 0.85% (w/v) NaCl (Saline solution) was added and 
vortexed for 5 minutes. The mixture was then centrifuged and chilled on ice for 5 minutes 
to improve the separation of the organic and aqueous phase. The aqueous layer (top 
phase) was removed and the organic layer was evaporated under vacuum and room 
temperature overnight. Ethyl acetate (0.9 mL) was added to each of the dried tubes to 
resuspend the fatty alcohols for GC-FID analysis. Each of the samples was spiked with 
0.1 mL of 0.5 mg/mL C17:0 alcohol, heptadecanol, prior to any of the above-mentioned 
extraction processes.   
 
GC-FID for Fatty Acid and Fatty Alcohol Analysis 
Both methylated FFAs and fatty alcohols were quantified using GC-FID (Agilent 
7890B). For fatty acid analysis, FAME species were separated on an Agilent J&W DB-
23 capillary column (30 m × 0.25 mm ×.0.15 μm), with helium carrier gas at a flow rate 
of 1 mL/min. The temperature of the oven started at 175°C and was ramped with a 
gradient of 5°C/minute until 200°C. The FID was operated at a temperature of 280 °C 
with a helium makeup gas flow of 25 mL/min, hydrogen flow of 30 mL/min, and airflow 
of 300 mL/min. Fatty alcohols were separated on an Agilent DB-Waxter capillary 
column (30 m × 0.25 mm × 0.15 μm) using helium carrier gas at a flow rate of 1 mL/min. 
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The initial temperature of the oven was 100 °C and was ramped to 220°C at a rate of 
20°C per minute and held for 2 minutes. The temperature was then ramped to 300°C at a 
rate of 20°C per minute and held for 5 mins. The temperature of the inlet was maintained 
at 250°C and the injection volume was 1uL with a split ratio of 1:10. 
 
Figure 5.1. Two commonly used pathways in yeast to produce fatty alcohols. The first 
pathway (above) utilizes two two-electron reducing steps to convert fatty acids to fatty 
alcohols. The second pathway (below) utilizes a single four-electron reducing enzyme to 
convert fatty acyl-CoA to fatty alcohol. 
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Figure 5.2. Fatty alcohol production pathway starting with glucose as the primary carbon 
source. Cytosolic fatty acyl-CoA can either be transported and produced in the 
peroxisome or shuttled into the ER for neutral lipid synthesis (TAGs, SEs). 
 
Results 
Increasing Cytosolic Fatty Acyl-CoA pools 
The first attempt at engineering a strain to increase peroxisomal fatty acyl-CoA 
pools was to knockout DGA1 (Figure 5.2) thereby reducing the loss of cytosolic acyl-
CoAs to TAG synthesis. This engineered strain, PO1fΔdga1Δfao1, has been previously 
used for fatty alcohol production resulting in greater than 600 mg/L produced with a yield 
of 18 mg/g glucose [92].  However, their strategy used a different FAR that showed 
strong specificity towards C16 fatty alcohol production. To reach the reported titers, five 
copies of the FAR had to be expressed in the cytosol using media containing very little 
nitrogen (0.273 g/L) and very high glucose (160 g/L) amounting to a C:N ratio of 
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~1000:1. Severely retarded growth was reported that they attributed the cause being fatty 
alcohol production inhibiting growth. 
Our engineered strain employed an episomally expressed a single FAR from 
Marinobacter aquaeolei VT8, MAACR, that included a C terminus PTS that should 
target it to the peroxisome. MAACR is known to have a broader range of activity towards 
fatty acyl-CoA substrate [327] with high activity toward short-chain acyl-CoAs (C8-
C12), which is of special interest to our future goals. Furthermore, lower glucose 
concentrations (80 g/L) and ~10 times higher nitrogen conditions than Chen. et. al. [92] 
were used (C:N of 60:1) that resulted in better overall cell growth.   
The initial hypothesis was that increasing the cytosolic fatty acyl-CoA pools 
should increase overall cellular fatty acyl-CoAs including that in the peroxisome. 
Cytosolic acyl-CoAs exists at the core of the metabolic pipeline and can be directed to 
various pathways such as beta-oxidation in the peroxisome, desaturation, elongation in 
the endoplasmic reticulum (ER), production of storage molecules such as TAGs in the 
ER then form into lipid bodies or conversion to FFAs that are excreted from the cell 
(Figure 5.2). The base engineered strain, PO1fΔdga1Δfao1 with peroxisomal targeted 
fatty alcohol biocatalysis produced ~150 mg/L total fatty alcohols (Figure 5.3 A). To 
further increase the cytosolic acyl-CoA concentrations, a gene encoding for fatty acyl-
CoA synthesis from free fatty acids, FAA1, was over-expressed. Surprisingly, this strain 
showed less fatty alcohol production dropping the total titers by ~ 33% compared to the 
original engineered strain.  
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High C:N ratios have been shown as a mechanism to upregulate pathways for 
lipid accumulation in Y. lipolytica [328, 329].  Although the DGA1 knockout should 
dramatically drop total neutral lipid accumulation, the high C:N ratio should still 
upregulate pathways favoring TAG accumulation. To release TAGs, the native TGL4 
lipase was overexpressed. After 5 days of growth in synthetic media, over 200 mg/L fatty 
alcohols were produced, a ~25% increase compared to the base engineered strain (Figure 
5.3A). The results indicate that increasing cytosolic fatty acid pools rather than fatty acyl-
CoAs were more beneficial to peroxisomal fatty alcohol production. In either of the three 
engineered strains, the fatty alcohol distribution did not change (Figure 5.3B), showing 
higher percentages of C18 alcohols produced. This result is unique because C18 fatty 
acyl-CoA specificity has never been reported with MAACR before.  
We were also able to detect C12 and to a lesser extent C10 fatty alcohols in the 
dodecane layer (Supplementary Figure 5.2 B) amounting to a total yield of greater than 
100 mg/L for each strain (Supplementary Figure 5.2A). Since no C14 alcohols were 
detected, we hypothesize the production of the C12 and C10 medium chain fatty alcohols 
was a result of the active alkane metabolism in Y. lipolytica, oxidizing C12 alkanes to 
fatty acids that are then converted to fatty alcohols. C10 fatty alcohols are a result of a 
single cycle of beta-oxidation to produce C10 fatty acyl-CoAs that are converted to fatty 
alcohols. Although not initially expected, this result suggests that peroxisomal localized 
MAACR is a promising strategy to capitalize on the native beta-oxidation pathway to 
produce fatty alcohols. This result needs to be validated with dodecane fed as the sole 
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carbon source to determine whether C10 and C12 alcohol production were a result of 
alkane oxidation and not beta-oxidation of fatty acids synthesized from glucose.  
 
 
 
Figure 5.3: (A) Peroxisomal fatty alcohol production from increasing cytosolic acyl-CoA 
pools by knocking out DGA1p, a critical enzyme in TAG synthesis, or over-expressing 
the primary fatty acyl-CoA synthetase enzyme, FAA1p. TGL4 lipase over-expression, an 
enzyme that metabolizes TAGs to fatty acids in the cytosol, shows best titers. (B) 
Distribution of fatty alcohols produced in the three engineered strains. Samples were run 
in technical replicates (n=3) and represented error is a standard error.  
 
Utilizing a Fatty Acid Responsive Promoter to Detect Intracellular Fatty Acid Production 
In the second strategy, we wanted to build intracellular free fatty acid pools 
instead of fatty acyl-CoA to determine if this would improve fatty alcohol production. 
Therefore, our first goal was to engineer a strain capable of producing high amounts of 
free fatty acids. In Chapter 3, a fatty acid GFP based sensor was engineered to show high 
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sensitivity and induction when extracellular fatty acids were used in the media. We were 
interested in testing whether the hybrid promoter can also be used to detect real-time 
changes in fatty acid pools produced intracellularly. If successful, this could serve as a 
powerful tool for engineering strains for high fatty acid production.  
 The episomally transformed hybrid fatty acid promoter fused to a GFP reporter 
was used to detect intracellular fatty acids in various engineered strains with knockouts 
and TLC was used to determine relative percentages of the two more important lipid 
classes, FFAs and TAGs (Figure 5.4A). Normalized fluorescence is a measure of cell 
fluorescence per OD600, an indication of GFP accumulation in each cell over time. We 
wanted to determine if this signal would correspond to fatty acid accumulation over time. 
The PO1f wildtype strain shows no fluorescence and can be correlated to very little fatty 
acids as observed on TLC plates. The knockout strains, PO1fΔdga1 and PO1fΔpex10 
both shows a slight change in fluorescence profile relative to the WT and also produced 
slightly higher free fatty acids. The two highest fatty acid producing strains were the 
PO1fΔfaa1 and PO1fΔmfe1Δfaa1 which resulted in intracellular fatty acid percentages of 
30% and 54%, respectively. The intracellular GFP fluorescence profile in the PO1fΔfaa1 
first drops slightly and then increases suggesting an accumulation of fatty acids over 
time. The highest and most stable GFP expression profile was observed from the 
PO1fΔmfe1Δfaa1 which correlated well with the high proportions of free fatty acids on 
TLC plates.  
 Interestingly, the PO1fΔmfe1 strain also showed a dramatic increase in 
fluorescence followed by a sharp drop, although fatty acid abundance from TLC does not 
 152 
explain this phenomenon if we hypothesize that intracellular fatty acids can be correlated 
to in vivo GFP expression from the fatty acid inducible promoter. This led us to believe 
that there is complexity associated with detection that needs further understanding.  
 
 
Figure 5.4. Fatty acid sensor (A1R1x3A3-GFP) used to detect intracellular fatty acid 
pools in Y. lipolytica engineered strains. The experiment was performed in a 48-well 
plate with cell growth and fluorescence recorded over time. Normalized fluorescence 
represents the ration of cell fluorescence to cell density to provide fluorescence 
quantification per OD600. Densiometric analysis on TLC plates is performed to quantify 
percentages of fatty acids and TAGs in each of the engineered strains.   
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Characterization of Fatty Acid Hybrid Reporter 
In Figure 5.4, the fluorescence profile PO1fΔmfe1 shows a transient increase in 
GFP signal prior to tailing off rapidly. TLC profiles, however, show minimum 
proportions of fatty acids but the highest accumulation of TAGs from all engineered 
strains. From Figure 5.2, knocking out MFE1, a gene encoding the second step of beta-
oxidation inside the peroxisome, should prevent fatty acyl-CoAs from shunting through 
the beta-oxidation pathway. The notable spike in expression from PO1fΔmfe1 does bring 
into question whether this behavior could be related to a transient flux of fatty acyl-CoAs 
or free fatty acids into the peroxisome that cannot be degraded and is therefore 
transported back into the cytosol to be activated to TAGs. This raises two questions. Is 
the transient spike in GFP a result of transient fatty acid or fatty acyl-CoA pools inside 
the peroxisome? Is the hybrid promoter reporting fatty acids, fatty acyl-CoAs or both?   
First, to test the impact of peroxisomes on GFP expression, cellular peroxisome 
formation was knocked out by deleting the peroxisome biogenesis factor, PEX10 gene in 
the engineered strain that showed highest free fatty acid accumulation, PO1fΔmfe1Δfaa1. 
As a result, we observed a dramatic drop in fluorescence from the 
PO1fΔmfe1Δfaa1Δpex10 (Figure 5.5A). TLC analysis showed a similar quantity of 
intracellular free fatty acids although the PO1fΔmfe1Δfaa1Δpex10 had ~7-fold higher 
TAG accumulation. In the absence of peroxisomes, fatty acids were directed into storage 
as TAGs. This result suggests that intact peroxisomes are required for activation of the 
hybrid promoter. The regulatory process behind this association needs to be investigated 
further.        
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 Next, we wanted to determine if the peroxisomal dependent intracellular hybrid 
promoter was detecting fatty acids or was it also exhibiting responsiveness to the 
activated form, fatty acyl-CoA. To test this hypothesis, the native peroxisomal fatty acid 
synthase gene, YlAAL1, was over-expressed to activate free fatty acids into fatty acyl-
CoAs inside peroxisome (Figure 5.2). YlAAL1 was reported to be a peroxisomal fatty 
acyl-CoA synthetase [330]. This experiment was also performed in the high fatty acid 
producing strain.  AAL1 overexpression caused a drop in intracellular fluorescence over 
time (Figure 5.5B). From TLC, total free fatty acid pools remained the same between the 
two strains but ~5 times more intracellular TAGs were produced in the engineered strain 
overexpressing AAL1 (Figure 5.5B). This suggests that there is increased activation of 
fatty acyl-CoA activation resulting in the assimilation into TAGs. The experiment, 
however, falls short in answering if the hybrid promoter responds to fatty acids and/or 
fatty acyl-CoAs in the peroxisome. Metabolite analysis of fatty acids and fatty acyl-CoAs 
inside the peroxisome is required to know which exists in more abundance. The 
experiments required to elucidate the process will be discussed further in Chapter 6.  
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Figure 5.5. Characterization of intracellular sensor A1R1x3A3-GFP. (A) Removal of 
peroxisome via ΔPEX10p shows a significant drop in fluorescence. From the 
densitometric analysis of TLC plates, the fatty acid percentage remains the same between 
both strains while TAG accumulation increases 7-fold in PO1fΔmfe1Δfaa1Δpex10 strain. 
(B) Over-expression of AAL1 in high fatty acid producing strain, PO1fΔmfe1Δfaa1, 
causes the fluorescence signal to drop over time. Densiometric analysis on TLC plates 
shows similar percentages of FFAs while TAG accumulation increases 5-fold. 
Fluorescence experiments were performed in a 48-well plate with cell growth and 
fluorescence measured over time. Normalized fluorescence represents the ration of cell 
fluorescence to cell density to provide fluorescence quantification per OD600. Cells from 
growth experiments were harvested for TLC experiment. 
 
 
Fatty Alcohol Production from Engineered Fatty Acid Producing Strain 
PO1fΔmfe1Δfaa1 has previously been shown to produce large amounts of 
intracellular and extracellular fatty acids surpassing 2 g/L combined [89] making it a 
good starting point for a fatty alcohol production platform. Analysis of the fatty acid 
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distribution of the intracellular pool revealed that there is a predominant percentage of 
C14 and C16 fatty acids produced which is different to the fatty acid profiles of total 
lipids, containing predominantly unsaturated fatty acids, C16:1 and C18:1 
(Supplementary Figure 5.3 A, B). Therefore, we anticipated C14 alcohol production. 
However, to our surprise, no C14 fatty alcohols were produced.  
The media used had a lower C:N ratio of 30:1 to facilitate peroxisome formation. 
High nitrogen concentration switches the cells global regulatory circuit from lipid 
accumulation to fatty acid degradation which requires peroxisomes [331]. In the wildtype 
overexpressing AAL1, very little fatty alcohols were produced, predominantly being 
C16:0 and C18:0 (Figure 5.6 A, B). In PO1fΔmfe1Δfaa1, we observed a 10-fold 
improvement in fatty alcohol production reaching 530 mg/L and 14% of dry cell weight 
(Supplementary Figure 5.5). In addition to a predominant abundance of C16:0 and C18:0, 
small proportions of monounsaturated alcohol peaks C16:1, and C18:1 were detected.  
In attempts to further increase the fatty acyl-CoA pools inside the peroxisome, 
AAL1 was over-expressed. Surprisingly, this perturbation to the pathway resulted in a 
35% drop in fatty alcohol production. The hybrid promoter was previously used to test 
GFP expression in PO1f Δmfe1 Δfaa1 over-expressing AAL1 (Figure 5.5B). We observed 
fluorescence drop over time relative to PO1fΔmfe1Δfaa1. Whether this effect can be 
attributed to an increase in peroxisomal fatty acyl-CoA pools needs to be determined. 
However, higher TAG accumulation was observed in the AAL1 over-expressing strain 
suggesting higher levels of fatty acid activation to fatty acyl-CoA. 
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Figure 5.6. (A) Peroxisomal fatty alcohol production from increasing cytosolic fatty acid 
pools and beta-oxidation by knocking out fatty acid synthase, FAA1 and multifunctional 
enzyme, MFE1 produced highest titers exceeding 500 mg/L fatty alcohols. Over-
expression of AAL1 in engineered strains leads to a ~30% drop in titers. (B) Percentage 
fatty alcohol distribution of all three strain show similar profile except the engineered 
strains, PO1fΔmfe1Δfaa1Δfao1 and PO1fΔmfe1Δfaa1Δfao1 with AAL1 over-expression 
shows production of unsaturated fatty alcohols, C16:1 and C18:1. Samples were run in 
technical replicates (n=3) and represented error is a standard error. 
 
Discussion and Conclusion 
Developing microbial platforms to produce fatty alcohols has garnered a lot of 
interest in recent years with the exploitation of several microbes ranging from bacterial 
systems such as E. coli, cyanobacteria and Marinobacter aquaeoli [322, 332-334] to 
yeasts, predominantly S. cerevisiae [308, 310, 315, 335]. One of the benefits of exploring 
yeast systems for this function is that metabolic processes are naturally separated into 
specialized yet distinct subcellular compartments called organelles. For example, in 
yeasts, beta-oxidation of fatty acids is localized into the peroxisome or transported into 
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the ER to be stored in the form of TAGs. Furthermore, fatty acids produced in the cytosol 
via the fatty acid biosynthesis are bound to acyl-CoA binding proteins and can be 
transported either into the peroxisome or the ER. In comparison to conventional 
engineering of pathways in the cytosol, compartmentalization provides additional 
advantages such as enabling faster reaction rates due the ability to concentrate 
metabolites and enzymes. One of the more predominant advantages of pathway 
localization is the capacity to segregate the biochemical process of interest from 
competing pathways and mitigating regulatory responses at the protein level [336]. 
The metabolic strategy we propose is a novel method to explore fatty alcohol 
production in Y. lipolytica inside the peroxisome. This provides the ability to highjack the 
hydrocarbon chain processing capabilities via beta-oxidation to eventually produce 
shorter chain fatty alcohols. By increasing the cytosolic fatty acid pools instead of the 
cytosolic fatty acyl-CoA pools, we were able to produce more than 2-fold higher fatty 
alcohol titers in the peroxisome. These results suggest that fatty acids may enter the 
peroxisome more readily than fatty acyl-CoA. The observation can be validated by 
quantifying fatty acid and fatty-acyl CoA pools in the peroxisome.  
PO1fΔmfe1Δfaa1 strain produced the most amounts of fatty acids as evidenced by 
the hybrid promoter signal and TLC analysis. We believe this strategy of over-producing 
fatty acids enables better diffusion of fatty acids to enter the peroxisome for fatty alcohol 
conversion.  
In attempts to improve the efficiency of fatty alcohol production inside the 
peroxisome, AAL1 gene was over-expressed to pull fatty acids towards fatty acyl-CoA 
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production, which are direct precursors to MAACR. This strategy, however, led to a 
~30% drop in fatty alcohol titers and increase in TAGs as evidenced by TLC. Given that 
AAL1 expression is peroxisomal, we could at this point only hypothesize that higher 
production of fatty acyl-CoA is imbalanced by a less active MAACR leading to 
activation of fatty acyl-CoA export from the peroxisome to the cytosol to be available for 
TAG synthesis. This bottleneck can be overcome by improving the activity of FARs, 
regulating peroxisomal fatty acyl CoA pools, and blocking TAG synthesis.  
To improve the fatty alcohol reductase activity, a codon optimized version of the 
MAACR gene will be expressed. We anticipate better translation efficiency of the gene, 
thereby increasing enzyme concentration and overall kinetics of the reaction. Codon-
optimized versions of other FARs, particularly, TaFAR1 and MmFAR1 should be tested. 
TaFAR1 has already been shown to be functional in Y. lipolytica [92]. Meanwhile, 
MmFAR1, from the mouse, Mus musculus, is yet another fatty alcohol that has proven to 
show high activity when expressed in S. cerevisiae, greater than TaFAR1 [65]. There is 
no published literature to date on its activity in Y. lipolytica. The activity and fatty 
alcohol profiles generated from these FARs in our engineered strain may provide new 
alcohol distributions and improve the overall efficiency of the final production step, 
thereby improving yields.  
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The PO1fΔmfe1Δfaa1 strain produced significant C14 fatty acids (Supplementary 
Figure 5.3) although, with MAACR, no C14 fatty alcohols were produced. We 
hypothesize MAACR has a lower affinity to C14 when there is a high abundance of C16 
fatty acyl-CoA. Furthermore, lower specificity of MAACR to C14 aldehydes has been 
demonstrated before [332]. The inability to convert abundant C14 fatty acids to fatty 
alcohols affects the yields and titers of the process and therefore motivates our work to 
investigate additional FARs.    
We can attempt to engineer higher accumulation of fatty acyl-CoA inside the 
peroxisome but this is challenging because there is little known about the mechanism of 
fatty acyl-CoA transport and regulation to and from the peroxisome [169]. The dimeric 
ATP- dependent transporter, YlPxa1p/ Pxa2p, is hypothesized to transport fatty acyl-CoA 
into the peroxisome, whether this transport is reversible is unknown. This transporter has 
been knocked out previously to increase cytosolic acyl-CoA pools, however, no change 
to fatty alcohol production was observed [92]. This result suggests that fatty acyl-CoA 
transport to the peroxisome may be more regulated than we currently understand. 
Another approach would be to place the expression of YlAAL1 under the expression of 
the fatty acid hybrid promoter. Instead of attempting to create stagnant fatty acyl-CoA 
pools, dynamically regulating the expression of the protein by placing the gene under a 
fatty acid hybrid promoter could improve process efficiency.   
Since we are observing more TAG accumulation due to peroxisomal AAL1 over-
expression, it would also be beneficial to block TAG formation via ΔDGA1 in the 
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engineered PO1fΔmfe1Δfaa1Δfao1. This strategy could push fatty acyl-CoA flux back 
into the peroxisome to improve production efficiency inside the peroxisome.  
While glucose may be a convenient substrate, it may not ideal from a standpoint 
of making fatty alcohol production economically viable (Table 5.2). The advantage to 
using Y. lipolytica as the model yeast to engineer fatty alcohol production as opposed to 
S. cerevisiae provides several benefits, notably, its ability to uptake and metabolize 
hydrocarbons efficiently. This opens opportunities to utilize cheaper and more abundant 
alternatives as feed such as crude glycerol from the biodiesel waste stream or rendered 
animal fats. Reducing feed cost can bias economic profitability of the process.  
Two alternate methods have been explored for localized production of fatty 
alcohols inside the peroxisome of Y. lipolytica. In the first pathway, we attempted to 
increase cytosolic acyl-CoA pools by knocking out the lipid storage capabilities. Higher 
fatty acyl-CoA pools were expected inside the peroxisome, however, this strategy proved 
less efficient with the production of slightly over 200 mg/L of fatty alcohols. In the next 
strategy, that proved more promising, higher fatty acid production was engineered in Y. 
lipolytica by knocking out the cytosolic acyl-CoA activation step and preventing fatty 
acid degradation via beta-oxidation. Using a fatty acid inducible promoter fused to a GFP 
reporter gene, real-time production of intracellular fatty acids was monitored. Using this 
strategy, close to 600 mg/L of fatty alcohols were produced. Attempts to further increase 
production were tested by overexpressing the fatty acyl-CoA production pathway inside 
the peroxisome, however, this led to a decrease in fatty alcohol production with increased 
TAG accumulation. The work presented here highlights the need to explore mechanisms 
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to improve the efficiency of fatty acyl-CoA conversion to fatty alcohol, better 
characterization of the hybrid promoter so it could be utilized more efficiently, and 
engineering fatty acyl-CoA pools inside the peroxisome. This work is the first of its kind 
to engineer localized fatty alcohol biosynthesis in Y. lipolytica.  
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CHAPTER SIX 
 
Conclusions 
The work in this dissertation establishes tools to improve engineering efforts in 
the industrial yeast, Yarrowia lipolytica. Metabolic pathways in microbes were 
constructed with enzymes and controlling the time and strength of expression can 
improve the efficiency of biochemical processes. A large part of this work focused on 
understanding and developing better gene expression systems in Y. lipolytica. Hybrid 
promoters with tunable and predictable strengths can be engineered by combining 
different elements that constitute a promoter, namely, UASs, proximal sequences, TATA 
element and core promoters.  In particular, UAS elements in hybrid promoters were used 
to control strength and timing of expression. Identifying UASs, however, is a limitation 
in non-conventional yeasts such as Y. lipolytica where there is little known about 
regulatory elements such as transcription factors or its binding motifs. Therefore, we 
explored a novel method to screen for new UASs from differences in DNA accessibility 
profiles in native promoters under different conditions. We explored this concept with the 
POX2 promoter and anticipate using it to determine novel UAS elements in other native 
promoters. Finally, a fatty acid hybrid promoter detailed in this dissertation was used to 
guide the engineering of a fatty acid producing strain of Y. lipolytica. By localizing the 
final step of fatty alcohol biosynthesis to the peroxisome, the engineered strain shows 
promise for future metabolic engineering geared to short and medium chain fatty alcohol 
production. There are still a number of interesting opportunities for further investigation 
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of hybrid promoters and application of these promoters to improve fatty alcohol 
production efficiency.   
 
Future Work 
     In Chapter 1, libraries of hybrid promoters were built by investigating the 
architecture of native promoters in Y. lipolytica. In addition to Upstream Activating 
Sequences (UASs), we studied the role of sequences near the transcriptional start site, 
namely the proximal, TATA box and core promoters from four promoter systems 
upstream of the genes, YlPOX2, YlPAT1, YlLEU2, and YlTEF1-α. The goal of this work 
was to elucidate how each these elements contributed to promoter activity, which of the 
elements had modular properties and most importantly, which elements contributed the 
most to promoter activity.  
 The TATA box is a highly conserved element across all eukaryotic species and is 
the recruitment site for the pre-initiation complex (PIC) machinery that initiates 
transcription [337].  Although the TATA element itself is conserved, there is a lot of 
sequence variability surrounding this element that can affect transcription [338]. The 
TATA element from the TEF1-α promoter elicited the strongest transcriptional response 
of the four promoters tested. Another interesting result was that the POX2 promoter 
contained two TATA boxes. Removing one TATA element severely weakened 
transcription. Our experiments were limited to four promoters with an 8 bp window 
around the TATA sequence. 
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I recommend increasing this sequence space to test more base pair diversity 
around the TATA box. It would be beneficial to determine if there is a maximum 
threshold for transcriptional activation using TATA elements by varying sequence 
diversity around the conserved TATA box. This information can be leveraged to increase 
the strength of inherently weak native promoters or applied to the development of hybrid 
promoters. The dual TATA box activity of the POX2 promoter strongly suggests that 
adjacent sequence can play a pivotal role for PIC affinity to the TATA element.  
This experiment can be performed on one core promoter such as the POX2 core 
promoter than can be used as the control of the experiment. Oligo mixes of ~60 bp can be 
synthesized with 6-8 random base pairs (N) before and after a conserved TATA box. 
Each end in the mix of forward oligos should have the same 20 bp sequence while the 
ends of reverse oligo mix should be complementary to the ends of the forward oligos. 
This would allow the oligo mix to be PCR amplified. The PCR amplified product can 
then be cloned downstream of a UAS sequence and upstream of a GFP reporter in the 
pSL16 shuttle vector. By transforming these vectors into E. coli DH10β cells, a library of 
vectors with variations to the sequence before and after the conserved TATA element can 
be created and sequence verified via Sanger sequencing. As a first round, around twenty 
different sequence variations can be transformed into Y. lipolytica and fluorescence can 
be measured in 48-well plates to determine which sequence provides the strongest 
expression relative to POX2 core promoter. Sequences of the optimal expressing core 
promoters from Y. lipolytica can be screened using colony PCR and Sanger sequencing 
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The initiator sequences in the core promoter are another under-studied promoter 
element that was not covered in Chapter 2. In Supplementary Figure 2.1, we identified 
potential initiator regions in the four promoters based on homology to metazoan 
sequences. In S. cerevisiae, RNA polymerase II performs a downstream scan in search of 
transcriptional start sites (TSSs) [339] that results in transcriptional initiating occurring 
40-120 bps downstream of the TATA box [197]. Given that core transcriptional 
machinery is strongly conserved in eukaryotes [340], it is likely that the identified 
initiator regions in Y. lipolytica have some impact the transcription process. Therefore, 
the significance of initiator sequences for transcriptional regulation needs to be further 
examined. 
The experimental set up to test for the effect of initiator sequences is similar to the 
process explained above for TATA elements. In this instance, we have mapped out 
putative initiator sequences in four core promoters, therefore, we have an idea of the 
sequence length that needs to be randomized using oligos.  
In Chapter 3, we set out to engineer the first hybrid fatty acid inducible promoter 
by identifying a key promoter element for transcription, enhancer binding regions, found 
within UASs. The focus, however, was to search for UAS elements that elicited inducible 
activation towards fatty acids.  The POX2 promoter of Y. lipolytica was used because it 
was induced by fatty acids and repressed in glucose and oleic acid [110]; however, its 
inducibility was weak, which makes its application in metabolic engineering limited. A 
heuristic approach was used to dissect the native promoters and fused to a GFP 
fluorescence reporter to quantify expression strength. We identified three oleic acid-
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inducible UASs, A1, R1, and A3 via truncations of the promoter. Tandem repeats of R1 
enabled strong activation when oleic acid was used as an extracellular inducer. 
Substituting in stronger core promoters led to higher activation of the hybrid promoter. 
The strongest hybrid promoter had an ~10-fold increased activation in oleic acid 
compared to the native POX2 promoter.  
The promoter was truncated such that we conserved the putative YlPOR1p 
binding sites within the truncations. Furthermore, in Chapter 4, we discuss DNA 
accessibility in relation to where the POR1p motifs are located on the promoter. 
However, to date, there has been no direct line of evidence suggesting that POR1p 
physically binds the POX2 promoter. BLAST analysis of the POR1p reveals a conserved 
DNA binding and activator domain belonging to the zinc finger transcription factor 
family.  
We should first demonstrate that POR1p binds to the POX2 promoter, and to 
determine DNA binding specificities to leverage this information towards building a 
library of hybrid promoters using smaller, well defined yet optimal UASs. As discussed 
in this dissertation, a commonly used approach to building stronger hybrid promoters 
relies on using tandem repeats of UASs. If the binding affinity of a transcription factor is 
weak in a UAS, then the tandem repeats of a UAS improves transcription strength by 
increasing number of transcription factors, thereby increasing the strength of 
transcription. The more efficient method would be to use few UASs containing motifs 
with higher binding affinity sites. The question remains as to how we search for these 
motifs.  
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To answer this question, I recommend an in vivo approach to determining POR1p 
DNA binding motifs by not only looking at the POX2 promoter but the whole genome. 
Chromatin Immunoprecipitation (ChiP) combined with either PCR tiling arrays or high 
throughput sequencing (ChiP-seq) can be used to locate POR1p binding sites in the 
POX2 promoter or the entire genome. POR1p attached to an epitope tag (Myc, V5 or 
HA) can be immunoprecipitated using antibodies after crosslinking the cells in 
formaldehyde (Figure 6.2). Proteinase digest of the pull-down should expose DNA 
protected by POR1p. 
In addition to elucidating the role of POR1p, we are also interested in identifying 
other co-regulators that associate with POR1p to mediate transcription. For this, I 
recommend ChiP combined to tandem mass spectrometry (ChiP-MS). The crosslinked 
and immunoprecipitated protein sample is subjected to enzymatic or chemical 
degradation to produce peptides that can then be sequenced using MS. The peptide 
sequences can be blasted against the Y. lipolytica protein database to identify the 
transcription factors.  
Usually, ChiP this may yield a larger than desired library of proteins due to non-
specific binding of the antibody or proteins. Therefore, there may be a need to narrow 
down the pool of proteins that are potential co-regulators. For this purpose, I recommend 
a yeast 2-hybrid promoter using POR1p as the bait and other identified proteins (preys) 
fused to a well-characterized activation domain. Using this system, we can elucidate the 
mechanism of oleic transcription activation and apply this system to engineer new types 
of hybrid promoters in Y. lipolytica. 
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In Chapter 4, we wanted to investigate whether UASs in native promoters can be 
identified by scanning DNA accessibility on the promoter. To test this, we used the fatty 
acid inducible POX2 promoter that was characterized in Chapter 3. The conclusion from 
this chapter was that we could begin to investigate new UASs based on differences in 
DNA accessibility between conditions that induce or repress transcription. Choosing 
UASs using this method reduces the number of combinations of UASs to be tested 
compared to using a truncation method in Chapter 3 that can generate many truncated 
sequences. 
 We would like to test this in other native promoters where there is no 
understanding of transcription factors or putative binding sites. We hope to determine 
whether differences in DNA accessibility across the promoter can guide the selection of 
UASs. We are currently in the process of testing this on another promoter that is induced 
by glycerol [224] from the gene, glycerol kinase (YlGUT1) that converts glycerol to 
glycerol-3-phosphate (G3P) [341]. Prior to publishing work in Chapter 4, there are other 
aspects of the project I would recommend testing, detailed below. 
 Recently, it was reported that there is an inherent bias in mononucleosome DNA 
preparation using micrococcal nuclease (MNase) [342]. Higher MNase activity by using 
higher concentrations of MNase releases mononucleosome DNA from regions of low 
DNA accessibility while low MNase activity has been used to map positions of “fragile” 
nucleosomes, which are nucleosomes harboring post-translational modification that make 
its interaction with DNA weak [343]. Crosslinking the histones to DNA can mitigate this 
issue. The approach that we used to “standardize” occupancy maps was to test more than 
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one MNase concentration and choosing a sample that showed a >90% mononucleosome 
DNA fraction but this still does not remove the inherent bias that MNase cleavage can 
have on reliably determining nucleosome probability. 
 The purpose of nucleosome profiling is to quantify the probability of a 
nucleosome forming in a region of the promoter in a DNA. When two nucleosomes are 
close to one another, and if the probability of this event happening is high, our data can 
be skewed by the MNase digestion affinity to separate the two nucleosomes because they 
are in proximity to one another. This leads to different populations of MNase-resistant 
and MNase-sensitive nucleosome that biases the DNA accessibility profiles (Figure 6.2).  
 My recommendation to troubleshooting this issue is (1) test nucleosome profiles 
for more than one MNase digestion condition and see if the DNA accessibility profiles 
are reproducible (2) attempt another method such as sonication to shear DNA into 
mononucleosome fragments after crosslinking, and (3) using ChiP to separate association 
of transcription factors and nucleosomes in DNA accessibility profiles. 
 When MNase digestions are performed, more than one digestion condition can 
provide greater than >90% mononucleosome DNA fractions. At this point, it is left up to 
the discretion of the experimenter to select a sample to move onto PCR tiling for DNA 
accessibility profiles. My recommendation here is that if we have more than one 
digestion condition that yielded >90% mononucleosome DNA fraction, then we should 
do DNA accessibility on all MNase digested samples with very high mononucleosome 
DNA and investigate the reproducibility of the profiles. We need to access the level of 
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variability and determine whether this could significantly affect our experimental goals, 
i.e. to efficiently identify UAS elements on the promoter. 
 My second recommendation is to attempt another method to retrieve 
mononucleosome DNA. If the chemical means such as MNase activity causes technical 
bias, then a physical process of preparing mononucleosome DNA such as sonication 
should be used to investigate if it is a better solution. 
 My final recommendations for Chapter 4 are to separate the difference between 
transcription factor binding to the DNA and nucleosomes occupancy. To obtain DNA 
accessibility profiles in Chapter 4, we used formaldehyde crosslinking to covalently bind 
the nucleosomes to the DNA, however, this also covalently binds transcription factors to 
the DNA (Figure 6.1B). How transcription factors bind to DNA in the presence of 
nucleosomes can vary depending on the type of mechanism. In S. cerevisiae alone, 
nucleosome eviction [277] and sliding [280] have been reported. More recently, 
nucleosome “loosening” due to post-translational modifications enable transcription 
factors to access binding motifs wrapped in nucleosome [342]. This mechanism does not 
change nucleosome profiles. Therefore, looking at the DNA accessibility data in the 
presence and absence of transcription factors can provide some mechanistic insight into 
transcription factors association with nucleosomes to regulate gene expression.    
 One method I propose is to investigate DNA accessibility without crosslinking 
with formaldehyde (Figure 6.1C). Transcription factors are known to have weaker DNA 
interactions that nucleosome. Without crosslinking, transcription factors would 
disassociate from the DNA easily. This experiment will be difficult to interpret because 
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crosslinking fixes nucleosomes to DNA that are otherwise dynamic. Without 
crosslinking, nucleosome can move during MNase treatment but the extent of this effect 
is not known in S. cerevisiae or Y. lipolytica. Without crosslinking, we would also not be 
protecting fragile nucleosomes on the promoter. The results from this experiment 
compared to the crosslinking data would be beneficial to predict promoter regions where 
nucleosomes have undergone post-translational modifications or regions protected by 
transcription factor complexes. Without performing the experiment, it is difficult to 
determine how important this data would be to better elucidate transcriptional regulation 
via nucleosomes and transcription factors.  
 ChiP for histones is a better-suited method prevent the interference of histones 
being dynamic and yet provide us with nucleosome occupancy data in the absence of 
transcription factor-DNA interactions. Cross-linking is possible in this step and 
immunoprecipitation is done using histone antibodies or beads targeted at histone 
modifications [344]. The difference in nucleosomes profiles between of histone 
modifications between repressed and induced conditions can provide insight into 
potential UASs.   
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Figure 6.1. ChiP can be used for the detection of protected DNA regions either protected 
by nucleosomes and transcription factors via crosslinking or nucleosome protected DNA 
by not crosslinking linking the reaction. Protected DNA on a single locus of the genome 
can be analyzed using PCR Tiling or protected DNA across the entire genome can be 
sequencing using a high throughput sequencing technique. 
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Figure 6.2. MNase digestion can bias DNA accessibility profiles based on cutting 
efficiency of the MNase. This biases nucleosome occupancy data that should capture 
probability of finding a nucleosome in a given region of the promoter.   shows MNase 
cleavage sites 
 
In Chapter 5, a novel pathway for fatty alcohol production is examined in Y. 
lipolytica by docking the final step of the enzymatic reaction, conversion of fatty acyl-
CoA to fatty alcohol, inside the peroxisome using a peroxisome targeting signal (PTS). 
The enzyme used to convert fatty acyl-CoA to fatty alcohols is a fatty acyl-CoA / 
aldehyde reductase (FAR) from Marinobacter aquaeoli, MAACR. We demonstrate that 
by engineering the strain to produce intracellular fatty acids, upwards of 500 mg/L fatty 
alcohols can be produced, although additional work needs to be done to improve the 
efficiency of the process. The current process yields 7 mg fatty alcohols / g glucose. The 
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future work for Chapter 5 will address two key issue. (1) Improving the efficiency of 
fatty alcohol biosynthesis in Y. lipolytica, and (2) characterization of the fatty acid hybrid 
promoter for future strain engineering applications.  
 The work demonstrated in Chapter 5 is a promising route for fatty alcohol 
production, however, there are different aspects of the metabolic pathway that need to be 
addressed to improve its efficiency. These are separated into modules as depicted in 
Figure 6.3. 
 
Figure 6.3. Five modules identified to improve the efficiency of engineering fatty alcohol 
production in Y. lipolytica. 
 
 
Module 1:  
Improving final reaction step. Figure 5.6A showed that attempting to increase 
fatty acyl-CoA inside the peroxisome, by overexpressing YlAAL1, led to lower fatty 
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alcohol production. Fatty acyl-CoA are direct precursors for MAACR therefore, we 
anticipated that this strategy would yield better fatty alcohol titers. One hypothesis to 
explain this result is that the expression of MAACR is not optimal because the MAACR 
is not codon optimized for Y. lipolytica. The MAACR is being expressed using the 
UAS1B8-TEF hybrid promoter, shown to be strong and constitutively expressed [82]. 
However, codon biases in microbes can have a large impact on the efficiency of gene 
expression [345].  We believe that codon optimization of MAACR for Y. lipolytica 
should relieve this bottleneck.  
Additionally, two more FARs, MmFAR1 (mouse) and TaFAR1 (barn owl) will be 
tested in Y. lipolytica to observe if better fatty alcohol production and different chain 
length specificities can be attained. We are unable to produce C14 alcohols although the 
engineered strain, PO1fΔmfe1Δfaa1Δfao1, produces a large abundance of C14 fatty acids 
(Supplementary Figure 5.3B). One of the goals is to investigate whether changing the 
FAR could improve selectivity for C14 fatty alcohol production.   
Module 2: Chain shortening using native β-oxidation.  
One of our primary objectives for compartmentalizing fatty alcohol synthesis to 
the peroxisome was to use the β-oxidation pathway to produce short and medium chain 
fatty alcohols. The work described in Chapter 5 does not test chain shortening since the 
MFE1 knockout in our engineered strain impairs beta-oxidation. To test fatty alcohol 
distribution via natural beta-oxidation, MFE1 function will be restored in the engineered 
strain to create PO1fΔfaa1Δfao1. This strain capable of beta-oxidation and yet 
accumulates fatty acids. Biasing the chain length specificity to short and medium-chain 
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fatty alcohols can be accomplished by knocking out the POX3 gene. POX3 has been 
shown to be a short chain fatty acyl-CoA oxidase [170]. 
Module 3: Dynamic regulation of fatty alcohol production.  
Our current engineering strategy utilizes two constitutively hybrid promoters to 
express AAL1 and MAACR genes encoding enzymes for fatty acyl-CoA and fatty alcohol 
production, respectively. To increase peroxisomal fatty acyl-CoA, AAL1 was placed 
under the expression of an early phase, strong constitutive promoter, PTEF-intron from the 
YlTEF gene of Y. lipolytica. The expression of MAACR was driven by UAS1B8-TEF, a 
strong late phase hybrid promoter. While AAL1 over-expression should have created 
more fatty acyl-CoA precursor for MAACR, a negative effect on fatty alcohol production 
was observed in PO1fΔfaa1Δmfe1Δfao1 + AAL1 relative to the engineered strain without 
AAL1 over-expression. An inadequate pull on fatty acyl-CoA pools as described in 
module 1 coupled to up-regulation of pathways to transport fatty acyl-CoA outside the 
peroxisome to maintain homeostasis could be a reason for the result we observe. I 
propose using a fatty acid inducible promoter to regulate AAL1 expression thereby using 
intracellular fatty acids to dynamically regulate fatty acyl-CoA production inside the 
peroxisome (Figure 6.4). In addition, it would be beneficial to test if improvement to fatty 
alcohol production is attainable via combinations of constitutive and hybrid promoters to 
drive expression of the AAL1 and FAR genes. 
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Figure 6.3. Using fatty acids to dynamically regulate fatty acyl-CoA pools inside the 
peroxisome should prevent fatty acyl-CoA build-up. Coupled with constitutive 
expression of a codon-optimized FAR, the process should improve fatty alcohol 
production efficiency. FA = Fatty Acids; FA-CoA = Fatty acyl-CoA; AAL1 = fatty acyl 
CoA synthetase 
 
Module 4: Maintaining high intracellular fatty acid pools.  
While PO1fΔmfe1Δfaa1 and PO1fΔmfe1Δfaa1+AAL1 creates large amounts of 
intracellular fatty acids (>1 g/L), we also observed high levels of extracellular fatty acids 
secreted to the media (Figure 6.4) 
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Figure 6.4. (A) Thin Layer Chromatography (TLC) for analysis of lipids in secreted to 
the media in strains PO1fΔmfe1Δfaa1 and PO1fΔmfe1Δfaa1+AAL1. (B) Visible turbidity 
in media due to fatty acids for both strains.   
 
The same analysis has not been performed on the engineered strain overexpressing 
MAACR, therefore, validating similar extracellular fatty acid accumulation is necessary 
prior to engineering the strain to accumulate intracellular fatty acids.  
 To date, there has been no published record for fatty acid transporters in Y. 
lipolytica, therefore, how fatty acids are transported in and out of peroxisomes or cells are 
unknown. Our results suggest that there may be no current limitation to fatty acid 
transport into the peroxisome to be activated for fatty alcohol production. However, we 
would need to first identify transporters responsible for fatty acid transport in and out of 
the cell to engineer a strain capable of higher intracellular fatty acid accumulation. 
Another strategy would be to bind the internal free fatty acids to fatty acid binding 
proteins. Fatty acid binding proteins have been characterized in Y. lipolytica [346] and 
binding free fatty acids to these proteins are required for activation of fatty acids to fatty 
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acyl-CoA [169]. Currently, there are no data to ascertain whether binding free fatty acids 
to fatty acid binding proteins would prevent fatty acids from being secreted to the 
extracellular matrix. Therefore, this strategy needs to be experimentally tested.  
Module 5: Investigating fatty alcohol production in the cytosol.  
Our immediate goal is to produce fatty alcohols inside the peroxisome. We 
accomplished this knocking out fatty acid activation to fatty acyl-CoA in the cytosol 
(ΔYlFAA1p) while maintaining this function in the peroxisome (YlAAL1p). However, we 
have yet not tested cytosolic fatty alcohol production capabilities of the engineered strain 
by expressing MAACR in the cytosol of Y. lipolytica. This would establish if fatty 
alcohol production predominantly occurs in the peroxisome for the current engineered 
strain. From an efficiency standpoint, this is important because we want to leverage 
peroxisomes for chain shortening and therefore, if significant fatty alcohols are produced 
in the cytosol, we would need to revisit our strategy and re-engineer the strain. 
Furthermore, this experiment would inform us whether there is a need to delete fatty 
alcohol oxidase deletion, ΔYlFAO1, which is cytosolic. FAO1p is responsible for the 
degradation of fatty alcohols. 
Final Recommendation: Further characterization of the fatty acid hybrid promoter 
In Chapter 3, we demonstrate the development of a hybrid promoter that is 
inducible by extracellular fatty acids while in Chapter 5, we utilize this hybrid promoter 
to profile real-time changes in intracellular fatty acid. What has not been established to 
date is whether the response from the hybrid promoter is directly related to fatty acids or 
products that are a result of fatty acid being processed. Activation of fatty acids to fatty 
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acyl-CoA is the first step of β-oxidation. In chapter 5, we show that by overexpressing 
the AAL1 enzyme that catalyzes this reaction in the peroxisome, we can observe a 
reduction in fluorescence from the hybrid promoter (Figure 5.5B). This experiment still 
does not tease out if the hybrid promoter is responding to concentrations of fatty acids, 
fatty acyl-CoA or both.  
Therefore, I recommend two experiments to characterize the responsiveness of 
the hybrid promoter. First, we need to knock out the fatty acid activation step inside the 
peroxisome (ΔAAL1) in the fatty acid producing strain, PO1fΔmfe1Δfaa1. AAL1 is the 
predominant fatty acyl-CoA synthetase, which should severely limit fatty acyl-CoA 
production. As a result, the fluorescence signal from the hybrid promoter should increase 
if the promoter is responding to fatty acids. Liquid chromatography coupled to mass 
spectrometry (LC-MS) can then be used to determine fatty acid and fatty acyl-CoA inside 
the peroxisome and total cellular pools. The same analysis should be used on the current 
engineered strain, PO1fΔmfe1Δfaa1 to determine how these metabolite pools change in 
comparison to PO1fΔmfe1Δfaa1Δaal1. 
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Appendix A 
Supplementary Tables for Chapter 2 
 
Supplementary Table 2.1 gBlock® and primer pairs used to construct base hybrid 
promoter containing restriction sites for cloning promoters. 
Name Sequence 
gBlock® GATCCCCCGGGTTCGAAGCTAGCCCTAGGGGCGCGCCATGGTG
AGCAAGCAGATCCTGAAGAACACCGGCCTGCAGGAGATCATGA
GCTTCAAGGTGAACCTGGAGGGCGTGGTGAACAACCACGTGTT
CACCATGGAGGGCTGCGGCAAGGGCAACATCCTGTTCGGCAAC
CAGCTGGTGCAGATCCGCGTGACCAAGGGCGCCCCCCTGCCCT
TCGCCTTCGACATCCTGAGCCCCGCCTTCCAGTACGGCAACCGC
ACCTTCACCAAGTACCCCGAGGACATCAGCGACTTCTTCATCCA
GAGCTTCCCCGCCGGCTTCGTGTACGAGCGCACCCTGCGCTACG
AGGACGGCGGCCTGGTGGAGATCCGCAGCGACATCAACCTGAT
CGAGGAGATGTTCGTGTACCGCGTGGAGTACAAGGGCCGCAAC
TTCCCCAACGACGGCCCCGTGATGAAGAAGACCATCACCGGCC
TGCAGCCCAGCTTCGAGGTGGTGTACATGAACGACGGCGTGCT
GGTGGGCCAGGTGATCCTGGTGTACCGCCTGAACAGCGGCAAG
TTCTACAGCTGCCACATGCGCACCCTGATGAAGAGCAAGGGCG
TGGTGAAGGACTTCCCCGAGTACCACTTCATCCAGCACCGCCTG
GAGAAGACCTACGTGGAGGACGGCGGCTTCGTGGAGCAGCAC
GAGACCGCCATCGCCCAGCTGACCAGCCTGGGCAAGCCCCTGG
GCAGCCTGCACGAGTGGGTGTAAGCTAGCCTCATGTAATTAGT
TATGTCACGCTTACATTCACGCCCTCCCCCCACATCCGCTCTAA
CCGAAAAGGAAGGAGTTAGACAACCTGAAGTCTAGGTCCCTAT
TTATTTTTTTATAGTTATGTTAGTATTAAGAACGTTATTTATATT
TCAAATTTTTCTTTTTTTTCTGTACAGACGCGTGTACGCATGTAA
CATTATACTGAAAACCTTGCTTGAGAAGGTTTTGGGACGCTCGA
AGGCTTTAATTTGCA 
F1 ACAATTTCGAATGCGGTACCCGAATTCCT 
R1 AAGCTTCTGCAGGCATGC 
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Supplementary Figures for Chapter 2 
 
Supplementary Figure 2.1. Identification of predicted transcription initiation sites in the 
TEF and POX2 core promoter region. 
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Appendix B 
Supplementary Tables for Chapter 3 
Supplementary Table 3.1. Detailed list of vectors and primers used to construct hybrid 
promoters tested in this study.    
F1 CCGGGTTCGAAGGTACCAAGGAAGCATGCGATATTCCGGTCCCG
AAACCCGAT  
F2 CCGGGTTCGAAGGTACCAAGGAAGCATGCTTCTCCCCCCTTTCA
CACTCTG 
F3 CCGGGTTCGAAGGTACCAAGGAAGCATGCCCGTCTCCTCTATAT
GTGTATCCG 
F4 CCGGGTTCGAAGGTACCAAGGAAGCATGCAAGTGAGACTGGCG
ATCGG 
F5 CCGGGTTCGAAGGTACCAAGGAAGCATGCGAGAAGCGATCGCC
CGTC 
F6 CCGGGTTCGAAGGTACCAAGGAAGCATGCGGTACCAGCGGGAG
GTTAC 
F7 CCGGGTTCGAAGGTACCAAGGAAGCATGCGGGATACCGGAATA
ACCCTGGCT 
F8 CCGGGTTCGAAGGTACCAAGGAAGCATGCATGTTTGTTTTTCCG
ATCTTTCGG 
F9 CCGGGTTCGAAGGTACCAAGGAAGCATGCCATGAAAACTATAA
CCTAGACTACACG 
F10 CTAAATTTGATGAAAGGGGGATCCCCCGGGTTCCTAGGGATATT
CCGGTCCCGAAACCC 
F11 TTGACGTGGTGAATGTCGCCCGTTCTCACGTGACAAGTGAGACT
GGCGATC 
F12 CCCTAAATTTGATGAAAGGGGGATCCCCCGGGTTCCTAGGCAAG
TGAGACTGGCGATC 
F13 AAGTATATTGAATGTGAACGTGTACAATATCACAATTGGACATG
TTTGTTTTTCCGA 
F14 GAATGTCGCCCGTTCTCACGTGAGCATGCAATTGGACATGTTTG
TTTTTCCGATCTTT 
F15 AAAGTATATTGAATGTGAACGTGTACAATATCACCCCGTCTCCT
CTATATGTGTATCCG 
F16 GTGGTGAATGTCGCCCGTTCTCACGTGAGCATGCCCCGTCTCCT
CTATATGTGTATCCG 
F17 GCACAAGGGGTAGGCGAATGGTACGATTCCGCCCCGTCTCCTCT
ATATGTGTATCC 
F18 AAGGGGTAGGCGAATGGTACGATTCCGCAATTGGACATGTTTGT
TTTTCCGA 
F19 TTCTCCCTCGGCTCTCGGTATTTCAGCATGCTTGTGGTTGGGACT
TTAGCC 
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F20 GACCAGCACTTTTTGCAGTACTAACCGCAGGTGAGCAAGCAGAT
CCTGAAGAACACC 
F21 GATGAAAGGGGGATCCCCCGGGTTCCTAGGCCCGTCTCCTCTAT
ATGTGTATCC 
F22 TTGATGAAAGGGGGATCCCCCGGGTTCCTAGGGATATTCCGGTC
CCGAAACCCCAGAGT 
R1 CTTCAGGATCTGCTTGCTCACCATGGCGCGCCGGCGTCGTTGCTT
GTGTGAT 
R2 CACCAACCCTTCTCCCGATCGCCAGTCTCACTTGTCACGTGAGA
ACGGGCGAC 
R3 CGTGTAGTCTAGGTTATAGTTTTCATGGCATGCTGATATTGTACA
CGTTCACATTCAAT 
R4 CGAAAGATCGGAAAAACAAACATGTCCAATTGTGATATTGTAC
ACGTTCACATTCA 
R5 GTGTAGTCTAGGTTATAGTTTTCATGGCATGCTGAAATACCGAG
AGCCGAGG 
R6 AAGATCGGAAAAACAAACATGTCCAATTGCATGCTCACGTGAG
AACGGGCGAC 
R7 GCCCGAAAGATCGGAAAAACAAACATGTCCAATTGCGGAATCG
TACCATTCGC 
R8 CCCTTGGCTAAAGTCCCAACCACAAGCATGCTGAAATACCGAGA
GCCGAGG 
R9 GCGTGACATAACTAATTACATGAGGCTAGCTTACACCCACTCGT
GCAGG 
R10 ATGTAAGCGTGACATAACTAATTACATGAGTTACACCCACTCGT
GCAGGCTGCC 
R11 GTAGTCTAGGTTATAGTTTTCATGGCATGCGCGGAATCGTACCA
TTCGC 
R12 GTAGTCTAGGTTATAGTTTTCATGGCATGCGGGCAGTGACGGAA
ACGACA 
R13 GGTTTCGGGACCGGAATATCCCTAGGCGGAATCGTACCATTCGC
CTACCC  
gBlock® CCCGCCCACCTCGATCCGGGCATGCCTGCAGAAGCTTTTGTGGT
TGGGACTTTAGCCAAGGGTATAAAAGACCACCGTCCCCGAATTA
CCTTTCCTCTTCTTTTCTCTCTCTCCTTGTCAACTCACACCCGAAA
TCGTTAAGCATTTCCTTCTGAGTATAAGAATCATTCAAAATGGT
GAGTTTCAGAGGCAGCAGCAATTGCCACGGGCTTTGAGCACAC
GGCCGGGTGTGGTCCCATTCCCATCGACACAAGACGCCACGTCA
TCCGACCAGCACTTTTTGCAGTACTAACCGCAGGGCGCGCCTGC
ATCGCATTGGATAGCCATTCTCCGAGTGTTTTAGCGTTAATTAA
AACCACAGAGCATAAAGAGAACCTCTAGCTGGCGATGCTTTGCT
AGCCTCATGTAATTAGTTATGTCACGCT 
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Supplementary Figures for Chapter 3 
 
 
Supplementary Figure 3.1. Additional hybrid promoters tested. A. New promoters were 
designed by combining parts of the POX2 promoter upstream of the POX2 core 
promoter. Activating (A1, A2, A3) sequences and regulatory (R2) sequences were 
defined by 5’ truncations. B. Promoter strength is determined by expression of hrGFP 
and measured as mean fluorescence of an equal number of transformed cells. The data 
are the average of mean fluorescence measurements from biological triplicates. The error 
bars are the standard deviation of biological triplicates. 
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Supplementary Figure 3.2. Engineering stronger fatty acid-responsive promoters based 
on the A1(R1x3)A3 hybrid promoter. A. Schematic of different promoters based on the 
A1(R1x3)A3 promoter. B. Promoter strength is determined by expression of hrGFP and 
measured as mean fluorescence of an equal number of transformed cells. Fluorescence 
from hybrid promoters containing TEF core and intron sequence improves oleic acid 
expression relative to the POX2 native promoter by 5 fold and 10 fold, respectively. 
Glucose samples are shown on the left and oleic acid on the right. C. Promoter induction 
using oleic acid as the carbon source relative to glucose as carbon source. In (B) and (C) 
the data are the average of mean fluorescence measurements from biological triplicates. 
The error bars are the standard deviation of biological triplicates.  
 
 
Supplementary Figure 3.3. Sensitivity and inducibility of the A1(R1x3)A3 hybrid 
promoter. Titration of the A1(R1x3)A3 hybrid promoter with 0.25% - 8.0% oleic acid 
resulted in identical activation. The data are the average of mean fluorescence 
measurements from biological triplicates. The error bars are the standard deviation of 
biological triplicates. Red is 0.25%, Orange is 0.5%, Green is 1.0%, Cyan is 4.0%, Purple 
is 8.0%. 
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Supplementary Figure 3.4. Promoter strength is determined by expression of hrGFP and 
measured as mean fluorescence of an equal number of transformed cells grown in 2% n-
decane or 2% oleic acid. 
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Appendix C 
Supplementary Tables for Chapter 4 
Supplementary Table 4.1: Primer sequences used to create the vectors containing 
mutations to the POR1p binding sites. 
Oligo Sequence Description 
F1 ATTTCCCCGAAAAGTGCCACCTGACGTCTAAGAAA 
CCATTATTATCATGACATT 
Vector Primer 
Forward 
F2 GATGGAGAGCGCCAGACGAGCAGAATAAATAGAC 
AGCGGATCGGGGGAGGGCTGT 
A1 Mutation 
Forward 
F3 AGACGAACAAGTGATAGGCCGAGAGTAAATAACGA 
GGTGGAGTGCACAAGGGGTAG 
R1 Mutation 
Forward 
F4 GTTAAGCTTGTAGCGAATTTCGCTAAATAACATCACC 
CCATACGACGGACACA 
A2 Mutation 
Forward 
F5 GTCCAAATACCCCCGTTTATTCTCTAAATACTCTCGG 
TATTTCACATGAAAACTATA 
A3 Mutation 
Forward 
R1 TAATGTCATGATAATAATGGTTTCTTAGACGTCAGGT 
GGCACTTTTCGGGGAAAT 
Vector Primer 
Reverse 
R2 ACAGCCCTCCCCCGATCCGCTGTCTATTTATTCTGCTC 
GTCTGGCGCTCTCCATC 
A1 Mutation 
Reverse 
R3 CTACCCCTTGTGCACTCCACCTCGTTATTTACTCTCG 
GCCTATCACTTGTTCGTCT 
R1 Mutation 
Reverse 
R4 GTCCGTCGTATGGGGTGATGTTATTTAGCGAAATTC 
GCTACAAGCTT 
A2 Mutation 
Reverse 
R5 TTTCATGTGAAATACCGAGAGTATTTAGAGAATAA 
ACGGGGGTATTTG 
A3 Mutation 
Reverse 
 
Supplementary Table 4.2. gRNA oligos used to create CRISPR based vectors and 
verification primers used in colony PCR. 
gRNA Sequence Purpose 
gRNA_POR1_F 
AATTCCGGGTCGGCGCAGGTTGACGTACT 
CACAAGCCCTGGAAGCTCGGTTTTAGAGC 
TAGAAATAGCAAGTTA 
Forward Oligo 
gRNA_POR1_R 
TAACTTGCTATTTCTAGCTCTAAAACCGAG 
CTTCCAGGGCTTGTGAGTACGTCAACCTGC 
GCCGACCCGGAAT 
Reverse Oligo 
gRNA_CFU1_F 
AATTCCGGGTCGGCGCAGGTTGACGTGAG 
GTCACAGAGACCCCCGAGGTTTTAGAGCT 
AGAAATAGCAAGTTAA 
Forward Oligo 
gRNA_CFU1_R 
TTAACTTGCTATTTCTAGCTCTAAAACCTC 
GGGGGTCTCTGTGACCTCACGTCAACCTG 
CGCCGACCCCGGAAT 
Reverse Oligo 
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POR1_Ver_F ATGTCTTCCAAGGTCAAAGAGGAG 
Colony PCR 
POR1_Ver_R CCTGCTGAAAGTGCATGAGC 
CFU1_Ver_F ATGCTTCCCGAGCTGGAAA 
CFU1_Ver_R GCAAATGGGGCACTGGAATG 
 
Supplementary Table 4.3. Primer pairs used to tile the POX2 native promoter. 
 
Forward Primer Reverse Primer 
1 CACGGTGGGACGTGTCTG CACGTGGCCCAAAAGCTC 
2 CACGGTGGGACGTGTCTG GTGTGAAGCCGGGAGGTC 
3 GACCTCCCGGCTTCACAC AAATGTGGGGGCAGATTCA 
4 GTGACCTCCCGGCTTCAC TGTGGGGGCAGATTCAGA 
5 CGGCTTCACACGTGGTTG GAGATAAAATGTGGGGGCAGA 
6 TCTGAATCTGCCCCCACA CGGTGCGGGGTTTATGTA 
7 CCCCCTTTCACACTCTGCT ACACCTAACGGCGGCTTC 
8 CCGCACCGTTTGGAACTC GGCGCTCTCCATCTGACA 
9 CCGCCGTTAGGTGTGTCA CGTCAACAGTGCCCTTCG 
10 GCAGAACCGAGGGACAGC TGAGAACGGGCGACATTC 
11 CGAAGGGCACTGTTGACG CCAAACAAAGAGGCGGATACA 
12 GAATGTCGCCCGTTCTCA CCAAACAAAGAGGCGGATACA 
13 TCCGCCTCTTTGTTTGGTT CAGGACGATGCAGATGTCTACTTT 
14 TCCGCCTCTTTGTTTGGTT TGGAATGCAGGACGATGC 
15 CCACCCCAATCACATGCT CCTCGGCTCTCGGCCTAT 
16 CCTGCATTCCATCCCACA CCATTCGCCTACCCCTTG 
17 AGAGCCGAGGACGAGGTG CCCGATCGCCAGTCTCAC 
18 CAAGGGGTAGGCGAATGG ATCCCCCATGACCACCAA 
19 CGATCGGGAGAAGGGTTG TCCGCTACTCGTAGTGGTTTTT 
20 TGGTCATGGGGGATAGAATTT CTTGCACTCCCACCATTGC 
21 ACCACTACGAGTAGCGGATTTG CTTGCACTCCCACCATTGC 
22 GCAATGGTGGGAGTGCAA CCGTATTGCCCCGTTTCT 
23 AGAAACGGGGCAATACGG TCGGACTTGTGGCGATTG 
24 CGTCTGTTCAATCGCCACA TGGCGCTTGTCCAGTATGA 
25 CCTGTCAATCATGGCACCAC CTCTGGCGCTTGTCCAGT 
26 ACTGGACAAGCGCCAGAG CCGTCGTATGGGGTGATG 
27 GAATTTCGCCCTCGGACA CAGCTACAATAAGAGAGGCTGTTTG 
28 CACCCCATACGACGGACA CCCGCTGGTACCTGATATTG 
29 CAGGTACCAGCGGGAGGT CCATCTCCAAGCCAGGGTTA 
30 CAGGTACCAGCGGGAGGT TGGACCGACCATCTCCAA 
31 CCCTGGCTTGGAGATGGT TCCAATTGGGGCAGTGAC 
32 CCCTGGCTTGGAGATGGT GCCCGAAAGATCGGAAAA 
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33 TCCGTGTCGTTTCCGTCA AGCAACAGTCCAGGAGACAGA 
34 GCGCCCTCTCCTTGTCTC GAACCAATGGAGGCCAAAG 
35 GCGCCCTCTCCTTGTCTC GACGGGGAGGAACCAATG 
36 TGGACTGTTGCTACCCCATT AGGGAAACCATGCAACCAT 
37 CATTGGTTCCTCCCCGTCT AACATGTGACTGTGGGGAAAA 
38 CCCGTCTTTCACGTCGTC CCCCTTGCACGTCAAAATTA 
39 GGGGTCTAGATGGAGGCCTAA GCCTTGCACCATGTCCAC 
40 ATTGGGGCGAGAAACACG CGGAAAAGCGTCGAATCA 
41 CGTGGACATGGTGCAAGG CGAGAGCCGAGGGAGAAT 
42 GGTTGATTCGACGCTTTTCC CGAGAGCCGAGGGAGAATA 
43 TATTCTCCCTCGGCTCTCG GGTTGCCCGTGTAGTCTAGGT 
44 CCCTCGGCTCTCGGTATT GCGTCGTTGCTTGTGTGA 
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Supplementary Figures for Chapter 4 
 
Supplementary Figure 4.1. Flow Cytometry data for expression of native POX promoter 
fused to GFP.  
 
 
 
Supplementary Figure 4.2. Frameshift mutations to create POf1Δpor1, POf1Δcfu1, and 
POf1Δpor1Δcfu1 strains. 
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Supplementary Figure 4.3. (A) BLAST of YlCFU1p (YALI0D18678) against fungal 
database did not reveal ScADR1p as strong homolog. (B) 65% sequence similarity 
between ScADR1p and YlCFU1p DNA zinc finger binding domain.  
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Appendix D 
 
Supplementary Tables for Chapter 5 
Supplementary Table 5.1: gRNA oligos for CRISPR vectors and primers for PCR 
amplification of genes tested in the study. 
Oligo Sequence Description 
F1 GAGGCCCAGATCCTCTAGAGTCGAAG 
CGGCCGCAGACCGGGTTGGCGGCGTAT 
TEF(404)-
Intron 
F2 GCACTTTTTGCAGTACTAACCGCAGCC 
CCAAATCATTCACAAATCTGC 
AAL-PTS 
F3 TATAAGAATCATTCAAAGGCGCGCAT 
ATGGCCATTCAGCAGGTCCATC 
MAACR-PTS 
F4 GGTCGGCGCAGGTTGACGTAGTTGTTC 
GTTCCACCTCCAAGTTTTAGAGCTAGA 
AATAGC 
Forward Oligo 
F5 GGTCGGCGCAGGTTGACGTATACTACC 
CTCTGGACGTCCGTTTTAGAGCTAGAA 
ATAGCA 
Forward Oligo 
F6  Forward Oligo 
F7 GGTCGGCGCAGGTTGACGTAAGATATG 
AAGATCTACACCAGTTTTAGAGCTAGA 
AATAGC 
Forward Oligo 
F8 TTCCGGGTCGGCGCAGGTTGACGTAGATA 
GGATATCTGCAACCCG 
Forward Oligo 
F9 TTCCGGGTCGGCGCAGGTTGACGTATGCT 
GCATAGCAGTGCACAG 
Forward Oligo 
F10 ATTTGATGAAAGGGGGATCCCCCGG 
CCCAGTTGCAAAAGTTGACA 
Dual gRNA 
vector 
R1 CTGCGGTTAGTACTGCAAAAAGTGC 
TGGTCG 
TEF(404)-
Intron 
R2 GACATAACTAATTACATGAGGCTAG 
CTTACAACTTACTCACATCAATGCC 
AAL-PTS 
R3 ACATAACTAATTACATGAGGCTAGTTAATT 
AATTAGAGCTTAGCGGCAGCCTTTTTTC 
MAACR-PTS 
R4 TGCTATTTCTAGCTCTAAAACTTGGAGGTG 
GAACGAACAACTACGTCAACCTGCGCCGAC 
Reverse Oligo 
R5 CCTCGGGCTCCGAACTTAACGTTTTAGAGC 
TAGAAATAGCAAGTTA 
Reverse Oligo 
R6 AACTTGCTATTTCTAGCTCTAAAACCGGG 
TTGCAGATATCCTATC 
Reverse Oligo 
R7 TGCTATTTCTAGCTCTAAAACTGGTGTAGA 
TCTTCATATCTTACGTCAACCTGCGCCGAC 
Reverse Oligo 
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R8 AACTTGCTATTTCTAGCTCTAAAACCGGG 
TTGCAGATATCCTATC 
Reverse Oligo 
R9 AACTTGCTATTTCTAGCTCTAAAACCTG 
TGCACTGCTATGCAGCA 
Reverse Oligo 
R10 GCTTCCTTGGTACCTTCGAACCCGG 
AAAAGCACCGACTCGG 
Dual gRNA 
vector 
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Supplementary Figures for Chapter 5 
 
 
Supplementary Figure 5.1. GFP expressing strains from Table 5.3. 
 
 
 
Supplementary Figure 5.2. Fatty alcohol production in the PO1f ΔDGA1ΔFAO1 
ΔDGA1ΔFAO1 + FAA1 and ΔDGA1ΔFAO1 + TGL4 strains due to oxidation of 
dodecane resulting in dodecanol (C12:0). Some decanol (C10:0) is observed due to intact 
β-oxidation pathway. 
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Supplementary Figure 5.3. (A) Fatty acid distribution from whole cell lipid analysis of 
PO1fΔfaa1Δmfe1 strain. (B) Fatty acid distribution from TLC extracted FFA component 
of PO1fΔfaa1Δmfe1 strain showing higher proportions of C14:0 FFAs.    
 
 
 
 
Supplementary Figure 5.4. Fatty alcohol production in the PO1fΔfao1, PO1fΔfaa1Δmfe1 
Δfao1 and PO1fΔfaa1Δmfe1Δfao1 + AAL1 due to oxidation of dodecane (C12:0) to 
produce dodecanol. 
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Supplementary Figure 5.5. Fatty alcohol production as a percentage of dry cell weight 
(DCW) in the PO1fΔfao1, PO1fΔfaa1Δmfe1 Δfao1 and PO1fΔfaa1Δmfe1Δfao1 + AAL1.  
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